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The prevalence of injuries from improvised explosive devices (IEDs) in recent U.S. 
military conflicts has highlighted the lack of knowledge of the acute and long-term consequences 
of blast exposure.  Real-world blast exposure is complex and multi-phasic.   It is unclear whether 
the shock wave component of blast exposure (primary blast) can cause traumatic brain injury 
(TBI); however, other blast components, such as tertiary blast (inertial loading mechanics), have 
known potential to injure the brain.  Clinical and in vivo studies suggest that complex blast 
loading of the whole body and head can result in acute and delayed behavioral deficits and 
neurodegeneration, yet tertiary blast exposure or injury to the body can initiate a systemic 
response that complicates understanding of this pathology.  To set safe thresholds for primary 
blast exposure and design headgear that can guard against primary blast, tolerance criteria for 
primary blast specific to brain must be defined.  We developed and validated a model of primary 
blast injury for use with in vitro organotypic hippocampal slice cultures (OHSCs) and 
determined that primary blast without concomitant tertiary blast loading or systemic response 
can injure isolated brain samples.  This work was the first to define a cell death tolerance 
criterion for OHSCs to primary blast and report that the threshold for deficits in neuron function 
was below the threshold for cell death.   
Mild TBI (mTBI) or concussion, by definition, results in an altered mental state that can 
include loss of consciousness (LOC) for less than 30 minutes, dizziness, confusion, and 
retrograde amnesia.  These symptoms typically subside within a week after injury; however, for 
	
	
some patients who experience multiple concussions over a relatively short period, these 
symptoms can persist for a year or longer; persistence of mTBI symptoms is called post-
concussion syndrome (PCS).  Studies suggest an initial mechanical trauma to the brain can 
initiate a period of time during which the brain is more vulnerable to additional injury.  Little is 
known about this phenomenon; therefore the current standard of care for patients suffering from 
concussion is rest and removal from activities with a risk of additional brain trauma.  During 
combat deployment, over 89% of service members reported an incidence of altered mental state 
and over 86% reported LOC following 2 or more exposures to blast.  We evaluated the response 
of OHSCs to repetitive primary blast (shock wave loading) and repetitive tertiary blast (stretch 
injury) separately, characterizing the period of vulnerability that follows an initial insult to define 
safe rest-periods after blast-exposure and better understand pathologies of more complex 
injuries, i.e. combined primary and tertiary blast.  Long-term potentiation (LTP) was 
significantly reduced by 2 primary blast exposures delivered 24 hours apart.  An initial shock 
wave exposure increased tissue vulnerability to subsequent exposure, which lasted as long as 72 
hours but not longer than 144 hours.  Repetitive primary blast exposure also increased microglial 
activation.  Similarly, a single mild stretch injury initiated a period of heightened vulnerability to 
subsequent mild stretch that lasted at least 72 hours but not longer than 144 hours long.  
Repetitive stretch injury significantly increased cell death, nitrite concentration, and astrogliosis 
and significantly reduced LTP.  We also tested delayed administration of memantine as a 
treatment for repetitive stretch injury.  Memantine is approved by the Food & Drug 
Administration for the treatment of Alzheimer’s disease, and preclinical studies suggest 
memantine may be neuroprotective following TBI.  Cell death was reduced and LTP was 
rescued by delayed memantine treatment.  Along with further preclinical and clinical 
	
	
investigation of repetitive primary and tertiary blast exposure, these studies may aid in setting 
safe rest periods and identifying new therapies for service members exposed to blast.   
This research has shown that primary and tertiary blast exposure can injure OHSCs 
causing cell death, altering neuron function, and increase vulnerability to a subsequent exposure.  
These studies expand our understanding of the neuropathology of primary and tertiary blast 
loading and evaluate methods to improve outcome after repetitive injuries with complementary 
strategies including rest periods and drug-treatment.  
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Traumatic brain injury (TBI) can be caused by different mechanical stimuli including an 
impact (such as a blow to the head), acceleration / deceleration of the head leading to inertia-
driven deformation of the brain tissue (closed-head injuries), a penetrating injury such as a gun-
shot wound, or blast exposure that may encompass all of these mechanisms in addition to shock 
wave loading. 1   Symptoms of TBI include, but are not limited to, acute and long-term deficits in 
cognitive function (problem solving, attention, memory, language skills) as well as personality 
changes (impulsivity, irritability, increased apathy, depression, affected emotional response). 
1  Annually in the United States, as many as 1.7 million new cases of TBI occur and the 
socioeconomic cost associated with medical care, rehabilitation, and loss of work for TBI 
patients is estimated to be $76.5 billion. 2, 3, 4  Nearly 250,000 service members have been 
diagnosed with mTBI since 2000. 5  However, these numbers underestimate the countless cases 
of concussion or sub-concussive injury that are unreported and untreated. 2, 3, 6  Given the 
prevalence and significant socioeconomic cost of mTBI, the focus of this thesis is mTBI. 
 
1.1 Traumatic brain injury from blast exposure  
Military service members are a population at increased risk for TBI from blast due to the 
increased use of improvised explosive devices (IEDs) in recent military conflicts. 7, 8, 9, 10, 11, 
12   Blast injury results from exposure to detonation of an explosive.  Blast injury is considered 
the ‘signature injury’ of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom 
(OEF). 12, 13  As much as 80% of all wounds suffered by U.S. service members in OIF and OEF 
were the result of improvised explosive devices (IEDs). 2, 12  The number of TBI diagnoses 
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among U.S. service members has also risen steeply with improved thoracic protection to protect 
the lungs and bowels, which are highly vulnerable to blast exposure, and with increased 
surveillance for brain injuries. 2, 7, 9, 10, 12, 14, 15, 16, 17, 18   
Blast exposure can be complex and multiphasic; injury can be caused by any of the four 
phases of blast in isolation or in combination.  Primary blast injury is a result of the shock wave 
interacting with the body, secondary blast injury is a penetrating injury from shrapnel or other 
ejecta from an explosive, tertiary blast injury is injury from inertial loading of the body, and 
quaternary blast injury encompasses injuries from all other injurious stimuli such as thermal, 
chemical, or radiation exposure. 8, 19, 20  Secondary, tertiary, and quaternary blast injury are well-
studied in the literature in other civilian injury contexts with known potential to independently 
cause injury to the brain. 8, 21, 22, 23  Primary blast is the only unique phase of blast with unknown 
potential to injure brain.  The key mechanical parameters of the shock wave responsible for 
primary blast loading include the peak overpressure, the overpressure duration, and the impulse 
of the positive pressure phase.  Principal strains associated with primary blast exposure are 
predicted to be below 10% with associated strain rates between 100 and 1,000 s-1, which is a 
much lower strain and higher strain rate than that of closed-head impacts that have associated 
strain up to or over 50% and strain rates of up to 100 s-1. 24  
An increasing number of in vivo studies have investigated the effect of blast injury on the 
brain in a number of animal species.  However, these studies, which employed both low and high 
peak pressures as well as short and long durations, present seemingly contradictory conclusions 
as to whether the brain can be injured by primary blast exposure. 25, 26, 27  Other in vivo studies 
have highlighted the difficulty of attempting to deliver primary blast without concomitant rapid 
head acceleration. 28, 29, 30  Uncontrolled acceleration of the head during blast exposure confounds 
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differentiation of the contribution of primary blast-loading (shock wave loading in isolation) 
from tertiary blast-loading (closed-head TBI) to the ensuing pathobiology, which may be the 
source of these discrepancies.  There is a need for experimental models that can investigate the 
effect of isolated primary blast on the brain.  Improved understanding of the potential for primary 
blast to injure brain will inform safety standards and design of headgear to protect the soldier 
exposed to blast. 
We have developed an in vitro model of primary blast that includes a shock tube and 
fluid-filled sample receiver, described in Chapter 2.  In the field, the shock wave impinges on the 
skull, and a translated pressure wave travels through the brain tissue. 8, 31  The receiver serves as a 
surrogate for the skull-brain complex.  Fluid in the receiver translates the pressure wave to the 
cultured tissue surrogates held within, which minimizes sample motion, bulk fluid flow, or wave 
reflections. 32, 33  Therefore, this model can be used to investigate the response of brain samples to 
isolated primary blast.  This blast injury model delivers military-relevant, reproducible, isolated 
primary blast and was employed in this thesis for 1) evaluating the effects of a single primary 
blast on brain tissue (Chapter 2 and Chapter 3), 2) determining primary blast injury tolerance 
criteria (Chapter 3), and 3) characterizing the pathology of repetitive primary blast exposure 
(Chapter 4). 
 
1.2 Repetitive mild traumatic brain injury 
Pathologies resulting from TBI are diverse, occur on a continuum from mild to severe, 
and can affect people of all ages.  In the United States, as many as 330,000 adults experience a 
sport-related concussion or mTBI each year, and it is estimated that over 75% of all TBI 
diagnoses are mTBI. 34  Over 85% of TBIs diagnosed among U.S. service members were mild. 
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35  Symptoms of mTBI include short-term confusion, memory dysfunction at the time of the 
injury, loss of consciousness for less than 30 minutes, headache, dizziness, and fatigue. 36    
Many service members experience multiple blast exposures and report similar symptoms 
to those of repetitive sport-related concussion. 37  During combat deployment, over 89% of 
service members reported altered mental state and over 86% reported loss of consciousness 
following 2 or more exposures to blast. 38  Studies of athletes who have sustained closed-head 
injuries suggest that with each additional concussion, symptoms of subsequent brain injuries 
become worse and recovery time increases. 39, 40  Clinical and experimental studies suggest that 
an initial closed-head mTBI initiates a period of heightened vulnerability during which an 
additional mTBI exacerbates biochemical sequelae initiated by the first injury. 41   Repetitive 
injuries thus interact resulting a combined injury response with damaging effects; once this 
window of vulnerability has been surpassed following the initial injury damaging effects from 
repetitive injury are no longer observed. 42, 43, 44, 45, 46, 47   This phenomenon is not well 
understood, and thus the current standard of care for patients with concussion is rest and removal 
from activities such as sports or active duty where additional injury is likely, until symptoms 
abate. 11, 48  Given this phenomenon and the prevalence of repetitive blast exposure there is much 
interest in the field as to the effect of repetitive blast-loading on brain.  Clinical studies of 
breachers, who are service members that use explosives to break perimeters like locked 
buildings, suggest that repetitive blast may result in brain injury. 49   During training, breachers 
can experience as many as 100 explosive detonations over 5 days of practical training. 
49  Symptoms of repetitive blast have been referred to as “breachers brain” anecdotally and are 
similar to those of sport-related concussion. 49, 50  Breachers may be exposed to primary blast 
without exposure to other blast phases, which suggests repetitive primary blast may cause injury 
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to the brain; however, the brain’s response to repetitive primary blast exposure is unknown.   
We utilized the model of isolated primary blast exposure, described in Chapters 2 and 3, 
to investigate the effect of repetitive primary blast loading on in vitro brain surrogates and to 
characterize the period of heightened vulnerability that follows primary blast exposure (Chapter 
4).  Also in this thesis, we investigated repetitive tertiary blast exposure and characterized the 
period of heightened vulnerability that follows tertiary blast exposure (Chapter 5). Improved 
understanding of the brain’s inherent response to these unique mechanical stimuli will aid in our 
understanding of the brain’s response to repetitive blast loading from a combination of these 
mechanical stimuli. 
	
1.3 Current treatment and prevention strategies for TBI and repetitive mTBI  
For military personnel who sustain concussion, mTBI is evaluated and monitored with 
the Military Acute Concussion Evaluation (MACE) to gauge orientation, immediate memory, 
concentration, and memory recall.  This assessment and the patient’s medical history inform the 
recommended medical care and a requisite 24-hour removal from active duty.  Personnel who 
have suffered two concussions are removed from active duty for a minimum of 7 days; after 3 
concussions a comprehensive concussion assessment by a specialty care provider is also 
required. 11   
The National Football League (NFL) Head, Neck, and Spine Committee have recently 
developed safe-return to play guidelines for the concussed athlete.  The NFL Sideline 
Concussion Assessment Tool 3 (SCAT 3 modified NFL Assessment) along with physician 
evaluation is used to diagnose concussion, to assess whether to remove a player from the active 
roster, and to evaluate a player’s recovery.  As symptoms improve, a player progresses from 
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attending meetings, to exercising, to returning to practice and play, typically over the course of a 
week.  48  
There are no therapeutics approved by the Food & Drug Administration (FDA) for 
treatment of the sequelae of mTBI and repetitive mTBI to prevent more significant cognitive 
dysfunction and neurodegeneration from repetitive mTBIs.  As such, treatment options are 
limited to rest and removing the patient from activity to aid in recovery and prevent additional 
injury.  Return to activity while still vulnerable to further injury may result in significant 
cognitive dysfunction, neurodegeneration, and increased risk for developing neurodegenerative 
brain disease. 28, 51, 52  In this thesis we investigated the duration of heightened vulnerability that 
follows an initial mechanical trauma using pathological, electrophysiological, and biochemical 
outcome measures (Chapters 3 and 4).  
 
1.4 Memantine and neuroprotection  
Memantine is an FDA-approved therapeutic for moderate to severe Alzheimer’s Disease 
(AD) and is also used clinically for treating some patients with Parkinson’s disease (PD). 
53  Memantine is a non-competitive, use-dependent, voltage-dependent N-methyl-D-aspartate 
receptor (NMDAR) antagonist, and is selective for NR2B-containing NMDARs  53, 54  The NR2 
family of NMDA receptor subunits contain a binding site for glutamate, which can be released in 
excess from brain cells upon injury. 55   When the NMDAR is activated, calcium enters the cell.  
Over-activation floods the cytoplasm with calcium, which can burden the mitochondria resulting 
in generation of reactive oxygen species (ROS) and activation of additional injury cascades 
leading to cell dysfunction or death. 56  Memantine is a potentially promising therapeutic for 
mTBI because it blocks cytotoxic effects of low-level, chronic glutamate exposure while 
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allowing for rapid depolarization necessary for normal synaptic transmission. 53, 57  Because of 
this inhibition profile, memantine does not have the negative side effects, such as coma or 
psychosis, that can result from treatment with other NMDAR antagonists. 55, 56, 58, 59  Preclinical 
data suggest that memantine may be neuroprotective in rodents following TBI. 60  Drugs 
currently approved by the FDA with known mechanism of action and toxicology, such as 
memantine, may be amenable for expedited approval for additional indications such as TBI or 
mTBI.  Therefore we investigated the potential for memantine to improve outcome after multiple 
mTBIs. 
 
1.5 Significance  
Nearly 30,000 cases of TBI were diagnosed in 2012 among US service members, and 
over 25,000 of these cases were classified as mTBI.  35   All numbers reported in this study by the 
Department of Defense were for service members experiencing first time incidence of TBI, and 
patients experiencing multiple TBIs in any year of reporting were counted only once. 
35  Therefore, the total incidence of mTBI in the military may be more than 25,000 annually.  
Treating veterans with TBI is roughly 3-5 times more costly than treating veterans without this 
condition.  Among civilians, every year over 75% of the 1.7 million cases of TBI that are 
diagnosed are concussion. 34  Socioeconomic costs associated with civilian TBI are as much as 
$76.5 billion annually. 1, 2, 3, 4, 36  In a study of nearly 3,000 college football players, 6.5% of 
players experienced multiple concussions during the same season of play. 39  Players with a 
history of three or more concussions were 3.0 times more likely to experience additional 
concussion during play than those without a history of concussion. 39  This significant part of the 
civilian and military population is at risk for neurodegeneration, debilitating symptoms, and 
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additional concussions, which may increase risk for significant functional and cognitive deficits 
and future development of neurodegenerative disease. 51, 61, 62, 63, 64  
The injurious effects of shock wave loading on the brain are mostly unknown and so is 
the protective capability of current military helmets against shock wave loading. 65  Improved 
understanding of the effects of primary blast loading on brain and the tolerance criterion of brain 
to primary blast is necessary for setting safety standards for military personnel exposed to blast 
and design of protective equipment that mitigates shock wave exposure.  In Chapter 2, we 
determined that primary blast can cause injury to OHSCs.  In Chapter 3, blast parameters were 
correlated with injury to determine safe exposure levels to primary blast and to evaluate which 
physical components of blast were responsible for causing blast-induced TBI. 31, 32, 66  For many 
types of safety testing, computational models can be used to simulate the effects of injury on the 
body and predict the efficacy of safety equipment prior to its testing in the field.  Tolerance 
criterion of brain to primary blast can be input to computational models of military-relevant blast 
exposure, and simulations can be used to select design and material modifications of headgear to 
prevent injury from blast.  
Service members, such as breachers, may be exposed to multiple blasts; one study 
reported that breachers experienced as many as 100 primary blasts over the course of 5 days of 
practical training, reporting concussion-like symptoms. 67  Not only is the effect of primary blast 
of brain unknown, but also the effect of repetitive primary blast loading of brain is unknown.  
Service members who have experienced primary blast exposure may risk more severe brain 
injuries when returned to active duty before they have fully recovered from the initial assault.  
Safe rest periods, which we evaluated in Chapters 4 and 5, can be used to remove the soldier 
from active duty where there is increased risk of additional injury while his or her tolerance to 
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additional injury is reduced.  We also determined the effect of repetitive primary blast (shock 
wave loading) and the effect of repetitive tertiary blast (stretch injury) on OHSCs.  By comparing 
the differences in pathobiology of these two distinct mechanical injuries, we may advance 
understanding of more complex blast injuries experienced by service members in the field, 
improving safety and injury prevention standards.   
While safe rest periods may be a useful injury prevention strategy, there is still a need for 
therapeutics to treat concussion or prevent synergistic injury in the event of repetitive injury.  
Memantine, which we evaluated in Chapter 6, may reduce the socioeconomic cost of mTBI for 
civilians and US service members.  In our preclinical study, delayed administration of 
memantine following each of two mild stretch injuries prevented cell death and astrogliosis and 
rescued LTP deficits caused by repetitive stretch injury.  Given that memantine is an FDA-
approved therapeutic for AD, memantine may be more successful in translational studies and 
approval processes for an additional indication of mTBI.    
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2 Methodology for inducing blast injury to in vitro organotypic 
hippocampal slice cultures 1  
2.1 Introduction 
The prevalence of injuries to service men and women resulting from improvised 
explosive devices (IEDs) in recent U.S. military conflicts has highlighted the knowledge-deficit 
that exists concerning the acute and long-term human health threat of blast-induced traumatic 
brain injury (bTBI).  Since 2001, nearly 80% of all U.S. service member casualties in Iraq and 
Afghanistan have been the result of IEDs, and the incidence of bTBI has increased sharply.  68, 69, 
70, 71  The total number of service members reported to be affected by traumatic brain injury 
(TBI) from 2000-2011 is over 220,000.  72  Experimental studies have shown that exposure to 
blasts below the threshold for pulmonary injury can result in acute and delayed behavioral 
deficits and neurodegeneration.  73, 74, 75, 76, 77, 78  In light of these studies, there is an urgent need to 
develop an injury risk-function for bTBI and to improve our understanding of the mechanisms 
that lead to acute and long-term deficits resulting from bTBI.    
Real-world blast loading can be exceedingly complex; therefore, simplified experimental 
models are necessary to begin developing blast injury risk-functions for brain tissue before 
investigating more complex conditions. 79   Peak overpressure, duration, and impulse of the 
positive pressure phase have been shown to be key parameters influencing the severity of bTBI.  
76, 80, 81, 82, 83   In our system, a compressed gas shock tube was used to reproduce a free-field blast 
wave (i.e. a Friedlander wave) characterized by a fast-rising overpressure with an exponential 
																																								 																				
1	A modified version of this chapter previously appeared in print: Effgen GB, Hue CD, Vogel EW, Panzer MB, 
Meaney DF, Bass CD, Morrison B III. A multiscale approach to blast neurotrauma modeling: Part II: Methodology 
for inducing blast injury to in vitro models, Front. Neurol. 2011, 3, p 23. 
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decay into a negative pressure phase.  This idealized blast injury model has been used 
extensively to study the effects of primary blast on the body.  73, 76, 80, 81, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 
93  
In vitro biological models offer several advantages including ease of accessibility, 
allowing the sample to be viewed directly and functional or biochemical measures to be taken 
before and after injury at multiple time points.  Serial sampling helps to determine the evolution 
of the pathology for identification of not only therapeutic targets but also critical delivery time 
points to treat bTBI.  In vitro injury models have the added advantage of precise control over the 
injury biomechanics.  Taken together, these advantages make it possible to correlate biological 
outcome measures to injury parameters for defining tissue-level tolerance criteria.  This is an 
advantage over using computational models to deduce the tissue-level injury criteria, since 
computational models can be highly sensitive to assumptions, including material properties, 
loading conditions, and interface parameters.  In vitro blast injury lays a strong foundation for 
the development of bTBI models with increased complexity, facilitating a correlation between 
microscopic physiological damage witnessed in vitro to macroscopic damage and behavioral 
deficits in vivo.    
In vitro models have increased our mechanistic understanding of TBI caused by blunt 
trauma or inertial mechanisms (i.e. motor vehicle accidents, falls, assaults) for both the initiating 
biomechanics and the ensuing pathobiology.  94, 95  The development of in vitro blast injury 
models that recapitulate intracranial blast physics could accelerate future bTBI research in a 
similar manner.  For this reason, we have developed an in vitro blast injury model that provides 
precise control of the overpressure biomechanics for correlating loading parameters to the living 
biological response.  96   To reproduce the intracranial milieu where the shock wave is translated 
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to a fast-rising pressure wave, tissue cultures were submerged in a fluid-filled reservoir to 
simulate the surrounding brain.  The resulting effect is an increase in the duration of the external 
pressure input that replicated pressure histories measured within the brain in experimental 
studies.  97, 98, 99, 100  Of particular significance, the blast injury methodology described here is 
compatible with many in vitro biological preparations with only minor adjustments;  96  we 
present data utilizing models of the brain parenchyma (organotypic hippocampal slice culture, 
OHSC) and the blood-brain barrier (BBB).  This work is in conjunction with complementary 
characterization of test devices for in vivo and in vitro blast injury and methodology for their 
implementation with in vivo models.  
 
2.2 Materials and Methods 
2.2.1 Shock tube 
Blast overpressures were generated with a 76 mm diameter aluminum shock tube with an 
adjustable-length driver section (25 mm used for the current studies) pressurized with helium and 
a 1240 mm long driven section.  96   The diaphragm was composed of polyethylene terephthalate 
(PET) membranes, and the thickness of the diaphragm was varied to control the burst pressure.  
Three piezoresistive pressure transducers (Endevco, San Juan Capistrano, CA) flush-mounted at 
the exit of the shock tube and oriented perpendicular to the direction of propagation recorded 
side-on pressure.  Analog outputs from the transducers were conditioned using instrumentation 
amplifiers (gain of 50) and low-pass filters (corner frequency of 40 kHz, Alligator Technologies, 
Costa Mesa, CA).  Signals were digitized with an X-series data acquisition card at 125 kHz using 
LabVIEW™ 2010 (National Instruments, Austin, TX).  Peak overpressure, duration, and impulse 
were calculated with custom MATLAB code (Mathworks, Natick, MA).  Room temperature, 
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ambient pressure, tank pressure, and regulator settings were recorded for each blast.   
 
2.2.2 In vitro receiver 
Cultures were placed in a fluid-filled blast receiver designed for use with the shock tube.  
96   The in vitro blast injury receiver was composed of a polyethylene 57 L reservoir with a 
polycarbonate test column.  The test column extended into the reservoir through a diverging 
nozzle.  The geometry of the receiver resulted in the mitigation of the majority of the internally 
reflected pressure waves to reduce subsequent mechanical loading of the tissue.  The end of the 
shock tube was placed flush with the top of the receiver and centered on its vertical axis.  





Figure 1 Schematic of the shock tube with receiver.   
A) A compressed helium source was connected to an adjustable driver section of the shock tube, 
which was aligned vertically over the sample receiver. In-air transducers were located at the exit 
of the shock tube. B) The sample within a bag rested on top of a PTFE membrane within the 
fluid-filled sample receiver. Submersible transducers were located directly above the sample bag 
and below the PTFE membrane. 
 
The test column was separated from the reservoir by a 250 µm thick 
polytetrafluoroethylene (PTFE) membrane to restrict bulk fluid motion.  A PTFE membrane was 
secured in the middle of the test column for a reproducible sample location in the receiver. A 
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silicone membrane (Specialty Manufacturing Inc., Saginaw, MI) was secured to the open end of 
the test column with a hose clamp to prevent spray.  Membrane materials used in the receiver 
were carefully chosen for impedance matching with water to prevent unintended reflections.  
Inclusion of air bubbles was meticulously prevented. 
The receiver was filled with water maintained at 37°C with a heating element (Innomax, 
Denver, CO) affixed to the receiver for all in vitro blast injuries and blast characterizations.  The 
water temperature in the test column was verified and recorded prior to and following each blast 
injury.  
To characterize the loading of the culture sample, two submersible pressure transducers 
(Millar Instruments, Houston, TX) were inserted into the test column adjacent to the sample.  
The face of each transducer was oriented into the direction of wave propagation.  Data from 
these transducers were recorded as described above.   
 
2.2.3 Organotypic hippocampal slice culture 
All animal procedures were approved by the Columbia University Institutional Animal 
Care and Use Committee (IACUC).  According to previously published culture methods, P8-10 
Sprague-Dawley rat pups were decapitated, and their brains were removed.  101, 102, 103, 104, 
105   Hippocampi were excised and sectioned into 400 µm thick slices using a McIlwain tissue 
chopper (Harvard Apparatus, Holliston, MA).  Slices were separated aseptically in ice-cold 
Gey’s salt solution supplemented with 25 mM D-glucose (Sigma, St. Louis, MO) using blunt, 
plastic spatulas (Fisher, Pittsburgh, PA).  Slices were plated onto porous Millipore Millicell cell 
culture membranes (Millipore, Billerica, MA).  Slices were initially fed with Neurobasal medium 
supplemented with 1 mM L-glutamine, 1X B27 supplement, 10 mM HEPES, and 25 mM D-
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glucose (Invitrogen, Carlsbad, CA).  Culture medium was changed to conditioned full-serum 
medium (50% Minimum Essential Medium, 25% Hank’s Balanced Salt Solution, 25% heat 
inactivated horse serum, 2 µM L-glutamine, 25 mM D-glucose, 10 mM HEPES, Sigma) 3 days 
following plating.  OHSC were subsequently fed with conditioned full-serum medium every 2-3 
days.  OHSC were cultured at 37°C and 5% CO2. 
After 10-14 days in culture, the baseline health of OHSC immediately prior to injury was 
assessed by quantifying pre-injury cell death with the fluorescent stain propidium iodide (PI, 
Invitrogen).  OHSC with PI fluorescence greater than 5% in any region (DG, CA3, CA1) were 
not included in the study (see 2.7.1 OHSC cell death quantitative analysis). 
 
2.2.4 Blast injury 
Prior to placing cultures in the receiver, individual culture wells were sealed inside sterile 
bags to prevent contamination, maintain medium pH, minimize bulk flow immediately around 
the sample, and minimize waste of culture medium.  Small sterile bags made of 57 µm thick, low 
density polyethylene (Whirl Pak, Fort Atkinson, WI) were filled with pre-warmed, serum-free 
culture medium that had been equilibrated with 5% CO2/ 95% O2 for 10 minutes.  Care was 
taken to prevent entrapment of air bubbles.  The culture and the bag were submerged in the test 
column of the receiver and oriented perpendicular to pressure wave propagation.  
Injured cultures were subjected to a single blast exposure.  Following blast exposure, the 
bag with the culture was immediately removed from the receiver, and the culture was returned to 
fresh, serum-free medium and incubated.  Sham-exposed samples were sealed into bags with 
equilibrated, warmed, serum-free medium and submerged in the receiver for an equivalent 
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period, but the shock tube was not fired.  Resultant cell death was measured 4 days following 
blast injury given the delayed cell death response of OHSC exposed to stretch injury.  94, 101, 102, 
104, 105, 106  
 
2.2.5 Excitotoxic injury 
After OHSC had been imaged for blast-induced cell death, total cell death resultant from 
an excitotoxic injury was induced. OHSC medium was switched to a 10-mM glutamate solution 
in serum free medium. Cultures were incubated for 3 h and then returned to fresh serum-free 
medium. Cell death resulting from excitotoxic injury was determined 24 h later with PI staining 
and imaging (see OHSC Cell Death Quantitative Analysis). 
 
2.2.6 Cell death quantitative analysis 
PI fluorescence was used to quantify cell death prior to and 4 days following injury and 1 
day following excitotoxic injury.  OHSC were incubated in 2.5 µM PI in serum-free medium for 
1 hour before imaging.  Images were acquired using an Olympus IX81 microscope with 568/24 
excitation and 610/40 emission filters.  Following imaging, cultures were returned to fresh, 
serum-free medium.  Cell death was determined for specific OHSC regions (DG, CA1, CA3), as 
previously described, using MetaMorph (Molecular Devices, Downingtown, PA.  101, 103, 104, 105, 
106   In brief, the same threshold for fluorescence was used to analyze all images at each time 
point. Tissue damage at a given time point was quantified as the percentage area of a specific 
region exhibiting fluorescence above the threshold.  Changes in percent cell death were 




2.2.7 Statistical analysis 
A univariate general linear model was used to analyze the complete data set for each 
region of the OHSC with cell death as the dependent variable and experimental group (sham, 
injured) as the fixed factor (SPSS v. 19, IBM, Armonk, NY, USA, significance *p <0.05).  
 
2.3 Results 
2.3.1 Characterization of the in vitro blast injury model 
Characterization of the shock tube was performed without the receiver in place (Figure 
2).  Pressure time-histories recorded at the end of the shock tube were typical of a Friedlander 
wave (Figure 2B) and demonstrated good inter-test consistency (Figure 2A).   Duration of the 
positive pressure phase was correlated with peak overpressure, and the relationship was well-
defined by a second-order polynomial fit (Figure 2C).  The impulse was also correlated with 





Figure 2 Characterization of the open shock tube.    
A) Three in-air pressure transducers located equidistant around the exit to the shock tube 
recorded pressure transients in-air for blast of a 1.5 mm thick PET burst membrane.  The peak 
overpressure (denoted by point C) for this blast was 534 kPa with a duration of 1.040 ms and an 
impulse of 184 kPa·ms.  B) The output of the shock tube was similar in shape to the Friedlander 
wave, which models the primary blast produced from an explosion in the free-field.  C) For the 
open shock tube, the durations were plotted as a function of the peak overpressures for each blast 
and fit to a second-order polynomial (n = 78).  D) For the open tube, the impulses were plotted as 




Placement of the receiver below the shock tube significantly altered the pressure recorded 
by the transducers at the end of the shock tube (Figure 3A).  Similar to the principles of 
transmission for acoustic waves, the pressure history revealed two waves produced from the 
interaction of the incident shock wave with the top surface of the fluid-filled receiver. The 
incident pressure of the shock wave exiting the shock tube (Figure 3A, point ‘I’) remained 
discernable in the pressure trace as the first peak. However, the subsequent, larger peak (Figure 
3A, point ‘R’) was due to the shock wave reflecting off the liquid surface and re-entering the 
shock tube.  The presence of the receiver effectively altered the pressure history, affecting the 
peak pressure, duration, and impulse.  These parameters were highly sensitive to the placement 
and interaction of the receiver with the shock wave, so we have chosen to characterize the 
applied blast loading by the pressure history in the open tube configuration and by the pressure 
experienced directly by the biological sample.  107   The close temporal relationship and the 
significantly higher magnitude of the pressure of the reflected wave can make it difficult to 
identify the peak pressure of the incident shock wave.  Misappropriation of the reflection as the 
incident shock could confound interpretation of the loading conditions and lead to the erroneous 





Figure 3 Characterization of the shock tube and fluid pressures with receiver in place.  
 A) An in-air pressure transducer (blue trace) located at the exit of the shock tube recorded 
pressure transients in-air for a shock produced from a 508 µm thick burst membrane with the 
receiver in place.  The peak pressure in-air of the incident shock wave upon exiting the shock 
tube is denoted by “I”, and the peak pressure of the reflection is denoted as “R.”  Two 
submersible transducers, located above or below the sample holder (including culture well, bag 
and PTFE membrane; red and green traces, respectively) demonstrated the absence of 
attenuation through the in vitro set-up.  B) The peak overpressures from the submersible 
transducer below the sample holder were correlated to peak pressures measured by the in-air 
transducers.  C) The durations within the fluid-filled receiver were plotted against peak 
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overpressures measured within the fluid-filled receiver, with no correlation to pressure found.  
D) The impulses within the fluid-filled receiver were correlated to peak overpressures measured 
within the fluid-filled receiver and approximated using a linear fit.  
	
Transducers located on the upstream and downstream side of the sample holder (culture 
well, bag, and PTFE membrane) recorded the pressure transients within the fluid-filled receiver 
(Figure 3A).  The peak overpressures measured by the upstream and downstream transducers 
were 405 ± 17.0 kPa and 405 ± 15.0 kPa with durations of 1.8 ± 0.036 ms and 1.8 ± 0.004 ms, 
respectively (n = 3).  These results indicated that the propagation of the pressure wave was not 
affected by the presence of the culture well, bag, or PTFE membrane.  The relationship between 
the peak incident pressure (in air) and the peak pressure in the sample receiver was linear (R2 = 
0.90474) over the pressure range tested (Figure 3B).  As peak pressure increased, the duration 
values remained consistent, increasing slightly over the upper range of pressures but did not 
correlate with the incident pressure (Figure 3C).  The durations ranged from 1.384 ms to 2.248 
ms. Impulse correlated linearly (R2 = 0.9331) to peak overpressure measured in the fluid-filled 
receiver (Figure 3D).  Impulse values ranged from 265.6 kPa·ms to 757.6 kPa·ms. 
 
2.3.2 Primary blast of OHSC 
 Exposure of OHSC to high intensity primary blast increased cell death 4 days following 
blast (Figure 4).  Injured tissue cultures experienced significantly more cell death 4 days 
following blast as compared to sham-exposed samples in all regions of the hippocampus 
(Figure 4A).  Injured tissue appeared darker in bright-field images (Figure 4B), 
indicative of ultrastructural changes inducible by cell death such as mitochondrial 
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swelling. 108  Resultant cell death in injured tissue was isolated to the principal cell layers 
(pyramidal and granule cells) as has been seen 4 days following in vitro stretch-injury of 
OHSC. 101, 102, 104, 106  OHSC exposed to the sham injury maintained healthy morphology 
and experienced minimal cell death over the same time course (Figure 4C).  
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Figure 4 In vitro blast injury of OHSC. 
OHSC were exposed to 554 kPa ± 8.8 kPa peak incident overpressure, 0.992 ms duration ± 0.006 






following blast.  Cell death increased significantly in the DG region of injured OHSC as 
compared to control OHSC (*p < 0.05; SEM; Control n = 4, Injured n = 4).  B) Bright-field and 
fluorescent images of injured tissue revealed edema and significant PI staining 4 days following 
injury.  C) Control cultures maintained normal morphology and experienced minimal cell death 
over the 4 day period following injury. 
	
2.4 Discussion  
Blast exposure tolerance criteria of the brain at the tissue level have yet to be published.  
In vitro models of the brain have proven to be highly predicative of the brain’s response to injury 
in vivo and additionally allow for precise control and characterization of injury biomechanics.  
95   The choice of the blast injury model and its characterization are critical for reproducing 
operationally relevant loading histories.  With a realistic injury model, understanding the energy 
transfer to the tissue and the resultant biological response can begin.  The in vitro blast injury 
model described here benefits from two-fold utility to this end: 1) an easily modifiable receiver 
to accommodate various in vitro biological models and 2) a high degree of characterization for a 
well-defined, direct correlation of primary blast to biological outcomes.  Development of an in 
vitro injury risk-function coupled with a strong understanding of damage mechanisms will 
supplement in vivo studies to facilitate an understanding of the intrinsic and extrinsic signals 
essential in the overall, neurological outcome following blast injury. 
 OHSC were chosen for this study because they have proven to be biofidelic in 
recapitulating the progressive neurodegenerative cascades and delayed cell death observed in 
animal models of neurodegeneration. 94, 95, 101, 102, 104, 109  After blast exposure, cell death in OHSC 
was largely isolated to the principal cell layers in all regions of the hippocampus (i.e. pyramidal 
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and granule cells), similar to cell death patterns observed in in vitro models of inertial injuries 
(i.e. stretch or shear).  Although the biomechanics of blast (low strain, high strain rate) and 
inertial injuries (large strain, relatively low strain rates) are fundamentally different, the similar 
pattern observed suggests that similar cell types are vulnerable to both loading conditions. 94, 101, 
102, 104, 105, 106  Future studies will determine whether the pathobiology initiated by both injuries 
leading to delayed cell death differs.  Studies in the rat have observed dose-dependent induction 
of axonal damage, activation of apoptotic transcription factors, and cell death in the 
hippocampus after exposure to 154 ± 2.2 kPa and 240 ± 3.4 kPa incident overpressure with 
associated 1.7 ± 0.1 ms and 2± 0.1 ms durations, respectively. 78, 110, 111   These changes occurred 
between 2 hours and 21 days following injury, suggesting that blast initiates an extended 
pathobiology that results in progressive neurodegenerative changes.  112   One limitation of these 
findings reported by Kaur et. al. was that the overpressure history was exceedingly complex 
being formed from an explosive charge detonated within a closed bunker. 110   Saljo et. al. 
utilized the same in-air blast injury parameters under more controlled conditions, utilizing an 
explosive-driven blast tube; however, one limitation of their studies was that the thorax was not 
protected during exposure such that the response could have been due to pulmonary effects of 
blast.  78, 111   A primary conclusion from our study is that principal cells of the hippocampus are 
vulnerable to primary blast injury and that the overpressure history need not be complex.  One 
limitation of our study is that we did not investigate the time course of this cell death response; 
therefore we are unable to report whether cell death was acute or delayed.  Future studies are 
necessary to explore the induced pathobiology in more detail, specifically to determine OHSC 
tolerance and mechanisms of cell death.  
Previously published in vitro models of bTBI have characterized the incident 
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overpressure but not the loading conditions at the tissue level. 113, 114, 115  Without a tissue-level 
biomechanical context, it is difficult to make quantitative comparisons between biological 
outcomes from different studies given the potential for vastly different loading conditions.  In a 
high-throughput model of blast, rodent and human derived neuroblastoma cell lines were injured 
by exposure to a single overpressure of 145 kPa; however, the study reported the paradoxical 
finding of reduced injury after multiple exposures. 113   For this study, cell cultures in 96-well 
plates were exposed to blast inside the shock tube.  The injury biomechanics at the sample-level 
were not reported.  In a different model, the excised spinal cord was subjected to strains as high 
as 60%, which does not accurately reproduce the low strain, high strain rate biomechanics of 
blast.  114  In each of these previous studies, overpressures were applied directly to the culture 
preparations, which were meant to represent intracranial or other internal tissues.  Because these 
studies did not account for the translation of the shock wave from air into the internal tissues, the 
loading conditions were not representative of internal physiological loading conditions.  Our 
model benefits from a unique fluid-filled receiver, which translated the shock wave in air to a 
fast rising pressure wave to reproduce intracranial biomechanics in situ. 96   In addition the 
receiver allows for measurement of the injury parameters that directly interact with the tissue.  
 Combining tissue culture models with blast modeling held additional challenges related 
to the maintenance of important culture conditions during injury.  Many of these challenges were 
surmounted by encasing the cultures within sterile, fluid-filled bags.  Isolating the cultures from 
the fluid in the receiver prevented infections, which was absolutely required for analysis of cell 
death over 4 days.  To maintain physiologic pH during injury, culture medium was equilibrated 
with 5% CO2/95% O2, which was critical since pH changes can induce excitotoxicity of 
pyramidal neurons  116  and interneurons. 72, 117  The fluid in the receiver was maintained at 37°C 
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to prevent  protection by hypothermia, which is highly neuroprotective in multiple models of 
neurodegeneration.  118, 119, 120  The sample bags also reduced bulk fluid flow in the immediate 
vicinity of the cultures, thereby reducing unwanted tissue deformation after passage of the 
pressure wave.  Critically, we showed that the bag, sample holder, and culture wells did not 
attenuate the passage of the pressure wave.  
 Development and implementation of a simplified model of blast injury for the definition 
of blast tolerance criteria is only a first step towards an understanding of the acute and long-term 
pathobiology of bTBI.  So, there were a number of limitations in this study.  Blast exposure was 
simulated as a Friedlander wave without the complexity caused by reflections that occur 
operationally.  Currently our model is not configured to reproduce more complex blasts but 
could be modified to do so, for example with insertion of materials into the receiver to provide 
surfaces for wave reflection.  96   Preparation of OHSC was a lengthy and technically challenging 
culture process with a culture period of 2 weeks prior to injury to ensure tissue health and 
maturation.  106  Although the shock tube requires minimal set-up, the preparation of the in vitro 
biological samples to prevent infection and control physiologic parameters during exposure 
decreased throughput. 
 With our unique system consisting of a shock tube and a specialized receiver, an in vitro 
model of OHSCs was exposed to simulated blast loading.  Our model was capable of inducing 
cell death in OHSC and disrupting tight junction integrity in our BBB cultures.  Our in vitro 
model benefited from the ability to measure the loading conditions at the level of the cell or 
tissue sample.  Future studies will utilize our well-characterized blast injury model and methods 
along with biomarkers previously shown to be valuable for bTBI to correlate injury 
biomechanics to biological responses.   
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3 Isolated primary blast alters neuronal function with minimal cell 
death in organotypic hippocampal slice cultures2 
3.1 Introduction 
A current controversy is whether shock wave loading, referred to as primary blast, can 
cause damage to the brain in the absence of other injury mechanisms, specifically penetrating or 
inertially-driven brain injury.  An increasing number of experimental studies have investigated 
the effect of blast injury in a number of animal species using shock or blast tube injury models. 
29, 121, 122, 123   However, these studies present seemingly contradictory evidence for tolerance of 
the brain to primary blast, some of which may be attributed to concomitant but uncontrolled head 
accelerations making it difficult to differentiate the contribution of primary versus tertiary injury 
mechanisms to the ensuing pathobiology. 28, 29  Interpretation of some studies is further 
complicated because the thorax was not protected; exposure of the unprotected thorax to blast 
readily damages the lungs and bowels resulting in secondary central nervous system (CNS) 
deficits. 20  
The current study was undertaken to answer two important questions: 1) can a shock 
wave cause brain cell death and 2) what are the safe exposure limits to pure shock wave loading?  
We hypothesized that primary blast exposure can cause injury to the brain because breachers, 
who are exposed to isolated primary blast, report symptoms of concussion or altered mental 
state.37, 28, 49 This data is critical for understanding the pathophysiology of blast and may lead to 
improvements in protective equipment, including combat helmets.  Current military helmets 
																																								 																				
2	A modified version of this chapter previously appeared in print:  Effgen GB, Vogel E III, Lynch, KA, Lobel, A, 
Hue CD, Meaney DF, Bass CD, Morrison B III. Isolated primary blast alters neuronal function with minimal cell 
death in organotypic hippocampal slice cultures, J Neurotrauma. 2014, 31 (12): p 1202-1210. 
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have been shown to be effective at preventing penetrating impact and are somewhat less 
effective at reducing neurotrauma from blunt-impact and inertially driven brain injuries. 39 
However, if a shock wave is capable of causing neurodegeneration or other pathobiology, being 
able to assess the tradeoffs for blast protection is essential for military personnel.  
To determine the safe exposure limits of isolated primary blast without confounds of 
inertially driven injury, we have previously developed a simplified blast injury model comprised 
of a shock tube and sample receiver for exposing organotypic hippocampal slice cultures 
(OHSC) to a shock wave. 31, 32  This unique design translates the primary shock wave in-air to a 
pressure transient in fluid, which interacts with the tissue and has a similar profile to the 
intracranial pressure (ICP) during blast. 31, 32  As previously reported, finite element modeling 
predicted tissue strain to be less than 5%, which is below the threshold for stretch-induced cell 
death in OHSC. 31, 124  This design mitigates the confounding effects of inertial loading (i.e. 
stretch) so that the effects of pure shock wave loading can be studied. 31, 32  
In the present study we investigated acute and delayed hippocampal cell death in 
response to a wide range of relevant blast exposures.  Neuronal function was quantified to 
determine whether blast-induced functional deficits were produced in the absence of cell death.  
Our results suggest not only that a shock wave can kill brain cells, but also that functional 
deficits occur in the absence of cell death.  However, as compared to other mechanisms of injury, 
isolated primary blast exposure resulted in low levels of cell death. 
	
3.2 Materials and Methods 
3.2.1 Organotypic hippocampal slice culture 
All animal procedures were approved by the Columbia University Institutional Animal 
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Care and Use Committee (IACUC).  OHSC were generated as previously described from 
approximately 25 dams and 100 pups.  In brief, P8-11 Sprague-Dawley rat pups were decapitated 
and the brains removed. 124, 125, 126  Hippocampi were excised, sectioned into 400 µm thick slices 
and separated aseptically in ice-cold Gey’s salt solution supplemented with 25 mM D-glucose 
(Sigma, St. Louis, MO).  2-3 slices were plated onto each porous Millipore Millicell cell culture 
inserts (Millipore, Billerica, MA) in Neurobasal medium supplemented with 1 mM L-
GlutaMAX, 1X B27 supplement, 10 mM HEPES, and 25 mM D-glucose (Life Technologies, 
Grand Island, NY).  Every 2-3 days, half of the medium was replaced with full-serum medium 
containing 50% Minimum Essential Medium, 25% Hank’s Balanced Salt Solution, 25% heat 
inactivated horse serum, 2 µM L-GlutaMAX, 25 mM D-glucose, 10 mM HEPES (Sigma, St. 
Louis, MO).  Cultures were grown for 10-14 days prior to testing. 
 
3.2.2 Blast injury 
Blast injury methods have been described in detail previously. 31, 32   In brief, a shock 
wave was generated with a 76 mm diameter aluminum shock tube with an adjustable-length 
driver section (25 mm, 50 mm, and 190 mm used for the current studies) pressurized with helium 
or nitrogen and a 1240 mm long driven section. 31, 32  Piezoresistive pressure transducers 
(Endevco, San Juan Capistrano, CA) were flush-mounted at the exit of the shock tube and within 
the fluid-filled blast receiver, at the location of the culture, and were oriented perpendicular to 
the direction of propagation to record side-on (incident) pressure.  Transducer outputs were 
amplified (50X gain) and low-pass filtered (corner frequency of 40 kHz, Alligator Technologies, 
Costa Mesa, CA) before being digitized at 125 kHz.  Peak overpressure, overpressure duration, 
and impulse were calculated with custom MATLAB scripts (Mathworks, Natick, MA). 32   For 
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in-air and in-fluid pressure histories, peak overpressure was defined as the maximum pressure of 
the positive overpressure phase, duration was defined as the length of time of the positive 
overpressure phase, and impulse was defined as the integral over time under the pressure history 
trace for the duration of the positive overpressure exposure (i.e. area). 
Primary blast levels were chosen for their relevance to real-world blast-loading 
conditions. 7, 17  Among those parameters investigated here, the range of peak overpressures 
tested was 92.7- 534 kPa, the range of durations tested was 0.25- 2.3 ms, and the range of 
impulses was 9.2- 248 kPa·ms determined from in-air measurements (Table 1), which are 
nominally referred to as Levels 1- 9. 
 At the time of experimentation, individual culture wells were sealed inside sterile 
polyethylene bags (Whirl Pak, Fort Atkins, WI) filled with pre-warmed, serum-free culture 
medium containing 75% Minimum Essential Medium, 25% Hank’s Balanced Salt Solution, 2 
µM L-glutamine, 25 mM D-glucose, 10 mM HEPES that had been equilibrated with 5% CO2/ 
95% O2.  These polyethylene bags were specifically chosen because their acoustic impedance 
matched that of water so as not to attenuate the pressure transient, which was validated 
previously. 32   Samples were immediately placed in the fluid-filled receiver, which was also 
maintained at 37 °C.  For injured cultures, the shock tube was then fired; sham cultures were 
treated identically except the shock tube was not fired.  Following blast- or sham-exposure, the 
sample was immediately removed from the receiver and returned to the incubator in fresh, full-
serum medium.  In preliminary studies with naïve OHSC, we found that maintaining cultures in 
serum-free medium caused cell death in the DG.  Therefore, OHSC were maintained in full-
serum medium after blast or sham exposure to eliminate this confounding cell death due to 
serum withdrawal.  
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Table 1: Primary Blast Exposure Levels 






open-tube 1 106 ± 2.2 0.25 ± 0.01 9.2 ± 1.6 
receiver 1 134 ± 1.9 1.5 ± 0.01 88.8 ± 0.02 
open-tube 2 92.7 ± 2.6 1.4 ± 0.01 38.5 ± 0.7 
receiver 2 270.1 ± 15 2.6 ± 0.2 295.1 ± 56 
open-tube 3 190 ± 2.1 1.2 ± 0.01 73.1 ± 1.3 
receiver 3 516 ± 31 1.3 ± 0.03 254 ± 35 
open-tube 4 336 ± 8.3 0.84 ± 0.01 86.5 ± 1.4 
receiver 4 598 ± 15 1.85 ± 0.3 440 ± 13 
open-tube 5 377 ± 8.3 0.89 ± 0.01 95.5 ± 1.5 
receiver 5 817 ± 22 1.53 ± 0.04 472 ± 16 
open-tube 6 469 ± 21 0.99 ± 0.005 143 ± 1.5 
receiver 6 1258 ± 26 1.46 ± 0.02 658 ± 22 
open-tube 7 364 ± 2.8 1.6 ± 0.01 151 ± 1.3 
receiver 7 956 ± 43 3.6 ± 0.1 1258 ± 43 
open-tube 8 534 ± 3.6 1.0 ± 0.007 184 ± 2.1 
receiver 8 991 ± 53 2.1 ± 0.2 686 ± 23 
open-tube 9 424 ± 6.4 2.3 ± 0.3 248 ± 3.4 
receiver 9 1510 ± 91 2.8 ± 0.1 1420 ± 87 
 
Table 1:  Experimental loading conditions were characterized by the primary blast peak 
pressure, duration, and impulse calculated from the pressure histories recorded by pressure 
transducers at different locations.  In-air values (open-tube) are characteristic of the shock tube 
alone without the receiver in place and were determined from pressure histories recorded at the 
exit of the shock tube in the incident configuration.  In-fluid values (receiver) were determined 
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from pressure transducers located in the fluid-filled receiver at the location of the sample 
(±SEM, n≥3). 
 
3.2.3 Cell death quantification 
Propidium iodide (PI) fluorescence was used to quantify cell death prior to and following 
injury at indicated time points.  OHSC were incubated in 2.5 µM PI (Life Technologies) in 
serum-free medium for 1 hour before imaging.  Images were acquired using an Olympus IX81 
microscope with 568/24 nm (peak/width) excitation and 610/40 nm emission filters and a 
CoolSNAP ES camera (Photometrics, Tucson, AZ).  Following the initial imaging to determine 
baseline health, cultures were immediately injured.  At the indicated time points, cell death was 
determined for all regions of interest (ROI: DG, CA3, CA1) of OHSC, as previously described, 
using MetaMorph (Molecular Devices, Downingtown, PA). 124   OHSC were evaluated for cell 
death at one time point only following exposure.  In brief, the same threshold for fluorescence 
was used to analyze all images at each time point.  The threshold was chosen just high enough to 
exclude background signal in pre-injury images of both sham and blast-exposed OHSC.  Tissue 
damage was quantified as the percentage area of a specific region exhibiting fluorescence above 
the threshold.  Any OHSC with 5% or greater cell death in any ROI at the pre-injury time point 
was excluded from the study. 
	
3.2.4 Electrophysiology 
Neuronal function was quantified for cultures receiving a 336 kPa, 0.84 ms, 86.5 kPa·ms 
(Level 4; sub-threshold for cell death) blast; a 424 kPa, 2.3 ms, 248 kPa·ms (Level 9; supra-
threshold for cell death) blast; or the sham injury.  Electrophysiological recordings were 
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performed 4-6 days following blast- or sham-exposure with 60-channel microelectrode arrays 
(8x8 electrode grid, 10 µm electrode diameter, 100 µm electrode spacing; MEA, Multi-Channel 
Systems, Reutlingen, Germany).  Recordings were taken from multiple slices (For mossy fiber 
stimulation the number of slices used for sham, Level 4, and Level 9 exposure was as follows: 9, 
5, 7 slices, respectively; For Schaffer collateral stimulation the number of slices used for sham, 
Level 4, and Level 9 exposure was as follows: 10, 5, 9 slices, respectively).  Prior to use, each 
MEA was plasma cleaned (Harrick Plasma, Ithaca, NY) and coated with 5 µL of 0.01% 
nitrocellulose in methanol (GE Healthcare Life Sciences, Piscataway, NJ) to ensure tissue 
adhesion.  Each sample was excised from its Millipore insert, cutting around each tissue slice, 
and inverted onto an MEA.  OHSC were held stationary with a nylon-mesh harp-slice-grid (ALA 
Scientific Instruments, Farmingdale, NY).  Samples were perfused with artificial cerebral spinal 
fluid (aCSF) containing 125 mM NaCl, 3.5 mM KCl, 26 mM NaHCO3, 1.2 mM KH2PO4, 1.3 
mM MgCl2, 2.4 mM CaCl2, and 10 mM glucose (pH = 7.40), which was bubbled with 5% CO2 / 
95% O2 and pre-warmed to 37°C.  Recordings were taken with a MEA1060-BC amplifier and 
data acquisition system (Multi-Channel Systems).  The system recorded neural signals at 20 kHz 
with a 6 kHz analog, anti-aliasing filter. 
Stimulus-response (S-R) curves were generated with a programmable stimulator 
(STG1004, Multi-Channel Systems) applying a constant current, bi-polar, biphasic stimulus (100 
µs positive phase followed by a 100 µs negative phase) of varying magnitude (0-200 µA in 10 
µA increments) to electrodes located in either the mossy fiber (MF) or the Schaffer collateral 
(SC) pathways.  The evoked response was recorded on all electrodes simultaneously.  As in 
previous studies, each electrode’s recording was fit to a sigmoidal curve based upon the 
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Rmax represents the maximum amplitude of the evoked response.  I50 represents the 
current necessary to generate a half-maximal response.  The term m, which is proportional to the 
slope of the sigmoidal fit, represents the spread in the firing threshold for the population of 
neurons.  These three parameters were calculated for each electrode in each slice, and results 
were grouped by electrode location in a ROI (DG, CA3, CA1), stimulus location (MF, SC), and 
exposure level. 
	
3.2.5 Excitotoxic injury 
A subset of OHSC exposed to the highest blast level (Level 9) were subjected to an 
excitotoxic injury (10mM glutamate for 3 hours) 4 days following blast exposure (i.e. 
immediately after measuring blast-induced cell death on day 4).   Glutamate-containing medium 
was subsequently changed to fresh serum-free medium, and cultures were imaged for resultant 
cell death 24 hours following glutamate exposure. 
	
3.2.6 Statistical analysis 
All data reported are from at least two experimental trials from cultures generated from at 
least two different litters.  Experimental outcomes were measured at only one time point for each 
culture, so analysis by repeated measures was not appropriate.  Statistical significance of the time 
course of blast-induced cell death at 24 hour intervals over the first 4 days following exposure 
was determined with an independent t-test for each time point of time-matched blast and sham 
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injured groups (SPSS v. 19, IBM, Armonk, NY, significance p< 0.05; For time points 0, 24h, 
48h, 72h, 96h: Sham: n= 75, 8, 11, 6, 51 slices, respectively; Blast: n= 31, 5, 6, 11, 36 slices, 
respectively).  Statistical significance of blast-induced cell death at 4 days for a range of primary 
blast levels was determined with a univariate general linear model for each ROI separately with 
cell death as the dependent variable and experimental group (sham and all blast injury levels) as 
the fixed factor with Tukey post hoc analysis (significance p< 0.05; For sham, Levels 1 through 
Level 9, and Level 9 + glutamate exposure: n=	89,	17,	9,	39,	14,	9,	20,	14,	25,	35,	17 slices, 
respectively).  For statistical analysis of S-R parameters calculated for each electrode, a 
univariate general linear model was used with each measure (m, I50, and Rmax) as the unique 
dependent variable and experimental group (sham and both blast injury levels) as the fixed factor 
(significance p< 0.05; For MF stimulation DG recording following sham, Level 4, and Level 9 
exposure: n= 60, 30, 82 electrodes, respectively; For MF stimulation CA3 recording following 
sham, Level 4, and Level 9 exposure: n= 94, 63, 135 electrodes, respectively; For MF 
stimulation CA1 recording following sham, Level 4, and Level 9 exposure: n=71, 61, 110 
electrodes, respectively; For SC stimulation DG recording following sham, Level 4, and Level 9 
exposure: n= 83, 45, 134 electrodes, respectively; For SC stimulation CA3 recording following 
sham, Level 4, and Level 9 exposure: n=126, 56, 175 electrodes, respectively; For SC 
stimulation CA1 recording following sham, Level 4, and Level 9 exposure: n=82, 56, 123 
electrodes, respectively) with a Bonferroni post hoc analysis.  Data for each ROI and stimulation 
site (MF or SC) was treated independently.	
	
3.3 Results 
3.3.1 Blast-induced cell death is protracted over several days following exposure 
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Cell death was evaluated every 24 hours for 4 days following sham injury or exposure to 
Level 9 (424 kPa peak pressure, 2.3 ms duration, 248 kPa-ms impulse; Table 1) primary blast.  
This level was the most severe used in the current study, delivering the greatest impulse.  Cell 
death reached significance in the DG and CA1 on day 4 as compared to time-matched sham-




Figure 5 Time course of primary blast-induced cell death in OHSC.	
Time course for cell death development over 4 days  (pre-injury and every 24 h) following sham 
or a Level 9 blast.  Cell death did not change from sham except at day 4 as compared to time-
matched controls in the DG and CA1 (±SEM; n≥5; *p<0.05 as compared to sham for the same 




3.3.2 Primary blast-induced cell death in the hippocampus was minimal 
OHSC were exposed to a range of relevant primary blasts levels (Table 1).  Cell death 
increased marginally (<5%) in all ROI at the 4-day time point following sham injury (Figure 6).  
Cell death increased significantly in the DG as compared to sham-injured controls at day 4 
following a Level 8 blast.  Additionally, cell death increased significantly in the DG and CA1 for 
cultures exposed to a Level 9 blast.  OHSC appeared darker in bright-field images 4 days 
following exposure to the highest levels of primary blast tested, indicating ultra-structural 
changes and injury (Figure 7).20	 In response to other blast levels tested, cell death in all ROI at 
day 4 following exposure was not significantly different from sham-injured controls (Figure 6). 
Cell death did not increase significantly in the CA3 for any of the levels tested (Levels 1- 9).  
The greatest amount of cell death was observed in the CA1 following a Level 9 blast yet was 
below 14% (Figure 6).  In contrast, glutamate exposure 4 days after Level 9 blast significantly 
increased cell death in all ROI as compared to OHSC exposed to sham or a Level 9 primary blast 





Figure 6 Cell death tolerance of OHSC to a range of primary blast levels. 
Cell death response for each ROI of the hippocampus (DG, CA3, CA1) on day 4 after injury.  
Groups are in order of increasing impulse from left to right.  Additional OHSC were exposed to 
glutamate following a Level 9 blast to evaluate tissue health and integrity following blast. Cell 
death increased significantly following a Level 8 and 9 blast but did not exceed 14% in any ROI 
(±SEM; n≥9; *p<0.05 as compared to sham for the same ROI; #p<0.05 as compared to Level 9 
for the same ROI).  After a Level 9 blast, exposure to glutamate significantly increased cell death 






Figure 7 Bright-field and fluorescent images of propidium iodide staining of OHSC. 
Images were taken immediately prior to injury and 4 days following blast exposure.  A) Tissue 
slices appeared darker in bright-filed images following low and high levels of blast.  B) PI 
fluorescence confirmed tissue health prior to experimentation.  Fluorescence increased 
minimally after low and high levels of blast.  Glutamate exposure following a Level 9 blast 
confirmed OHSC viability following blast.  All cultures shown met the a priori criteria for 




3.3.3 Mild primary blast decreased excitability 
In response to MF stimulation, I50 increased significantly in the DG following a Level 4 
blast (336	kPa,	0.84	ms,	86.5	kPa·ms) as compared to sham (Figure 8A).  Following exposure 
to a Level 9 blast, I50 returned to baseline in the DG.  I50 increased significantly in the CA1 
following a Level 9 blast.  In response to SC stimulation, I50 was significantly increased in the 
DG following a Level 4 blast as compared to sham (Figure 8B).  Following a Level 9 blast 
exposure, I50 returned to baseline in the DG, similar to MF stimulation.  I50 for SC stimulation 
increased significantly in the CA3 following a Level 9 blast only. 
 
3.3.4 Mild primary blast decreased neuronal firing 
Following MF stimulation, Rmax decreased significantly in the CA3 and CA1 following 
exposure to a Level 4 blast (Figure 8A).  Following a Level 9 blast exposure, there was a return 
to baseline in Rmax in both of these regions.  In response to SC stimulation, Rmax (Figure 8B) 
decreased in the DG following both blast exposures, as compared to sham.  Following a Level 9 
blast, Rmax increased significantly in CA3 as compared to a Level 4 blast. 
	
3.3.5 Mild and moderate primary blast decreased neuronal firing synchrony 
In both the DG and CA3, m decreased significantly in response to MF stimulation for 
both blast injury levels (Figure 8A).  In the CA1, m decreased significantly following a Level 9 
blast, as compared to sham.  Following SC stimulation, there were no (Figure 8B) significant 





Figure 8 Basal evoked response of OHSC following primary blast. 
OHSC functional response following mild and moderate blast exposures.  Following a Level 4 
(sub-threshold for cell death) and Level 9 (supra-threshold for cell death) blast injury, 
electrophysiological parameters (I50 [Top], Rmax [Middle], m [Bottom]) were measured 4-6 
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days after blast exposure.  Responses were measured in all three ROI after stimulation of either 
the mossy fiber (A) or Schaffer collateral (B) pathways (±SEM; n≥30; *p<0.05 as compared to 
sham for the same ROI , stimulation location, and ROI; #p<0.05 as compared to Level 4 
exposure for the same ROI , stimulation location, and ROI). 
 
3.4 Discussion 
In the current study, we have demonstrated that 1) a shock wave in isolation can cause 
delayed brain cell death; 2) the safe exposure limit to pure shock wave loading for significant 
cell death is below 534 kPa, 1.0 ms, 184 kPa·ms (Level 8); and 3) blast-induced, 
electrophysiological (functional) deficits can occur in the absence of significant cell death (Level 
4).  While cell death increased significantly following exposure to both Level 8 and Level 9 
primary blast exposures, average resultant cell death in any ROI was less than 14% (Figure 6). 
However, primary blast-induced functional deficits were observed following a Level 4 primary 
blast exposure (Figure 4), which did not increase cell death. 
The delayed cell death observed is suggestive of cell death resulting from second 
messenger cascades initiated by the mechanical stimulus.  124, 126, 128  These	 data scaled to 
humans by lifespan and physiology are consistent with clinical findings in US service members. 
5  Similarly, stretch injury of OHSC, which simulates inertially-driven injury, has been reported 
previously to produce protracted cell death over several days.  124, 128, 129   Inertially-driven 
injuries are characterized by relatively high strains at lower strain rates in contrast to the primary 
blast injuries of the current study, which are characterized by low strains at high strain rates. 
31  The different biomechanics of these injuries resulted in a similar delayed progression of cell 
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death.  Future studies will be necessary to determine the cell death pathways and secondary 
messenger systems influential in these injury models and whether they differ. 
Primary blast levels were chosen for their relevance to real-world blast-loading 
conditions. 7, 17  Among those parameters investigated here, the range of peak overpressures 
tested was 92.7 - 534 kPa, the range of durations tested was 0.25 - 2.3 ms, and the range of 
impulses was 9.2 - 248 kPa·ms (Table 1).  One study has previously investigated effects of 
scaling of the blast biomechanics in different species and demonstrated that blast injury scales 
with duration only. 130   The un-scaled in-air values for levels tested were within this relevant 
range for exposures with relatively short durations.  Alternatively, given that the tissue samples 
used in these studies were derived from the rat brain, Bowen scaling to the mass of the rat brain 
can be used to interpret these blast levels. 131   Again, this scaling demonstrates that parameters 
fall within a relevant range for real-world blast exposure but have relatively long durations.  Both 
un-scaled and scaled parameters equate to a range of real world blast exposure conditions from a 
small mortar round (M49A4 60 mm Mortar, standoff distance 0.25-2 m) to a large bomb (M118 
Bomb, standoff distance 10-32 m; Conventional Weapons Effects, CONWEP).  The unique 
design of the fluid-filled receiver translates the shock wave into a pressure wave that travels 8 cm 
before it interacts with the tissue.  Therefore, it is likely that scaling for this injury is more 
complicated yet falls between the extremes of the un-scaled and rat-scaled interpretations and 
within a range of real-world blast exposure levels. 
Only those levels that	were	on	the	high	range	with	respect	to	the	typical	exposure	for	
a	US	soldier	were	capable	of	inducing	cell	death.		Similar amounts of cell death in OHSC on 
day 4 following injury have been reported following exposure to a 10-20% strain stretch injury, 
which has been characterized as a mild stretch injury level. 124, 126  Low levels of PI staining 
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could be the result of cells not dying following primary blast or a lack of cells in OHSC to stain.  
To rule out the latter possibility, an excitotoxic injury was delivered following the highest level 
of blast tested (Level	 9),	 which	 confirmed the presence of living cells in OHSC following 
primary blast exposure (Figure 6 & Figure 7) Therefore, we conclude that while isolated primary 
blast exposure can result in cell death, primary blast exposure in the absence of higher order blast 
injury mechanisms is capable of a mild degree of cell death. 
Although OHSC were exposed to varying peak pressures, durations, and impulses, cell 
death increased significantly only following exposure to the 2 blasts with the highest levels of 
impulse tested.  Cell death was not significantly increased after other exposures with either 
greater peak pressures or longer durations, suggesting that impulse, which is dictated by the 
shape of the pressure history and influenced by both peak pressure and duration, may form an 
appropriate basis for a tolerance criterion to primary blast for brain injury.  Blast impulse has 
previously been shown to correlate with increased poration of human promyelocytic leukemia 
cells (HL-60). 132  Investigation of apnea following blast suggests that across species blast scales 
with duration. 17 These finding shed light on the importance of reporting complete 
characterization of blast injury parameters (peak pressure, duration, impulse) for better 
understanding of the observed pathology.   
Given that isolated primary blast resulted in minimal cell loss even for the highest levels 
of exposures our group also investigated the effect of isolated primary blast on an in vitro model 
of the blood-brain barrier (BBB) and evaluated the effect of primary blast exposure on other 
outcome measures.  These studies were performed in parallel to this work and do not appear in 
this thesis.34, 66 ,164  We investigated changes in neural function in OHSCs following exposure to 
primary blast and showed that primary blast may alter long-term potentiation (LTP).164 
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Our findings may have implications for physical protection of the US soldier, including 
the future design of improved protective headgear.  The protective capability of current military 
helmets for shock wave loading and blast is mostly unknown. 39  The injury criterion described 
here may help to inform design criteria for blast-protective helmets over a range of blast impulse.  
Future studies are necessary to determine the correlation of these biomechanical parameters to 
resultant cell death. 
Previous studies have demonstrated neurodegeneration in vivo following blast injury 
pressure histories with lower peak overpressures but longer durations.  In the rat, damage has 
been observed for peak pressures of 48.9 kPa- 240 kPa with durations between 2 ms and 18.2 
ms. 26 , 25   In the non-human primate, free-field blast exposure with peak pressures of 80 kPa and 
200 kPa and 10 ms duration were injurious. 27   These results taken together emphasize that peak 
pressure and duration are not sufficient to predict blast-induced injury and further suggest the 
relevance of impulse as a predicative measure of primary blast-induced brain injury.  However, 
experimental limitations of some in vivo blast injury models may complicate interpretation of the 
observed pathologies in these studies.  In one of these studies, lung injury was found upon 
necropsy in rats post-blast. 25   In this case, free-field explosive exposure without thoracic 
protection exposes the whole body to blast, which can result in damage to the gut and / or lungs 
with downstream influence on CNS damage. 8, 20, 133   An in vivo study in the rat has similarly 
reported minimal neurodegeneration in the absence of tertiary blast-loading following more 
severe blast injury exposure.  28   When the head was not restrained, exposure to a 77 kPa, 4.8 ms 
(impulse not reported) shock wave resulted in head accelerations in excess of 950 krad/s2, 
myelinated axonopathy, neuroinflammation, as well as hippocampal-dependent learning and 
memory deficits. 28   Critically, this same study mitigated tertiary blast loading by restraining the 
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head, producing minimal neurodegeneration and reduced learning and memory deficits following 
isolated primary blast. 28   These findings support that primary blast in the absence of inertial 
loading results in minimal neurodegeneration. 
In the current study, significant functional changes were observed in the absence of blast-
induced cell death (Figure 8).  Additionally, we observed changes in neuron function in 
conjunction with cell death following the highest level of blast studied.  The parameters I50 and 
Rmax were altered after mild primary blast exposure but then returned to sham levels when 
exposed to a more severe blast intensity.  Alterations in the parameter m suggested that primary 
blast preferentially altered the MF pathway.  In recent studies, electrophysiological changes 
following blast have been investigated infrequently.  After exposing isolated slices of guinea pig 
spinal cord white matter to increasing blast severities (30-70 kPa overpressure, ~200 µs 
durations), compound action potential (CAP) amplitude (analogous to Rmax) was reduced up to a 
maximum of 56%. 134   All injury exposures in that study caused significant deficits in membrane 
permeability, demonstrating that morphological disruptions are linked to functional changes.  
Other electrophysiological studies following blast exposure have presented mixed results.  
Following low-level primary blast exposure in rats, in which increased cell death was measured 
in the corpus callosum at three days post-injury, a significant reduction in CAP amplitude was 
measured for unmyelinated fibers.  However, no significant change in CAP duration was 
measured for either myelinated or unmyelinated fibers in acute brain slices. 135   It is important to 
note that the blast parameters in that study were not operationally relevant being of low 
magnitude and very short duration (66 kPa and ~200 µs) and no evidence of damage was 
reported in the hippocampus or cortex.  
Previous studies using inertially-driven TBI models have similarly reported functional 
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deficits in the absence of cell death.  For example, reductions in miniature inhibitory post-
synaptic currents (mIPSC), inhibitory synaptic transmission, and hippocampal excitability in the 
DG and CA1 were measured in acute hippocampal slices generated from mice subjected to a 
moderate lateral fluid percussion (LFP) injury sufficient to cause cell death. 136   In the current 
study, neuron function was altered following a Level 9 blast accompanied by cell death.  Stretch 
injuries (10%, 5 s-1 equi-biaxial strain) supra-threshold for inducing cell death in OHSC, reduced 
Rmax and increased I50 (reduced excitability) in all hippocampal regions. 127    
Injury models replicating inertially-driven injuries (i.e. tertiary blast injury), such as LFP 
injury, can also induce behavioral and memory deficits with no gross morphological damage to 
the cerebral cortex or hippocampus. 137  Stretch injuries (5%, 5 s-1 equi-biaxial strain) sub-
threshold for inducing cell death in OHSC, reduced Rmax and increased I50 across all 
hippocampal regions. 127   Our data confirmed that neuron function changes following a non-cell 
death inducing injury (Level 4).  Our data substantiates the hypothesis that cell machinery 
controlling neuron function can be damaged and yet still transmit electrical signals, such that 
after primary blast exposure, cellular death is not a requirement for alterations in hippocampal 
function. 
Our results suggested that excitatory neurons may be more susceptible to changes from 
primary blast exposure than inhibitory neurons.  This hypothesis is based upon the measured 
changes in I50 and Rmax across both stimulation pathways.  After mild blast (Level 4), excitability 
decreased (I50 increased) and the number of firing neurons decreased (Rmax decreased), but both 
parameters returned to sham-levels after more severe blast exposure (Level 9).  While no single 
study has reported direct evidence of a bi-modal electrophysiological response following injury, 
separate experiments have reported damage to excitatory processes following mild, non-cell 
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death inducing injuries and to inhibitory processes following more severe, cell-death inducing 
injuries.  Following a 74 kPa blast exposure to rats, which caused no morphological damage, 
axonal initial segment length was shortened, which resulted in decreased neuronal excitability, 
when utilized in computational simulations of network functionality. 138   After exposing rats to 
cell death inducing LFP injury, excitability increased when measured in either acute 
hippocampal slices in vitro or with hippocampal electrodes implanted in vivo. 139, 140, 141, 142  
Additional studies suggest severe injuries decrease excitability.  Following moderate LFP 
injury to mice, which induced significant morphological changes, field excitatory post-synaptic 
potential (fEPSP) recordings measured decreased excitability in the CA1 region by nearly 100%, 
out to two days post-injury in acute in vitro hippocampal slices.  In another study, after moderate 
LFP injury in the mouse, inhibition was increased in the CA1, although excitability was 
increased in the DG. 136, 143   While our hypothesis of a bi-modal electrophysiological response 
following injury is indirectly supported by previous studies, it requires direct testing in future 
experiments. 
Recovery of S-R parameters after more severe primary blast exposure may be due to the 
role each region plays within the hippocampal circuit.  The DG has been hypothesized to be the 
“filter” for the tri-synaptic circuit. 144   When stimulated, neurons in the DG may be able to 
dynamically adapt to prevent loss of this filtering function.  Following MF stimulation, these 
changes may be evidenced in the parameter m, which decreased after blast, suggesting greater 
heterogeneity in excitability. 
While we can conclude that primary blast results in altered functional changes and mild 
cell death, there are several limitations to this study to be considered.  Further studies are 
necessary to evaluate the appropriate scaling between our fluid-filled receiver and human 
52 
	
exposure.  Additionally, cell death was evaluated at day 4 following exposure given results from 
the time course evaluation and an in light of previous literature using OHSC; it is possible that 
cell death continues to increase after this time point. 124, 126  This is similarly true for the 
electrophysiological data, which were recorded 4- 6 days post-injury.  In future studies, the time 
course of functional changes will be evaluated.  In the current study, blast levels were chosen 
given their relevance to real world blast exposure; however, these blast injury parameters were 
not de-correlated from each other.  While the data suggests that impulse is an important criterion 
for primary blast-induced injury, further experiments over an even larger range of parameters are 
necessary to elucidate this correlation in greater detail.  Lastly, functional data shows close 
comparisons between sub-injurious stretch (5%, 5s-1) and sub-threshold blast results (Level 4).   
Finite element simulations have demonstrated that maximum strains following blast are about 
5%. 13  The tissue-level biomechanics following blast are limited to computational results and 
direct comparisons between injury models are prevented until strains can be directly measured 
during a blast exposure, which may be possible in future studies with use of a high-speed multi-
camera system. 
Here we have utilized an in vitro model of the brain parenchyma to identify the effect of 
a range of operationally relevant, pure blast-loading conditions on structure and function.  This is 
the first study to expose brain to a range of relevant pure primary blast-loading conditions and to 
elucidate a threshold for blast-induced cell death.  Primary blast injury was capable of killing 
brain cells;	however,	an	isolated	severe	primary	blast	exposure	resulted	in	minimal	delayed	
cell	death.		Function may be more sensitive than cell death as an outcome measure for the brain 
following primary blast.  However, identification of a blast-induced functional threshold may be 
more complex than that of blast-induced cell death given the bimodal effect of blast severity on 
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S-R parameters.  Future studies will be necessary to determine these thresholds and to elucidate 
the correlation of individual blast injury parameters to structural and functional outcome 




4 Primary blast exposure increases hippocampal vulnerability to 
subsequent exposure reducing long-term potentiation 3 
	
4.1 Introduction 
Nearly 86% of all brain injuries experienced by US service members are mild traumatic 
brain injury (mTBI). 145  Blast injury is considered the ‘signature injury’ of recent military 
conflicts. 13, 146, 147  Some service members experience multiple blast exposures while on active 
duty, including breachers, who regularly use explosives to penetrate perimeters such as locked 
buildings. 67  During training, breachers can experience as many as 20 explosive detonations over 
5 days of practical training. 67  Anecdotal symptoms reported by breachers following repetitive 
blast have been referred to informally as “breachers brain” and are similar to those of people who 
have suffered multiple non-blast concussions, such as sport-related concussion. 49, 50  
There is some controversy in the literature as to whether or not repetitive blast exposure 
even results in injury, let alone progressive neurodegeneration.  In vivo models suggest that 
repetitive blast results may produce persistent neuromotor dysfunction, axonal injury, learning 
deficits, and increased oxidative stress. 148, 149, 150  However, in two in vitro studies using the same 
shock tube injury model and cell line, repetitive blast had conflicting results.  In the first study, 
viability of human neuroblastoma cells was in fact improved and production of inflammatory 
cyclophilin A was decreased after repetitive blast exposure, suggesting repetitive blast improves 
outcome.  In the second study, neuroblastoma permeability, indicating injury, was increased by 
																																								 																				
3	A modified version of this chapter previously appeared in print:  Effgen GB, Ong, T, Nammalwar, S, Ortuno, AI, 
Meaney DF, Bass CD, Morrison B III. Primary blast exposure increases hippocampal vulnerability to subsequent 
exposure reducing long-term potentiation, J Neurotrauma. 2015,  In press. 
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repetitive blast. 151, 152  These in vivo and in vitro blast studies employed complex models of blast, 
loading the samples with both primary blast (shock wave-loading) and tertiary blast (acceleration 
/ deceleration or inertial loading) mechanisms, which may have contributed to these conflicting 
results.  
Past studies suggest multiple mTBI from impact loading of the head can cause 
progressive brain injury. 39, 42, 43, 44, 45, 46, 62, 153, 154, 155, 156, 157, 158, 159, 160   Both clinical and 
experimental studies of repetitive mTBI from inertial loading not associated with blast, such as 
sport-related mTBI, suggest that an initial mTBI begins a period of increased likelihood for 
subsequent brain injuries and heightened vulnerability to subsequent injury. 39, 155, 161, 162, 
163  However, the injury biomechanics of sports concussion differ from those of primary blast.  
Primary blast exposure deforms brain tissue with less than 10% strain but with associated strain 
rates of 100 to 1000 s-1, whereas inertial loading deforms the brain in excess of 5% strain with 
associated strain rates from 5 to 50 s-1. 31  Despite these differences in causal biomechanics, 
breachers and other service members exposed to repetitive primary blast without concomitant 
rapid acceleration or impact loading of the head are reporting symptoms of progressive cognitive 
dysfunction much like athletes with head injuries. 49, 50  It is still unknown whether primary blast 
exposure in isolation increases vulnerability of the brain to subsequent exposure, 
neurodegeneration, and brain dysfunction.   
To more directly determine if an initial, isolated primary blast predisposes the brain to 
greater damage from a subsequent exposure we used an in vitro primary blast injury model 
developed in previous studies and exposed organotypic hippocampal slice cultures (OHSCs) to 
repeated primary blast exposures.  Given that breachers, who experience repetitive exposure to 
primary blast, report symptoms of concussion and that multiple  non-blast mTBI can result in 
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more significant brain injuries we hypothesized that repetitive mild shock wave exposures can 
interact resulting in significant neurodegeneration.49, 39, 155  Our results suggest that low-level, 
real-world primary blast loading conditions may predispose the hippocampus to greater injury 
upon exposure to a subsequent blast.  Depending on the exposure level and time interval between 
exposures, delivery of two primary blasts significantly and synergistically reduced long-term 
potentiation (LTP).  This loss of LTP was accompanied by an increase in microglia activation.  
Current guidelines for soldier treatment may need further preclinical and clinical evaluation to 
consider the effects of repetitive exposure to primary blast.  
 
4.2 Materials and Methods 
4.2.1 Organotypic hippocampal slice culture 
All animal procedures were approved by the Columbia University Institutional Animal 
Care and Use Committee (IACUC).  Organotypic hippocampal slice cultures (OHSCs) were 
generated as previously described.  32, 66, 164   Hippocampi were excised from P8-11 Sprague-
Dawley rat pups.  The hippocampus was sectioned into 400 µm thick slices and grown on porous 
Millipore Millicell cell culture inserts (Millipore, Billerica, MA). 32, 66, 164  Every 24-72 hours, 
half of the culture medium was replaced with full-serum medium (50% Minimum Essential 
Medium, 25% Hank’s Balanced Salt Solution, 25% heat inactivated horse serum, 2 µM L-
glutamine, 25 mM D-glucose, and 10 mM HEPES; Sigma, St. Louis, MO).  32, 66, 164  Cultures 
were maintained for 11-14 days prior to experimentation. 
 
4.2.2 Blast injury 
Blast injury methods have been described in detail. 31, 32, 66, 164  In brief, a shock wave was 
57 
	
generated with a 76 mm diameter aluminum shock tube with an adjustable-length driver section 
(25 mm and 190.5 mm lengths were used for the current study) pressurized with helium or 
nitrogen and a 1240 mm long driven section. 31, 32, 66, 164  This shock tube model was characterized 
previously and provides a range of real-world primary blast-loading conditions.  31, 32, 66, 164  The 
range of peak pressures used in this study was 93 to 424 kPa, the range of durations was 0.25 to 
2.3 ms, and the range of impulses was 9.2 to 248 kPa·ms (See Table 1). 32, 66  Experimental 
pressure histories closely matched a Friedlander waveform, which represents a shock wave 
pressure history in the open field. 8, 31, 32  Following blast- or sham-exposure, the sample was 
immediately removed from the receiver, placed into fresh full-serum medium, and returned to 
the incubator. 32, 164, 165  Samples not receiving a blast at a given time point received a sham 
exposure.  Most samples received two blast or sham exposures, and for these studies the inter-
injury duration was either 24 (Figure 9), 72, or 144 hours.  A subset of samples received 3 Level 




Table 2: Repetitive Primary Blast Exposure Levels 
 In-air Parameters In-fluid Parameters 












1 106 ± 2.2 0.25 ± 0.001 9.2 ± 1.6 134 ± 1.9 1.5 ± 0.01 88.8 ± 0.02 
2 92.7 ± 2.6 1.4 ± 0.01 38.5 ± 0.7 270.1 ± 15 2.6 ± 0.2 295.1 ± 58 
4 336 ± 8.3 0.89 ± 0.01 86.5 ± 1.4 598 ± 15 1.85 ± 0.3 440 ± 13 
9 424 ± 6.4 2.3 ± 0.3 248 ± 3.4 1510 ± 91 2.8 ± 0.1 1420 ± 87 
 
Table 2:  OHSCs were exposed to single or repetitive primary blast of varying levels (1, 2, 4, or 
9). In-air parameters were evaluated from pressure-history traces collected at the end of the 
shock tube without the receiver in place. In-fluid parameters were collected in the fluid of the 
receiver adjacent to the sample. These blast injury levels were characterized and reported in a 





Figure 9 Experimental paradigm for primary blast exposure with a 24-hour inter-injury 
interval. 
OHSCs were exposed to 0, 1, or 2 primary blasts 24 hours apart. Samples not receiving a 
primary blast at any time point received a sham exposure. Cell death was evaluated and 
electrophysiological recordings were started 72 hours following the second exposure time point. 
 
4.2.3 Cell death quantification 
Propidium iodide (PI) fluorescence was used to quantify cell death prior to the first 
exposure time point to assess culture health and 72 hours following the second exposure time 
point.  A subset of samples was subsequently exposed to an excitotoxic injury to serve as a 
positive control for cell death, with these positive control cultures imaged 24 hours following the 
excitotoxic injury (see ‘Excitotoxic injury’ below).  OHSCs were stained with PI and imaged 
using previously published methods. 32, 164, 165   Following pre-injury imaging, cultures were 
immediately injured (Figure 9).  Cell death was determined for all regions of interest (ROI) of 
OHSCs (dentate gyrus, DG; cornu ammonis 1, CA1; cornu ammonis 3, CA3), as previously 
described, using MetaMorph (Molecular Devices, Downingtown, PA). 32, 66, 124, 125, 164  Any 





4.2.4 Excitotoxic injury 
As a positive control for cell death, a subset of OHSCs were exposed to glutamate as 
previously described. 66  These samples received two blasts (Level 4) 24 hours apart and were 
subjected to an excitotoxic injury (10 mM glutamate in serum-free medium for 3 hours) 72 hours 
following the second blast exposure (i.e. immediately after measuring blast-induced cell death).  
After 3 hours, the glutamate-containing medium was changed to fresh, full serum medium.  
Cultures were imaged for resultant cell death 24 hours following glutamate exposure. 
 
4.3 Electrophysiological recordings 
Electrophysiological function was recorded and quantified as previously described. 66, 164, 
166, 167  Recordings were performed 3-5 days following the final blast or sham exposure. 
Stimulus-response (S-R) curves were generated as previously described, applying a 
constant current, bi-polar, biphasic stimulus (100 µs positive phase followed by a 100 µs 
negative phase) of varying magnitude (0-200 µA in 10 µA increments) to electrodes located in 
the Schaffer collaterals (SC). 66, 164  The evoked response was recorded on all electrodes 
simultaneously, and the peak-peak response recorded for each stimulus intensity was fit to a 
sigmoidal curve for each electrode based on the following equation: 166  
R S =
R!"#
1+  e! !!"!!
 
As described previously, Rmax represents the maximum amplitude of the evoked 
response, I50 represents the current necessary to generate a half-maximal response, and m is 
proportional to the slope of the sigmoidal fit and represents the spread in the firing threshold for 
the population of neurons. 66, 164  For S-R recordings, these three parameters were calculated for 
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each electrode, and an average for each parameter across electrodes in each region (DG, CA3, 
CA1) was calculated for each slice. Data for each ROI of all OHSCs was averaged within 
experimental groups. 
Each slice was evaluated for changes in LTP utilizing published methods. 164  The 
baseline response was recorded for 30 minutes prior to LTP induction by stimulating the SC at 
the I50 every 60 seconds and recording from all electrodes simultaneously.  LTP was induced by 
stimulating a slice with 3 successive trains of 100 Hz stimulation at I50 for 1 second with 10-
second intervals between trains.  The post-induction response was recorded for 60 minutes, 
stimulating the SC at I50 every 60 seconds and recording from all electrodes simultaneously. 
Potentiation was calculated as the difference between the average peak-peak voltage of the last 
ten minutes of the post-induction recording and that of the last ten minutes of the baseline 
recording normalized to the baseline recording.  For calculating potentiation, data was calculated 
for electrodes within the CA1 only. 164   
 
4.3.1 Histology and immunohistochemistry 
A subset of samples that received 0, 1, or 2 Level 2 blasts were fixed with neutral 
buffered 10% formalin (Sigma), dehydrated in a gradient of alcohols followed by xylene before 
embedding in paraffin.  Samples were cut into 6 µm thick sections and mounted on slides.  
Paraffin was removed, and sections for histology were stained with hematoxylin & eosin (H&E; 
Gill’s Hematoxylin 3 and Eosin Y, Thermo Fisher Scientific, Waltham, MA), dehydrated with a 
gradient of alcohols, and mounted for routine pathological analysis (N=4 for each group).  
Separate, adjacent sections were stained with an antibody for microtubule associated 
protein 2 (MAP-2; anti-MAP2 AB5622, Millipore; 1:100) to visualize dendrites, antibodies for 
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phosphorylated neurofilament heavy (NF-H; SMI-31, BioLegend, San Deigo, CA; N=3; 1:500) 
and non-phosphorylated NF-H (SMI-32, BioLegend; N=3; 1:500), an antibody for glial fibrillary 
acidic protein (GFAP) to visualize activated astrocytes (anti-GFAP Ab7260, Abcam, Cambridge, 
MA; N=4; 1:2000), and an antibody for IBA1 to visualize activated microglia (anti-IBA1, Wako 
Pure Chemical Industries, Richmond, VA; N=4; 1:400).  Paraffin was removed. Antigen 
retrieval was performed for samples stained for GFAP, IBA1, SMI-31, and MAP-2 by 
microwaving in citrate buffer (0.01 M, pH 6.0, Fisher Scientific) for 20 minutes and cooling to 
room temperature for 30 minutes before being washed.  Antigen retrieval was performed for 
samples stained for SMI-32 by warming for 25 minutes in a low pH retrieval solution (DAKO, 
Carpinteria, CA) before cooling to room temperature for 20 minutes.  GFAP, IBA1, SMI-31, and 
MAP-2 samples were blocked with 10% normal goat serum (Vector Laboratories, Burlingame, 
CA) for 25 minutes and then incubated overnight at 4°C with the primary antibody. SMI-32 
samples were blocked with 5% horse serum for 25 minutes and then incubated overnight at 4°C 
with the primary antibody. GFAP, IBA1, SMI-31, and MAP-2 samples were incubated with 
biotinylated anti-rabbit IgG secondary antibody (1:200 for GFAP, IBA1, and MAP-2) or with 
horse anti-mouse secondary antibody (1:200 for SMI-31 and SMI-32; Vector Laboratories) for 
30 minutes at room temperature.  All samples were washed, incubated with ABC reagent (A 
1:50, B 1:50) for 30 minutes at room temperature, washed, added to 3,3’-diaminobenzadine 
solution (DAKO) for 1 minute (with the exception of GFAP: 30 seconds), and counterstained 
with hematoxylin.  Samples were dehydrated with a gradient of alcohols and mounted. As 




Samples were analyzed semi-quantitatively by an individual blinded to the identity of the 
sections.  To evaluate H&E stained sections, a four-point rating scale of 0-3 was devised to 
assess (0: none, 1: rare, 2: occasional, 3: frequent) pathological findings such as shrunken 
neurons, vacuolization, neuronal loss, and dark neurons.  For MAP-2 immunohistochemistry, a 
rating scale of 0-3 corresponded to intensity and consistency of dendritic staining (0: uniform 
staining, 1: patchy loss of staining, 2: extensive loss of staining, 3: complete loss of staining).  
Samples stained with SMI-31 for phosphorylated NF-H were visually inspected for loss of 
axons, axonal swellings and discontinuities, and graded on a four-point scale of 0-3 (0: uniform 
staining, 1: patchy loss of staining, 2: extensive loss of staining, 3: complete loss of staining). 
Samples stained with SMI-32 for non-phosphorylated NF-H were visually inspected for presence 
of non-phosphorylated and injured axons and graded on a scale from 0-3 (0: uniform staining, 1: 
patchy loss of staining and beading, 2: extensive loss of staining and significant beading, 3: 
complete loss of staining). Relative presence of microglia and macrophages was evaluated and 
graded on a scale from 0-3 (0: no IBA1 expression; 1: minimal number of IBA1 positive cells; 2: 
moderate number of IBA1 positive cells with varying presence of activated microglia (amoeboid 
shape) and macrophages; 3: high number of IBA1 positive cells with large number of activated 
microglia and macrophages).  Presence of activated astrocytes was evaluated with GFAP and 
graded on a scale of 0-3 (0: no GFAP expression; 1: minimal number of GFAP positive 
astrocytes; 2: moderate number of GFAP positive astrocytes; 3: large number of GFAP positive 
astrocytes).    
 
4.3.2 Statistical analysis 
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Statistical significance among LTP responses for varying repetitive injuries was first 
determined with a one-way ANOVA followed by a post hoc Bonferroni analysis (SPSS v. 22 
IBM, Armonk, NY).  For statistical analysis of S-R parameters, a one-way ANOVA was used to 
determine significance among groups (sham, single, double) for a given parameter (I50, Rmax, m) 
followed by a post hoc Bonferroni analysis for each ROI separately.  Statistical significance 
among cell death responses for varying repetitive injuries was determined with a one-way 
ANOVA followed by a post hoc Bonferroni analysis for each ROI separately.  A one-way 
ANOVA was used to determine significance among groups (sham, single, double) for semi-
quantification of H&E, SMI-31, SMI-32, MAP-2, GFAP, and IBA1 separately, followed by a 
Dunnett post hoc analysis with the sham-injured group as the control condition for comparisons.  
Statistical analysis of the extended interval LTP data was performed with a one-way ANOVA to 
determine significance among groups and a Bonferroni post hoc analysis to determine 
significance.  Significance was set for all calculations as p < 0.05. 
	
4.4 Results 
4.4.1 Long-term potentiation was significantly depressed following repetitive primary blast 
without altering basal evoked response 
Potentiation was roughly 64% in the CA1 in sham-injured samples (Figure 10).  LTP 
decreased, non-significantly, following both a single and double Level 1 primary blast with a 24-
hour interval between exposures.  LTP was not significantly reduced following a single Level 2 
primary blast exposure; whereas it was significantly reduced as compared to sham after two 
exposures of Level 2 primary blast delivered 24 hours apart.  LTP decreased significantly 
following both a single and double Level 4 primary blast with a 24-hour interval between 
exposures as compared to the sham. 
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There were no statistically significant changes in any S-R parameter (I50, Rmax, m) in any 
of the three ROI (DG, CA3, CA1) after sham, single, or repetitive Level 2 blast exposures 





Figure 10 Repetitive primary blast altered LTP. 
The percent increase in potentiation of evoked response following induction of LTP was 
calculated for samples receiving 0 (‘Sham’), 1 (‘Single’), or 2 (‘Double’) primary blasts of 
varying Levels (1, 2, or 4). LTP was significantly reduced for the single and double Level 4 blast 
groups as compared to sham. LTP was not significantly reduced for the single and repetitive 
Level 1 blast groups. LTP was not reduced significantly for a single Level 2 blast, but LTP was 




Figure 11 Stimulus-response parameters after repetitive Level 2 primary blast with a 24 
hour-inter injury interval. 
Prior to LTP induction, evoked responses to a range of stimuli was evaluated. A) There was no 
significant change in the I50 parameter following single or repetitive Level 2 primary blast. B) 
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There was no significant change in the Rmax parameter following single or repetitive Level 2 
primary blast. C) There was no significant change in the m parameter following single or 
repetitive Level 2 primary blast (N≥5; ±SEM; not significant). 
 
4.4.2 Cell death was not increased by single or repetitive primary blast  
Cell death increased minimally (< 5%) in all ROI after sham injury (Figure 12).  Cell 
death increased minimally following single and repetitive primary blast (Levels 1, 2, 4; Table 2) 
with an inter-injury interval of 24 hours. Given that multiple, primary blasts (Levels 1, 2, 4) did 
not result in significant cell death, we investigated the potential for repetitive exposure to our 
highest primary blast level (Level 9) to cause cell death.  Three Level 9 blasts delivered within 
10 minutes did not increase cell death, either.  However, cell death increased substantially and 
significantly following glutamate exposure (after blast), which served as the positive control 




Figure 12 Cell death following single and repetitive primary blast injury. 
Cell death did not increase significantly following single or repetitive primary blast alone (N≥9; 
±SEM; * p < 0.05) in any ROI (DG, CA3, CA1).  Cell death increased substantially and 




4.4.3 Single and repetitive primary blast did not significantly alter histology or structure of 
axons or dendrites. 
Samples stained with H&E were evaluated for loss of neurons, vacuolization, and dark or 
shrunken neurons. No histological damage was observed in samples receiving the sham, single 
Level 2, or repetitive Level 2 blasts with the 24h interval (representative images shown in Figure 
13).  Staining with MAP-2 and SMI-31 was uniform and did not suggest a significant loss of 
dendrites or axons, respectively (Figure 13D-F & J-L).  Staining with SMI-32 was consistent 
with neuronal cell bodies and dendrites in the hippocampus and did not show appreciable 
differences between groups suggesting no de-phosphorylation of NF-H or axonal damage 
(Figure 13G-I).  
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Figure 13  Histological and immunohistochemical evaluation of axons and dendrites in 
OHSCs following exposure to single and repetitive Level 2 primary blast. 
 (A-C) H&E staining of OHSCs receiving the sham (A, scale bar=1 mm), a single Level 2 blast 
(B), or two Level 2 blasts 24 hours apart (C) revealed intact principal cell body layers. (D-F) 
SMI-31 staining of OHSCs receiving the sham (D), a single Level 2 blast (E), or two Level 2 
blasts 24 hours apart (F) showed the majority of axons were undisturbed by primary blast. (G-I) 
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SMI-32 staining of OHSCs receiving the sham (G), a single Level 2 blast (H), or two Level 2 
blasts 24 hours apart (I) revealed minimal damage to axons. (J-L) MAP-2 staining of OHSCs 
receiving the sham (J), a single Level 2 blast (K), or two Level 2 blasts 24 hours apart (L) 
showed the majority of dendrites were undisturbed by primary blast. 
	
4.4.4 Microglia activation was increased after Level 2 primary blast exposure; however, 
astroglial response was unaffected by blast exposure. 
Samples stained with GFAP did not show any significant differences in activated 
astrocytes with either single or repetitive primary blast as compared to the sham (Figure 14A-C). 
The number of IBA1 positive cells (microglia and macrophages) was increased by Level 2 
primary blast exposure (Figure 14D-I).  This response was significantly higher for the double 




Figure 14 Immunohistochemical evaluation of OHSC glial response following exposure to 
single and repetitive Level 2 primary blast. 
(A-C) GFAP staining of OHSCs receiving the sham (A, scale bar=1 mm), a single Level 2 blast 
(B), or two Level 2 blasts 24 hours apart (C) did not reveal an increase in astrogliosis. (D-F) 
IBA1 staining of OHSC receiving the sham (D), a single Level 2 blast (E), or two Level 2 blasts 
24 hours apart (F) suggested an increase in activated microglia with primary blast. (G-I) Under 
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higher magnification of the indicated regions in D-F (scale bar = 100 µm) activated microglia 
(arrows) were observed in a region of the CA1 of the samples shown Semi-quantification of the 
samples (J) suggests there was a nearly significant increase in microglia response to a single 
primary blast (p=0.058) and a significant increase in microglia response to the double primary 
blast exposure as compared to sham (N=4; ±SEM; * p<0.05). 
 
4.4.5 Heightened vulnerability to subsequent primary blast persisted for at least 72 hours  
Increasing the interval to 72 hours did not mitigate the deficit in LTP, which was still 
significantly depressed by both Level 2 primary blast exposures (Figure 15A).  When the interval 
was increased to 144 hours, potentiation was decreased but was not significantly lower than 
sham from the 24-hour interval study or its own time-matched sham (Figure 15A: Sham 144h 
Interval).  LTP was not decreased when the inter-sham interval was extended to 144 hours, 
indicating that the extended experimental duration did not negatively impact induction of LTP.  
Similarly, cell death did not increase with the extended duration of the experiment.  All samples 




Figure 15 The duration of heightened vulnerability to subsequent primary blast may be 72 
hours to 144 hours long. 
A) The interval between exposures was extended from 24 hours shown in Figure 9 and here (A-
Left) to 72 hours (A-Middle) and 144 hours (A-Right) (N≥4; ±SEM; * p < 0.05). Potentiation 
was still significantly depressed for the 72h ‘Double Level 2’ group but was not for the 144h 
‘Double Level 2’ group as compared the ‘24h Interval’ sham. To determine if the samples were 
modified by the extended duration of the experiment, potentiation was evaluated after 2 sham 
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exposures delivered 144 hours apart and was not different from the ‘24h Interval’ sham. B) Cell 
death for sham, single and repetitive Level 2 groups with the 24h interval shown in Figure 12 
and here (B-Left) were compared to that of the extended inter-injury intervals. On average, cell 
death was below 5% in all ROI for the 72h and 144h repetitive blast-injured groups and the 144h 
sham-injured group (N≥6; ±SEM; not significant). 
	
4.5 Discussion 
This study is the first to report that an initial primary blast (Level 2) leads to a period of 
heightened vulnerability to subsequent primary blast injury.   These studies suggest repetitive 
primary blast may exacerbate brain injury resulting in significant microglia activation and LTP 
deficits; however, this LTP deficit may be overcome by increasing the interval between 
exposures.  We report that heightened vulnerability following Level 2 primary blast may last as 
long as 72 hours but does not exceed 144 hours.  Furthermore, repetitive injury may specifically 
alter long-term plasticity given that there was no significant loss of cells, overt structural damage 
to axons or dendrites, or altered basal evoked function. 
Clinical reports and in vivo experimental studies suggest that cell loss, dendritic damage, 
and axonopathy can be caused by blast. 28, 168, 169, 170, 171  However, given the difficulty of 
delivering isolated primary blast in vivo without confounding effects of rapid head motion and 
the complexity of human exposure and medical histories, it is unclear whether to attribute these 
pathologies to primary blast or potentially confounding  effects of rapid head motion, which is 
well known to injure the brain. 8   This is the first study to show repetitive exposure to isolated 
primary blast can alter LTP without significant changes in axon or dendrite structure or loss of 
cells.  In addition, basal evoked response was not changed with single nor repetitive primary 
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blast.  Previous work from our laboratory has evaluated OHSC cell death and 
electrophysiological functional tolerance, and we reported a single primary blast even at the 
highest level tested (Level 9) can reduce LTP deficits without altering short-term synaptic 
plasticity, increasing cell death, or changing basal evoked response. 66, 164  Taken together, these 
studies suggest deficits in LTP from primary blast may be specific to long-term neuronal 
plasticity and not the result of overt physical damage to axons and dendrites, loss of neurons, or 
damage to pre-synaptic signaling.   
Despite the intense interest in the mechanisms and consequences of primary blast TBI, 
there remains relatively little data in the literature on specific impairments to the hippocampal 
circuitry from primary blast.  In other studies, LTP measured in acute mouse hippocampal slices 
was reduced by a single, in vivo blast (167 kPa·ms) out to 4 weeks following exposure 
accompanied by astrogliosis, axonal injury, and cell loss. 28  Outside of our own work, 164  to our 
knowledge, this is the only evidence of LTP deficits after blast exposure, but these results are 
difficult to interpret further because the head was allowed to accelerate / decelerate during the 
blast exposure, raising the possibility that these deficits were at least in part due to brain 
deformation caused by head motion. 42  To this end, these LTP deficits disappeared when the 
head was restrained during blast exposure. 28  Inertial loading resulting in rapid head acceleration 
and deformation of brain is well known to reduce potentiation in vivo and can be accompanied 
by cell loss and microglia activation. 172, 173, 174, 175, 176, 177  Other in vitro studies with OHSCs have 
reported significant reductions in LTP following barotrauma; however cell loss was not 
evaluated. 178, 179, 180, 181, 182  Additionally, there is precedent for observing deficits in neural 
plasticity after inertial injury without significant cell loss, as reported in the current study after 
primary blast.  One study reported reduced capacity for experience-dependent plasticity in rats 
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following fluid percussion injury (FPI) without neuron loss, and a second study reported deficits 
in working memory in rats subjected to mild and moderate FPI for at least 15 days following 
exposure without neuron loss. 183, 184   
In the current study, the biomechanical threshold for a single primary blast to reduce LTP 
was between Level 2 and Level 4 (Table 2).  However, this threshold is lower when considering 
the effects of multiple blast exposures, as exposure to Level 2 primary blast loading 24 hours 
following the first exposure lead to significant impairment in long-term neural plasticity (Figure 
10).  Ours is the first study to report that a second primary blast (Level 2) within a certain period 
resulted in LTP deficits that were synergistic or more than twice that of the single exposure.  
Given these changes, we considered how the levels of primary blast used in this study (Table 2) 
compared to real-world loading conditions. 66   Using proposed scaling relationships for blast 
exposure, we observe a Level 1 primary blast is comparable to exposure to a M49A6 60 mm 
mortar round at a 0.25 to 2 meter stand-off distance, and a Level 9 primary blast is comparable to 
exposure to a M118 Bomb at a 10 to 32 m stand-off distance. 66  For comparison, breachers may 
use up to 4.5 kg of composition C-4 explosive (cyclotrimethylene-trinitramine) to gain entry to a 
reinforced concrete wall.  In the free-field, 2.7 kg of C-4 at a 5 m stand-off distance produces a 
shock wave with a 96 kPa peak pressure and 4.6 ms duration (CONWEP), which is a much 
longer duration and thus higher impulse than our Level 2 exposure (92.7 kPa, 1.4 ms, 38.5 
kPa·ms). 185  For all blast levels used in this in vitro study, both the unscaled in-air parameters 
and these parameters scaled for rat-brain mass according to Bowen’s relationships are consistent 
with real-world loading conditions for human’s exposed to blast. 66, 186, 187  Compared to the in-air 
shock wave, the intracranial pressure (ICP) wave has a slower rise-time and may be otherwise 
modified as it transitions through media with varying properties and reflections are introduced 
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(see Table 1). 31, 32, 66, 188  In an in vivo study, exposure to a 70 kPa overpressure, 7 ms duration 
shock wave generated by a shock tube produced an intracranial pressure (ICP) history with a 
rise-time 0.5-1 ms longer than that of the shock wave input, a peak pressure of 60-145 kPa, and  
a 7-7.5 ms duration. 189  Peak pressure was modified greatly by animal mass and head orientation 
relative to the direction of shock wave propagation.  In our experimental set-up, the pressure 
history recorded at the sample in the receiver closely mimicked the ICP history following 
primary blast exposure. 32, 66  Our in vitro results, when combined with limited human volunteer 
data, detailed reconstructions, and extensive computational modeling together will yield a much 
more informed estimate of the tolerance to primary blast exposure, which has implications for 
designing equipment to better protect service members from blast-induced brain injury.  
Activation of glia is commonly observed after blast exposure, which is also a 
consequence of FPI or controlled-cortical impact injury. 172, 190  In one in vivo study in which rats 
were exposed to detonation of an explosive charge within a tube (154 kPa, 1.7 ms), resulting in a 
complex blast exposure, microglia activation (stained with OX-42) increased in the hippocampus 
2 days following exposure and returned to sham levels 7 days following exposure. 26  This same 
study reported an increase in GFAP staining for astrocytes in the hippocampus over the course of 
21 days following blast (240 kPa, 2 ms) through the mossy fiber region and at astrocytic end-feet 
surrounding capillaries,  26  suggesting compromise of the blood-brain barrier (BBB).  In a 
separate study utilizing an in vivo explosive blast model, microglia activation (stained with OX-
42) increased as early as 1 day and persisted out to 28 days following blast exposure (202 dB or 
240 kPa peak pressure and 2 ms duration), and increased microglia, macrophage, and 
lymphocyte staining (OX-18 and OX-6) was observed with evidence of subarachnoid 
hemorrhage between 1 and 14 days following exposure. 170   Hippocampal microglia were also 
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activated after exposure of rodents to blast generated from an air-driven shock tube (120 kPa) 
accompanied by BBB breakdown.  191   An in vivo study reported microglia activation (Iba1) 
without increased astrogliosis (GFAP) in rats 7 days following low-level exposure (69 kPa, 5.5 
ms), which was similar to our finding, albeit for a different level blast in vitro. 192  Together, 
these studies suggest that blast increases microglia activation as we also report.  However, given 
the complexities of in vivo blast loading, the contribution from primary versus tertiary loading 
mechanisms could not be separated, as was possible in our study.  Additionally, opening of the 
BBB, which may occur in vivo and may have occurred in those studies, can independently result 
in gliosis. 26, 170, 191, 193  However, we observed activation of microglia by a pressure impulse in 
the absence of BBB opening.  Characterization of microglia in OHSCs suggests that the 
functional characteristics of these in vitro microglia resemble those of microglia in the in vivo 
environment. 194, 195  Microglia reactivity in response to sustained barotrauma (15 or 30 mm Hg 
for 24 hours) in vitro suggests mechanical stress can activate microglia inflammatory responses 
without exposure to blood-serum constituents that accompanies BBB compromise. 196   Ours is 
the first study to report that repetitive isolated primary blast exposure alone can increase 
microglia activation.  Microglia may play a part in hippocampal plasticity and synaptic pruning. 
197, 198  In the mouse primary visual cortex, it was observed that increased microglia contact with 
synaptic elements resulted in a prolonged reduction in size or elimination of dendritic spines. 
199   Loss of dendritic spines or abnormalities can negatively impact LTP. 200   Further studies are 
necessary to elucidate the potential influence of activated microglia on LTP deficits following 
trauma.  
There are limitations to consider when interpreting the results of our study.  Here we have 
investigated the effect of repetitive primary blast exposure to OHSCs grown in vitro and 
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subsequently exposed to injury without the surrounding brain-skull complex or the rest of the 
body.  As previously described, our motivation was to investigate primary blast in isolation, 
necessitating the in vitro approach. 28, 30, 31, 201  Some service members may experience multiple 
primary blasts of varying intensity, inter-injury interval, complexity, and repetition while on 
active duty or in practical training. 67  Here, we have principally focused on investigating the 
effects of two primary blasts with simple pressure histories with a 24-hour inter-injury interval 
for three different levels of primary blast.  These levels correspond to real-world blast loading 
conditions, but may not represent the most common exposures or even those that can be 
withstood without concomitant head motion in the real world.  We chose to investigate a 
simplified and highly controlled set of repetitive injury paradigms given the wide range of 
parameters that could be modulated.  We also chose to investigate a simplified subset of primary 
blast loading that mimics the Friedlander waveform given the unknown potential for more 
complex pressure-histories to cause injury.  Additionally, it is unclear how in vitro 
electrophysiological measures relate to in vivo behavioral measures or clinically reported 
symptoms. 28, 202  Service members who experience single or repetitive primary blast loading 
report difficulty thinking, confusion, retrograde amnesia, amnesia, difficulty concentrating, and 
other concussion-like symptoms. 7, 15, 67  Although LTP is considered an in vitro correlate for 
learning and memory, the LTP deficits observed in our study cannot be directly related to 
learning and memory deficits experienced by service members exposed to blast.   
The effects of repetitive concussions and mTBI from sport-related injury have been 
studied both clinically and experimentally, suggesting that an initial mTBI increases brain 
vulnerability to subsequent mTBI. 34, 39, 45, 46, 155, 161, 162, 203, 204, 205, 206   While this result is similar 
to those here, it is important to highlight that the biomechanics of sport-related TBI and primary 
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blast loading are dissimilar, and for this reason interpreting our data in the context of sports 
injury would be inappropriate. 8, 31  Here, we report that the period of time during which OHSCs 
may experience heightened vulnerability to primary blast may be more than 72 hours but fewer 
than 144 hours in duration.  Understanding the time course of blast-induced injury may be useful 
for future experimental studies investigating safe rest periods following blast exposure, which 
could ultimately inform medical guidelines for the soldier who is exposed to blast.  Translating 





5 Electrophysiological and pathological characterization of the 
period of heightened vulnerability to repetitive injury in an in 
vitro stretch model4 
5.1 Introduction 
As many as 330,000 adults experience a sports-related mild traumatic brain injury 
(mTBI), also known as concussion, in the United States each year, and over 307,000 U.S. high 
school athletes experienced mTBI during the 2013-2014 academic year. 39, 207, 208   Young 
children and the elderly are also at increased risk for concussion especially from falls due to a 
lack of muscle tone, balance, and visual depth perception. 209   Each year in the United States 
144,000 children are diagnosed with concussion and over 56,000 people aged 65 or older are 
hospitalized for head injury. 207   Symptoms of mTBI include short-term confusion, memory 
dysfunction at the time of the injury, loss of consciousness for less than 30 minutes, headache, 
dizziness, and fatigue. 36   The standard treatment for concussion is rest to allow for recovery 
from symptoms and to prevent additional brain injury while symptomatic. 
The National Football League (NFL) Head, Neck, and Spine Committee has developed 
safe return-to-play guidelines for their concussed athletes to prevent additional concussion 
during recovery.  The NFL Sideline Concussion Assessment Tool 3 (SCAT 3 modified NFL 
Assessment) and physician evaluation are used to diagnose concussion, remove the player from 
the active roster, and evaluate a player’s recovery. 48   As symptoms improve, a player is slowly 
re-introduced to team activities from attending meetings, to exercising, to returning to practice 
																																								 																				
4	A modified version of this chapter previously appeared in print: Effgen GB and Morrison, B III. 
Electrophysiological and pathological characterization of the period of heightened vulnerability to repetitive injury 
in an in vitro  stretch model, J Neurotrauma. 2016, In press. 	
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and play.  A concussed player is typically removed from play for one week. 48   Clinical studies 
suggest that athletes who have had one concussion are at a higher risk for multiple concussions. 
39  Patients with a history of past concussions may experience more significant verbal, memory, 
and motor deficits that persist for longer periods following each additional concussion. 
39   Because this period of heightened vulnerability has not been studied systematically, safe 
return-to-play guidelines are disputed.  48, 210, 211   These guidelines may be important for 
protecting concussed athletes from much more significant injury from repetitive concussions. 
Students who have sustained concussion and are still symptomatic report academic 
trouble such as problems studying, spending more time on homework, and difficulty taking 
notes. 212   Challenges in learning and forming new memories may suggest injury to the 
hippocampus. 213  However, concussion is defined by a set of symptoms that may independently 
arise from injury to the head, neck, and / or body that can confound interpretation of the effects 
of repetitive impacts on the brain tissue itself. 214   In an effort to evaluate the effects of repetitive 
mild mechanical loading on brain tissue alone, we used in vitro organotypic hippocampal slice 
cultures (OHSCs), which maintain complex hippocampal morphology, neuronal connections, 
and physiological maturation ex vivo and can be useful for evaluating changes in histology, 
gliosis, and neuron function following injury. 125, 194, 215  We exposed OHSCs to a well-
characterized stretch injury model that delivers a mechanical stimulus relevant to mild brain 
injury and evaluated electrophysiology and pathology following a single or repeat stretch 
delivered at various time intervals to characterize and define the period of vulnerability after 
initial injury. 125  We hypothesized that mild stretch injury would result in minimal injury; 
however, a second injury delivered during a period of vulnerability that follows the initial 




5.2 Materials and Methods 
5.2.1 Organotypic hippocampal slice cultures 
All animal procedures were approved by the Columbia University Institutional Animal 
Care and Use Committee (IACUC).  According to previously published culture methods, 
hippocampi were removed from P8-10 Sprague-Dawley rat pups and sectioned into 400 µm 
thick slices. 124   Slices were plated onto silicone membranes (Specialty Manufacturing, Saginaw, 
MI) coated with poly-L-lysine (0.32 mg/mL; Invitrogen, Carlsbad, CA) and laminin (0.08 
mg/mL; Invitrogen).  Cultures were initially fed with Neurobasal medium supplemented with 1 
mM GlutaMAX, 1X B27 supplement, 10 mM HEPES, and 25 mM D-glucose (Invitrogen).  
Culture medium was changed to full-serum medium with a 50% medium change at each feeding 
time (50% Minimum Essential Medium, 25% Hank’s Balanced Salt Solution, 25% heat 
inactivated horse serum, 2 µM GlutaMAX, 25 mM D-glucose, 10 mM HEPES, Sigma, St. Louis, 
MO  and Invitrogen).  Three OHSCs were maintained in each well.  Samples were fed 3-4 days 
following plating and every 2-3 days thereafter.  OHSCs were cultured at 37°C and 5% CO2 and 
maintained on a rocker to aid gas exchange and diffusion.  Cultures were maintained for 14, 12, 
or 9 days prior to injury for the 24-, 72-, and 144-hour inter-injury interval studies, respectively.  
 
5.2.2 Stretch injury 
The stretch-injury device and loading mechanism have been previously characterized in 
detail. 125, 126   In brief, culture medium was aspirated, and each culture well was placed on the 
injury-device, which was pre-warmed to 37°C.  An equibiaxial stretch injury was achieved by 
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displacing the well and silicone tissue substrate over a hollow, cylindrical indenter. 125, 126  Tissue 
strains were verified via image analysis of high-speed video with custom MatLab code (Natick, 
MA).  Cultures received 0, 1, or 2 mild stretch injuries 24, 72, or 144 hours apart.  All samples 
not scheduled to receive a stretch injury at a given time point were exposed to the sham injury 
(Figure 16).  For sham injury, samples were clamped on the injury device, but the device was not 





Figure 16 Schematic of 24-hour interval injury paradigm and stretch injury biomechanics. 
A) Samples were imaged prior to and following injuries.  For each experiment, the inter-injury 
interval was either 24 (A), 72, or 144 hours long.  Samples receiving a single injury were 
stretched at the first exposure time point and sham-injured at the second exposure time point.  
Cell death was evaluated 3 days following the second exposure time point, and 
electrophysiological function was recorded the following three days.  B) Tissue-level strain was 
equibiaxial and reproducible (N≥49, ±SEM).  C) Tissue-level strain rates in the X- or Y-




5.2.3 Excitotoxic injury 
As a positive control for cell death, a subset of samples exposed to the repetitive injury 
received an excitotoxic injury, as previously described. 32   On the third day after the second 
injury and following cell death evaluation, a subset of cultures were challenged with 10 mM 
glutamate (L-glutamic acid; Sigma) in serum-free medium for 3 hours.  Culture medium was 
changed to fresh full-serum medium, and resultant cell death was evaluated 24 hours later (see 
Cell death quantification). 
 
5.2.4 Cell death quantification 
Cell death in each sample was evaluated and quantified for each anatomical region of 
interest (ROI; dentate gyrus, DG; cornu ammonis 3, CA3; cornu ammonis 1, CA1), as previously 
described, with propidium iodide (PI; 1.5 µM; Invitrogen) immediately prior to the first injury 
and 72 hours following the second injury. 216  For the subset of samples that received excitotoxic 
injury (positive control) cell death was evaluated additionally 24 hours following excitotoxic 
exposure.  Samples with PI fluorescence greater than 5% in any region prior to the first injury 
were eliminated from the study. 
 
5.2.5 Nitrite quantification 
Sample medium from each well was removed 72 hours following the second exposure 
time point (sham or stretch) and assayed for nitrite.  The concentration of nitrite was determined 
with the Griess Reagent Kit (Life Technologies) according to the manufacturer’s instructions, 




5.2.6 Electrophysiological recordings 
Electrophysiological function was quantified as previously described. 216  In brief, 
electrophysiological recordings were performed between 72 and 120 hours after the second 
exposure time point with 60-channel microelectrode arrays (Figure 16; 8x8 electrode grid, 10 µm 
electrode diameter, 100 µm electrode spacing; MEA, Multi-Channel Systems, Reutlingen, 
Germany). 
Stimulus-response (S-R) curves were generated as previously described, applying a 
constant current, bi-polar, biphasic stimulus (100 µs positive phase followed by a 100 µs 
negative phase) of varying magnitude (0-200 µA in 10 µA increments) to electrodes located in 
the Schaffer collaterals (SC) of each OHSC. 216   The evoked responses were recorded on all 
electrodes simultaneously.  For each electrode, the peak-to-peak response for each stimulus was 
fit to a sigmoidal curve based upon the following equation: 166  
𝑅 𝑆 =
𝑅!"#
1+  𝑒! !!"!!
 
 
These parameters have been described previously. 216  Rmax represents the maximum 
evoked response, I50 represents the current necessary to generate a half-maximal response, and 
the term m is proportional to the slope of the sigmoidal fit and represents the heterogeneity in 
firing thresholds. 66   Parameter values for each electrode were averaged within a ROI of the 
OHSC for each tissue slice.  Parameters for a ROI and slice were then averaged within 
experimental groups. 
Short-term plasticity was evaluated with delivery of paired stimuli at the I50 with varying 
inter-stimulus intervals (ISIs), as previously described. 216  ISIs were assigned to one of 4 bins 
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relevant to short-term synaptic plasticity—Short-Term ISI (20 ms), Early-Mid ISIs (35-100 ms), 
Late-Mid ISIs (140-500 ms), and Long-Term ISIs (>500 ms).  The paired-pulse ratios (PPRs; 
response elicited by the second stimulus: response elicited by the first stimulus) for all electrodes 
in a region for all ISIs in the same bin were averaged together for each OHSC separately.  These 
values were then averaged across samples in the same experimental group for each region and 
bin separately. 
Potentiation following induction of long-term potentiation (LTP) was evaluated for each 
OHSC utilizing published methods. 216   Baseline evoked response was recorded for 30 minutes, 
stimulating at the I50 once every minute.  LTP was induced by delivering 3 high frequency 
stimulation (HFS) trains at the I50 current at 100 Hz.  Trains were 1 second long with a 10 second 
delay between trains.  Post-induction response was recorded for 60 minutes, stimulating at the I50 
once every minute.  The average peak-to-peak voltage of the last ten minutes of the pre-induction 
recording and of the last ten minutes of the post-induction recording was calculated for each 
electrode in the CA1.  To calculate percent potentiation for these electrodes, the difference in 
these responses was normalized to the average peak-to-peak voltage of the last ten minutes of the 
pre-induction recording.  An average ‘% Potentiation’ was calculated for each slice; these values 
were subsequently averaged for each experimental group. 
 
5.2.7 Histology and immunohistochemistry 
A subset of cultures were prepared for histology and immunohistochemistry 72 hours 
following the second injury time point as previously described. 216   Samples were fixed in 
neutral buffered 10% formalin (Sigma), dehydrated in a gradient of alcohols followed by xylene, 
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and embedded in paraffin.  All samples were cut into 6 µm thick sections manually and mounted 
on slides.   
For histology, one section from each sample was dewaxed and stained with hematoxylin 
& eosin (H&E; Gill’s Hematoxylin 3 and Eosin Y, Thermo Fisher Scientific) and mounted for 
routine pathological analysis.  
For immunohistochemistry, separate sections were stained with an antibody for 
microtubule associated protein 2 (MAP-2; anti-MAP2 AB5622; Millipore; 1:100; N=4) to 
visualize dendrites, an antibody for phosphorylated neurofilament heavy (pNF-H; SMI-31, 
BioLegend, San Deigo, CA; N=4; 1:500) to visualize axons, an antibody for glial fibrillary acidic 
protein (GFAP) to visualize astrocytes (anti-GFAP Ab7260, Abcam, Cambridge, MA; 1:2000; 
N=4), and an antibody for IBA1 to visualize microglia and macrophages (anti-IBA1, Wako Pure 
Chemical Industries, Richmond, VA; 1:400; N=4), as previously described. 216   As negative 
controls, additional sections received the same staining protocol without the primary antibodies. 
All samples were evaluated by an individual blinded to the identity of the sample 
sections.  Staining was graded on a continuous scale (0-3), as previously described: for grading 
consistency certain pathological indicators for each stain were assigned as the minimum criterion 
for integer value assignment and samples were further graded down to the hundredths place on a 
continuous scale to assess relative degree of pathology beyond that minimum criterion. 216   For 
H&E, pathological indicators of injury such as shrunken neurons, vacuolization, neuronal loss, 
and dark neurons were assessed (0: none, 1: rare, 2: occasional, 3: frequent).  For MAP-2, 
intensity and consistency of dendritic staining was assessed (0: uniform staining, 1: patchy loss 
of staining, 2: extensive loss of staining, 3: complete loss of staining).  For SMI-31, samples 
92 
	
were assessed for loss of axons and axonal swellings and discontinuities (0: uniform staining, 1: 
patchy loss of staining, 2: extensive loss of staining, 3: complete loss of staining).  For IBA1, 
relative presence of IBA1-positive cells and morphology of those cells was assessed (0: no IBA1 
expression; 1: minimal number of IBA1 positive cells; 2: moderate number of IBA1 positive 
cells with varying presence of activated microglia (amoeboid shape) and macrophages; 3: high 
number of IBA1 positive cells with large numbers of activated microglia and macrophages).  For 
GFAP, the relative presence of astrocytes was assessed (0: no GFAP expression; 1: minimal 
number of GFAP positive astrocytes; 2: moderate number of GFAP positive astrocytes; 3: large 
number of GFAP positive astrocytes).    
 
5.2.8 Statistical analysis  
A univariate general linear mode was used to determine significance for all outcome 
measures (strain; strain rate; cell death; nitrite; LTP; I50, Rmax, and m S-R parameters; PPR; 
H&E, MAP-2, SMI-31, GFAP, and IBA1 semi-quantitative data) with the respective outcome 
measure as the dependent factor and the experimental group (sham, single, double) as the fixed 
factor for each inter-injury interval separately (SPSS v. 19, IBM, Armonk, NY).  For cell death, a 
Bonferroni post hoc analysis was used to assess significance for each inter-injury interval group 
separately.  To evaluate changes in nitrite concentration a Bonferroni post hoc analysis was used 
to determine significance for each inter-injury interval group separately.  For LTP, a Bonferroni 
post hoc analysis was used to determine significant differences in potentiation among all 
experimental groups and inter-injury interval groups together.  For S-R data, a Bonferroni post 
hoc analysis was used to determine significant differences for each parameter (I50, Rmax, m) 
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separately among all experimental groups and inter-injury interval groups together.  For PPR, a 
Bonferroni post hoc analysis was performed on data from each ISI bin separately to determine 
significance among all experimental groups and inter-injury interval groups together.  For semi-
quantitative histology and immunohistology data, Dunnett post hoc analysis was performed for 
those stains that showed significance in the ANOVA for each inter-injury interval group 
separately.  Significance was evaluated for all statistical analyses as p< 0.05. 
 
5.3 Results 
5.3.1 Tissue strain and strain rate were equibiaxial and repeatable. 
Stretched samples received 1 or 2 mild stretch injuries delivered 24, 72, or 144 hours 
apart (Figure 16 A).  Injury severity was not statistically different between single and double 
injury groups or between the first and second injury (Figure 16B & 16C).  Strain was also 
equibiaxial for all groups (Figure 16B).  The average equibiaxial strain was 12.9% ± 0.3% 
(±SEM; N=492).  The average strain rate was 5.3 s-1 ± 0.2 s-1 (±SEM; N=492). 
 
5.3.2 Cell death was more vulnerable to additional injury up to 24 hours following an initial 
mild stretch. 
 Cell death was less than 5% in all ROI in all sham-injured groups (Figure 17).  Similarly, 
among samples that received a single mild stretch and a subsequent sham injury (24, 72, or 144 
hours later), cell death was less than 5%, as designed by choosing a mild level of stretch.  Cell 
death increased significantly following two injuries delivered 24 hours apart as compared to that 
of samples receiving a single mild stretch or no stretch injury (sham).  Cell death was below 5% 
in samples that received 0, 1, or 2 mild stretch injuries 72 or 144 hours apart, and there was no 
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significant difference in cell death between samples receiving 0, 1, or 2 injuries for either inter-
injury interval (72 or 144 hours).  Subsequent excitotoxic exposure, which served as a positive 
control, increased cell death significantly in all ROI for all inter-injury interval groups.  The 
positive control suggested that OHSCs contained viable cells that were not killed by stretch 
injury and that a lack of cell death in repetitively injured OHSCs for the 72- and 144-hour 
intervals was not due to a lack of living cells in the samples. 
 
 
Figure 17 Cell death resulting from repetitive mild stretch injury.  
Cell death increased significantly in all ROI following 2 mild stretch injuries delivered 24 hours 
apart as compared to the time-matched sham and single stretch groups (Left, N≥15, ±SEM, 
*p<0.05). When the interval between injuries was increased to 72 hours (Middle) or 144 hours 
(Right) cell death did not increase significantly in any ROI as compared to the time-matched 
sham or single stretch groups (N≥12, ±SEM, *p<0.05).  Excitotoxic exposure to glutamate 
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following repetitive injury served as a positive control for the presence of living cells (N≥12, 
±SEM, *p<0.05).   
 
5.3.3 Nitrite production was more vulnerable to additional injury up to 24 hours following an 
initial mild stretch. 
Nitrite concentration in the medium was significantly increased following the repetitive 
mild stretch injury with the 24-hour interval as compared to the sham (Figure 18).  When the 
interval between exposures was increased to 72 or 144 hours, nitrite concentration was no longer 
significantly elevated following the repetitive injury. 
	
Figure 18 Nitrite concentration in medium following single and repetitive mild stretch 
injury. 
Nitrite was increased significantly following repetitive injury with the 24-hour interval (N≥10, 




5.3.4 Long-term potentiation was more vulnerable to additional injury up to 72 hours following 
an initial mild stretch. 
Potentiation following the sham exposure (24h interval) was over 50% (Figure 19).  LTP 
was not significantly reduced by a single mild stretch injury but was significantly reduced by 
repetitive mild stretch injury (24h Interval).  When the inter-injury interval was extended to 72 
hours, LTP was still significantly depressed compared to that of the 24-hour interval sham group.  
When the inter-injury interval was extended to 144 hours, LTP was no longer significantly 
reduced as compared to the sham group for the time-matched controls (144h interval) or shams 
of the 24-hour interval.  Samples that received two sham injuries 144-hours apart did not have 
significantly different LTP as compared to that the 24-hour interval sham group, suggesting that 
the extended time course of the experiment was not detrimental to potentiation. 
 
Figure 19 Long-term potentiation following single and repetitive mild stretch injury. 
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LTP was reduced significantly following repetitive stretch injury for the 24- and 72-hour 
intervals (N≥6, ±SEM, *p<0.05 as compared to sham 24h interval and 144h interval).  LTP was 
not significantly altered when the interval between stretch injuries was extended to 144 hours.  
LTP following sham injury with a 144-hour interval was not significantly different from that of 
sham injury with a 24-hour interval.  
 
5.3.5 Stimulus-response parameters were not altered significantly by repetitive mild stretch 
injury. 
S-R parameters were minimally altered as a result of single or repetitive mild stretch 
injury for any of the inter-injury intervals evaluated (Figure 20).  Neither I50  (Figure 20A), Rmax  




Figure 20 Stimulus-response parameters following single and repetitive mild stretch injury  
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A) I50 was not significantly altered by any experimental paradigm (N≥5, ±SEM, not significant).  
B) Rmax was not significantly altered by any experimental paradigm (N≥7, ±SEM, not 
significant).  C) The parameter m was not significantly altered by any experimental paradigm 
(N≥6, ±SEM, not significant). 
	
5.3.6 Short-term plasticity was mostly not altered significantly by repetitive mild stretch injury. 
Short-term plasticity was minimally altered as a result of single and repetitive mild 
stretch injury (Figure 21).  There was no significant change in PPR for any group for any ROI 
with the exception of the double injury group with a 72-hour inter-injury interval, which was 
significantly different from that of the 24-hour interval single injury group in the DG.  There was 
no significant change in PPR for any experimental group in any ROI for the Early-Mid ISIs 





Figure 21 Short-term plasticity was mostly unaltered by repetitive stretch injury. 
A) For Short-Term ISIs, paired-pulse inhibition was observed in all ROI with a significantly 
reduced PPR in the CA3 (N≥6, ±SEM, *p <0.05 compared to ‘Single 24h’).  B) For Early-Mid 
ISIs response, paired-pulse facilitation was observed in all ROI (N≥6, ±SEM, not significant).  
C) For Late-Mid ISIs, no significant change in PPR was observed (N≥6, ±SEM).  D) For Late-




5.3.7 Cell injury and astrogliosis was more vulnerable to additional injury; astroglial 
vulnerability persisted for 72 hours following mild stretch. 
 Increased cell loss and shrunken cell bodies were observed along principal cell layers of 
the hippocampus, primarily in the CA1, of repetitively injured OHSCs with the 24-hour inter-
injury interval (Figure 22C & 22E).  Semi-quantitative analysis of H&E stained sections revealed 
a significant increase in pathology in repetitive injured samples as compared to sham for the 24-
hour interval, which was not observed for the 72- or 144-hour intervals (Figure 23A).   
All samples stained with SMI-31 to visualize pNF-H had consistent and complete 
staining throughout OHSCs (images not shown).  There was no significant difference in semi-
quantitative data for any group and the 3 different inter-injury intervals for SMI-31 staining 
(Figure 23B). 
Loss of MAP-2 staining, discontinuities in dendrites, and areas of darker staining were 
observed along the principal cell layers of the hippocampus of repetitively injured OHSCs with 
the 24-hour interval (Figure 22H & 22J).  Semi-quantitative analysis of MAP-2 staining to 
visualize dendrites revealed a significant increase in grade, i.e. increased pathology, in samples 
that were repetitively injured as compared to the shams for the 24-hour interval (Figure 23C).   
An increase in density of GFAP-positive cells and GFAP immunoreactivity was observed 
in samples that received repetitive injury with either a 24- (Figure 22M & 22O) or 72-hour 
interval (not shown).  Semi-quantitative analysis of GFAP staining revealed a significant 
increase in astrogliosis in these samples as compared to their time-matched controls.  There was 
no significant difference in GFAP grade among experimental groups for the 144-hour interval 
(Figure 23D). 
IBA1 staining for microglia and macrophages did not appear different among samples 
(images not shown).  Semi-quantitative analysis of IBA1 stained samples confirmed there was no 
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significant difference between each experimental group and its time-matched control for any of 






Figure 22 Histology and immunohistology of the 24-hour inter-injury interval. 
 
A-E) A subset of samples was stained with H&E.  Sham (A) and single injury (B) samples had 
minimal cell loss, and double injury samples (C) had significant cell loss along the principal cell 
layers.  D) Higher magnification of region in subpanel A shows occasional shrunken cell bodies 
(arrow) in the CA1 of sham samples.  E) Higher magnification of region in subpanel C shows 
high density of shrunken cell bodies (arrow) in the CA1 after repetitive injury.  F-J) A subset of 
samples was stained with an antibody to MAP-2.  Sham (F) and single injury (G) had robust 
immunoreactivity for MAP-2, whereas samples that received 2 mild stretch injuries (H) had 
decreased MAP-2 immunoreactivity along cell bodies in the principal cell layers.  I) Higher 
magnification of region in subpanel F shows mostly uniform immunoreactivity for MAP-2 with 
occasional discontinuities in dendrites (arrow) and small regions with absence of MAP-2 staining 
(^) in the CA1.  J) Higher magnification of region in subpanel H shows many discontinuities in 
dendrites (arrow) and larger regions with absence of MAP-2 staining (^) in the CA1 after 
repetitive injury.  K-O) A subset of samples was stained with an antibody to GFAP.  Sham (K) 
and single injury (L) samples had a low density of GFAP-positive cells, whereas samples that 
received 2 injuries (M) had a high density of GFAP-positive cells with increased 
immunoreactivity.  N) Higher magnification of region in subpanel K shows a moderate density 
of GFAP-positive cells in the CA1.  O) Higher magnification of region in subpanel M shows a 
dense distribution of cells in the CA1 highly immunoreactive for GFAP after repetitive injury.  
Scale bar in subpanel A (1 mm) is scale for subpanels A-C, F-H, and K-M.  Scale bar in subpanel 







Figure 23 Semi-quantification of histology & immunohistology. 
A) There was a significant increase in cell loss and other pathology identified by H&E in the 
double injury group for the 24-hour interval as compared to sham (N≥4, ±SEM, *p <0.05).  B) 
For SMI-31, there was no significant difference among sham, single, or double injury groups for 
any inter-injury interval.  C) There was a significant loss of MAP-2 staining, corresponding to an 
increase in MAP-2 grade, for the double injury group with the 24-hour interval as compared to 
sham (N≥4, ±SEM, *p <0.05). D) There was a significant increase in GFAP-positive cells in the 
repetitively injured groups as compared to the time-matched shams for both the 24- and 72-hour 
inter-injury intervals (N≥4, ±SEM, *p <0.05).  E) For IBA1, there was no significant difference 
among sham, single, or double injury groups for any inter-injury interval.   
	
5.4 Discussion  
Previous studies have suggested that an initial mTBI initiates a period during which the 
brain is more vulnerable to subsequent injury, such that a second injury results in a supra-
additive injury response. 45, 46  Ours is the first to study this phenomenon using OHSCs, and we 
report that this period of increased vulnerability lasted for at least 24 hours.  For cell death, 
dendritic loss, and nitrite, this vulnerability lasted as long as 24 hours but did not exceed 72 
hours.  For LTP and astrogliosis, this vulnerability lasted as long as 72 hours but did not exceed 
144 hours.  These findings suggest that increasing the time between mTBI exposures can 
mitigate a synergistic injury-response and that our culture system may be valuable for further 
investigation into the mechanisms responsible for this phenomenon. 
A major strength of our in vitro stretch injury model is its precise control of the tissue 
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biomechanics, which can be adjusted to concussion-relevant loading.  Video analysis and 
accelerometers have been used to quantify head motion of athletes during safe play as well as 
play resulting in brain injury. 217, 218, 219  Subsequently, finite element models (FEMs) were used 
to predict deformation of the brain in response to these head motions and macroscopic 
kinematics. 217, 218, 220  In the parahippocampal gyrus, average peak strain out to 8 ms following 
impacts causing concussion was 10.8% ± 9.4% at 24.5 ± 28.2 s-1 strain rate (mean ± standard 
deviation).  In non-injurious head impacts, strain was significantly lower (4.3% ± 3.7%, 17 ± 9.3 
s-1 strain rate). 218  These studies begin to define the macroscopic biomechanics of concussion, 
but it is important to note that those approaches have limitations.  For example, several studies 
have examined systematic as well as large random errors associated with helmet-based 
accelerometers. 221, 222, 223  Additionally, parameters extracted from video analysis can be limited 
by the frame rate of the recording and ability to extract three-dimensional measures 
stereographically. 224  Predicting the tissue-level response from macroscopic biomechanics is 
limited by the biofidelity of the FEMs, many of which have not been adequately validated for 
shear strain and are constrained by the limited characterization of brain tissue mechanical 
properties under large deformations at high strain rates. 225, 226  To directly characterize the 
biomechanics of brain tissue for non-injurious head motion, magnetic resonance imaging (MRI) 
has been used to measure tissue-level strains in the human brain under volunteer-conditions. 227, 
228  These studies reported that brain-motion at or below 5% strain was non-injurious.  Similarly, 
using our stretch injury model, we have previously shown that a single stretch injury with strains 
below 20% does not cause significant cell death in OHSCs, independent of strain rate. 
129  Therefore, we delivered a ~12.9% strain, ~5.3 s-1 strain rate stretch to evaluate the inherent 




Another strength of the in vitro stretch injury model with OHSCs is that a mechanical 
stimulus is delivered directly to a brain tissue sample.  OHSCs maintain in vivo neural 
connectivity, complex neuron and glia interactions, and neural function. 129, 229  In vitro OHSCs 
also respond to mechanical injury similarly to the brain in vivo. 129, 229  At the conclusion of all 
experimentation, OHSCs were P30-32, which is approaching the age of adulthood for a rodent 
and is thought to be comparable to a 10-12 year old human in terms of brain maturation.  
Therefore our model of repetitive mTBI may be especially relevant for study of repetitive mTBI 
in juveniles. 230, 231, 232, 233, 234  Other preclinical in vivo studies have suggested that increasing the 
inter-injury interval may mitigate a synergistic injury response. 43, 46, 235  However, in vivo studies 
can be confounded by systemic effects, and clinical studies can be confounded by complex 
patient-histories.  By corroborating these findings with an in vitro slice culture model, we have 
shown that this phenomenon is an inherent response of the brain tissue.  Our results suggest that 
heightened vulnerability following an initial mTBI lasts for as long as 72 hours and may have 
subsided by 144 hours post-injury.  Other clinical studies suggest that an initial concussion may 
increase vulnerability to further injury for 15 days or longer. 47, 236, 237, 238, 239  In other in vitro 
studies, the duration of heightened vulnerability was at least 1 hour long but not longer than 24 
hours; repetitive injury with a 1-hour inter-injury interval resulted in significant cell death and 
loss of MAP-2 staining. 52  Both the 1- and 24-hour inter-injury intervals significantly increased 
extracellular neuron-specific enolase and S-100β. 52  In most recent in vivo studies, heightened 
vulnerability lasted 3 days or longer, depending on the outcome measure assessed. 43, 175, 240, 
241  Here, we also showed that the period of heightened vulnerability was dependent on the 
outcome measure, which may account for discrepancies between studies.   
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Repetitive mild injury with a 24-hour interval between exposures resulted in as much as 
20% cell death.  This injury paradigm significantly altered LTP but did not significantly change 
S-R parameters or most PPRs.  Using our previously defined tolerance criteria, a single stretch of 
12.9% at 5.3 s-1 is predicted to not alter neuronal function or cause cell death. 124, 167   Although it 
may seem unlikely that cell death may occur in the absence of changes to basal evoked function, 
our previously published tolerance criteria for single injuries predicted that strains of 20-41% 
with a 5.3 s-1 strain rate would result in cell death but would not significantly alter S-R or PPR 
parameters. 124, 167   Similarly, in a study of repetitive closed head injury in vivo, PPRs of 
hippocampal tissue harvested from mice that received 3 closed head injuries (CHIs) 24-hours 
apart was not significantly different from that of single and sham injury. 242   It may be possible 
that there exists a spectrum of cell loss and a critical amount of cell loss beyond which changes 
in basal evoked function are also observed; however, to our knowledge, there have been no 
studies directly correlating cell loss with basal evoked function or neural function in general.  
Therefore, a 41% strain, 5.3 s-1 strain rate stretch injury may result in the critical value of cell 
loss, which was previously reported to result in over 40% cell death in the CA3 and CA1 and 
nearly 30% cell death in the DG. 124  In this same study, repetitive CHI significantly increased 
LTP and modified action potential amplitude and width in ipsilateral CA1 hippocampal neurons 
compared to sham. 242   However, many in vivo studies report that single and repetitive mTBI 
result in loss of LTP in hippocampal slices excised from injured animals. 172, 243, 244, 245  For the 
72-hour inter-injury interval, we observed no change in cell death or basal evoked function; 
however LTP was significantly reduced.  Several studies have reported altered LTP without 
significant loss of cells. 183, 216   These findings together suggest that repetitive stretch injury may 
disrupt post-synaptic signaling mechanisms responsible for LTP induction. 
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Experimental studies suggest that heightened injury vulnerability and a synergistic injury 
response from repetitive injury are associated with oxidative stress resulting from mitochondrial 
damage or dysfunction. 46, 246   Damage to the mitochondria and production of reactive oxygen 
species (ROS) have been observed in many studies both in vivo and in vitro following TBI; even 
mild mechanical stimulation of the brain or brain cells can initiate changes in ROS that can 
persist for days. 46, 160   Stretch injury of isolated primary astrocytes can initiate astrocyte 
activation and increase nitrite production, which we observed in our studies. 247   While we did 
observe a significant increase in astrogliosis for the double injury for both the 24- and 72-hour 
intervals, we did not see a significant increase in nitrite production for the 72-hour interval.  
These results suggest that the observed increase in nitrite production may not be tied directly to 
astrogliosis.  Our data does suggest that repetitive injury resulting in a significant increase in cell 
death is associated with a significant increase in nitrite.  It is unclear whether the observed 
increase in nitrite caused the increased cell death, or vice versa; however, other studies suggest 
that oxidative stress may lead to the cumulative and chronic effects of repetitive mTBI including 
deficits in cognitive function and neuroplasticity, such as the LTP deficit we observed. 160, 248, 
249   Therefore, indicators of oxidative stress may be promising biomarkers or therapeutic targets 
for mild injury and for preventing heightened vulnerability following concussion. 249, 250, 251  
Previous studies suggest TBI and mTBI can result in loss or abnormalities in neuronal 
cytoskeletal proteins such as NF-H and MAP-2 in the hippocampus. 252, 253, 254  We observed loss 
of MAP-2 staining following repetitive mild stretch injury with a 24-hour inter-injury interval 
without a significant difference in pNF-H.  In studies of spinal cord injury and TBI the loss of 
MAP-2 immunoreactivity has been suggested to precede loss of pNF-H, which was delayed up 
to 1 week following injury. 254, 255   Additionally, an in vitro study of repetitive stretch injury of 
111 
	
primary hippocampal cells reported cell death and preferential loss of MAP-2-positive cells 24 
hours following two mild stretch injuries delivered 24 hours apart; neurofilament was not 
evaluated in this study. 45   
We observed an increase in GFAP-positive cells following repetitive mild stretch injury 
for the 24- and 72-hour inter-injury intervals without a significant change in the presence or 
activation of microglia and macrophages (Figures 22 & 23).  In vivo studies of TBI and mTBI 
report gliosis following injury and repetitive injury in the hippocampus. 172, 252   However, in vivo 
TBI can also cause injury to the blood-brain barrier (BBB), which can expose the brain to blood-
serum constituents that may independently initiate gliosis. 256  Here, OHSCs were stretch-injured 
in the absence of a BBB and blood-serum constituents that could have initiated the glial 
response.   The astrogliosis we observed was thus an inherent response of the brain tissue to 
repetitive mild stretch injury.  Astrogliosis can cause injury to neurons; therefore, useful 
strategies to mitigate injury from repetitive close-head trauma may need to target astrocyte 
activation. 247  
Conclusions from our study are limited to the scope of in vitro OHSCs.  Therefore, it will 
be important to evaluate repetitive mTBI experimentally in vivo and clinically to better identify 
appropriate rest periods for the injured athlete.  Additionally, our samples may be at a similar 
maturity as the juvenile brain; as such, studies of brain samples at an adult maturity level will be 
necessary to better understand age-dependent effects on the phenomenon we identified here.  We 
evaluated brain response starting at 72 hours following the second exposure because our 
previous studies suggested that cell death develops slowly over the course of 72-96 hours 
following a single stretch injury. 22,30   Repetitive injury may have a different time course for 
development of pathology; evaluation of pathology at more regular intervals over time may be 
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valuable to understanding the tissue’s response to each injury repetition and identifying critical 
time points for intervention.  Additionally, although we identified that repetitive injury with the 
24-hour interval resulted in a significant increase in nitrite production, future studies are 
necessary to determine the mechanism for this phenomenon and the role of oxidative stress in 
this response.  Lastly, delivery of the injury to the OHSC is limited to proper adhesion of the 
sample to the stretchable substrate; however, we characterized high-speed video of the injury to 
calculate maximum strain and strain rate experienced by each tissue sample. 
In this study we have shown that heightened vulnerability following mild mechanical 
injury is an inherent phenomenon of brain tissue.  LTP deficits, astrogliosis, nitrite production, 
cell loss, and dendritic damage experienced a supra-additive increase with repetitive injury.  We 
quantified the duration of this heightened vulnerability and found that LTP and astrogliosis 
remained vulnerable to repetitive injury for a longer period of time than some structural or 
biochemical indicators of tissue health such as cell loss, dendritic damage, or nitrite production.  
These findings suggest that rest periods to increase the interval between concussions may be 
effective for preventing a synergistic pathological response to subsequent injury.  
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6 Memantine reduced cell death, astrogliosis, and functional 
deficits in an in vitro model of repetitive mild traumatic brain 
injury5 
6.1 Introduction 
During the academic year 2014-2015, over 102,390 concussions occurred during sports 
practice and over 190,980 concussions occurred during sports competitions among high school 
athletes. 208   Concussion is a mild traumatic brain injury (mTBI) that results from impact to the 
head.  Symptoms of mTBI can include short-term loss of consciousness and confusion, memory 
dysfunction at the time of the injury, headache, dizziness, and fatigue. 36   Clinical studies suggest 
that athletes with a history of concussion may be at risk for additional mTBI, and repetitive 
exposure to mTBI increases risk for more significant and persistent symptoms, termed persistent 
concussive syndrome (PCS), with each subsequent exposure. 39, 40, 62, 63, 153, 237, 239, 
257   Additionally, clinical studies suggest that multiple concussions can lead to increased 
likelihood for future development of neurodegenerative diseases such as Parkinson’s disease 
(PD), amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), or chronic traumatic 
encephalopathy (CTE). 51, 61, 62, 63, 64   It is unknown how multiple mTBIs can result in PCS, PD, 
ALS, AD, or CTE.  Although there are therapeutics approved by the Food and Drug 
Administration (FDA) for treating the symptoms of PCS, PD, ALS, and AD, there are no cures 
for these pathologies.  Currently, symptoms of mTBI are managed with rest and pain medication; 
there are no drugs approved by the FDA that target the biochemical pathology underlying mTBI 
																																								 																				
5	A modified version of this chapter is in revision for publication: Effgen GB and Morrison, B III. Memantine 
reduced cell death, astrogliosis, and functional deficits in  an in vitro model of repetitive mild traumatic brain injury, 
J Neurotrauma. 2016, In revision.	
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to treat or prevent acute and long-term effects of repetitive mTBI. 62   An ideal therapeutic for 
mTBI would treat the injury, be effective when administered after the injury, and have no 
negative side effects.  Additionally, drugs previously approved by the FDA, even for indications 
other than mTBI, may be especially amenable for expedited approval for additional indications 
such as TBI or mTBI given their known mechanism(s) of action and toxicology.    
Preclinical data suggest that memantine may be neuroprotective in rodents when 
delivered immediately or at delayed time points following a single, moderate to severe TBI or 
secondary injuries of TBI, such as excitotoxicity, hypoxia, and ischemia. 53, 60, 258  Memantine is a 
use-dependent, voltage-dependent N-methyl-D-aspartate receptor (NMDAR) antagonist with a 
high binding affinity for NMDARs containing the NR2B subunit with rapid binding kinetics. 
53  Memantine does not compete with glutamate or glycine, the physiologic agonists for 
NMDARs, at the binding site, which allows memantine to block pathological activation of 
NMDARs while allowing for normal activation and synaptic transmission. 259  NR2B-containing 
receptors are largely expressed in the extra-synaptic space and are mechano-sensitive; 
stimulation of NR2B-containing NMDARs by glutamate or mechanical injury initiates a 
cytotoxic response. 260  We postulated that memantine may prevent injury from mechanical 
stimuli of the brain by inhibiting pathological activation of NR2B-containing NMDARs.  For 
these reasons, memantine may be a promising candidate for treatment of mTBI.   
Furthermore, memantine is an FDA-approved drug for the treatment of moderate to 
severe AD and is also used clinically for the treatment of some patients with PD. 53  Memantine 
does not have the significant negative side effects, such as hallucinations and coma, of other 
NMDAR antagonists. 53, 55, 58, 59, 259  In recent clinical trials of AD patients receiving memantine 
(20-40 mg/day), side effects were minimal, including rare dizziness and occasional restlessness 
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or agitation, and were only reported for the highest doses. 259   
In this study, we investigated the potential for delayed administration of memantine to 
improve outcome from repetitive mTBI using a well-characterized stretch injury model and 
organotypic hippocampal slice cultures (OHSCs). 126  We hypothesized that repetitive injury 
would result in significant loss of cells and changes in LTP given our findings from Chapter 5, 
and we further hypothesized that memantine would prevent injury given its preclinical success in 
models of secondary injury for TBI, TBI, and dementia.  Here, memantine, administered one 
hour after each of two mild stretch injuries delivered 24-hours apart significantly reduced cell 
death, gliosis, and deficits in long-term potentiation (LTP).  Memantine did not cause aberrant 
neuronal function or alter immunopathology not affected by repetitive injury.  These findings 
suggest that memantine may mitigate pathologies that can result from multiple mTBIs, and with 
further preclinical and clinical testing, memantine may be a promising strategy for improving the 
quality of life for those who suffer multiple mTBIs. 
 
6.2 Materials and Methods 
6.2.1 Organotypic hippocampal slice cultures 
All animal procedures were approved by the Columbia University Institutional Animal 
Care and Use Committee (IACUC).  Methods for generating and maintaining OHSCs have been 
published previously. 58  Sprague-Dawley rat pups aged P8-10 were decapitated, the brain and 
hippocampi were excised, hippocampi were sectioned into 400 µm thick slices, and slices were 
plated onto the silicone membrane of a custom well (Specialty Manufacturing, Saginaw, MI).  
Wells were coated with poly-L-lysine (0.32 mg/mL; Invitrogen, Carlsbad, CA) and laminin (0.08 
mg/mL; Invitrogen) prior to culture.  Cultures were initially fed with Neurobasal medium 
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(Neurobasal-A supplemented with 1 mM GlutaMAX, 1X B27 supplement, 10 mM HEPES, 25 
mM D-glucose; Invitrogen, Carlsbad, CA).  Samples were fed 3-4 days following plating and 
every 2-3 days thereafter.  At each feeding time, 50% of culture medium was changed to full-
serum medium (50% Minimum Essential Medium, 25% Hank’s Balanced Salt Solution, 25% 
heat inactivated horse serum, 2 µM GlutaMAX, 25 mM D-glucose, 10 mM HEPES; Sigma and 
Invitrogen).  All samples were incubated at 37°C and 5% CO2 and maintained on a rocker to aid 
gas exchange and diffusion.  Cultures were grown for 10-14 days prior to injury. 
 
6.2.2 Stretch injury 
The stretch-injury device and injury mechanism have been published and characterized in 
detail. 126  For each well of cultures receiving the injury, an equi-biaxial stretch injury was 
achieved with controlled strain and strain rate by displacing the well and silicone substrate over a 
hollow, cylindrical indenter. 126  Both substrate and tissue strains were verified via image analysis 
of high-speed video of the injury using custom MatLab code (Natick, MA).  Stretch injury was 
equi-biaxial with an average equi-biaxial stain of 12.9% ±0.3% and an average strain rate of 5.1 
s-1 ±0.2 s-1 (Figure 16).  The injury device was maintained at 37°C during experimentation.  






 One hour following stretch, all culture medium was removed from each well and replaced 
with full-serum medium containing either 1.5 µM memantine (Sigma) or the vehicle (phosphate 
buffered saline solution, PBS; Sigma; Figure 24).  After the first injury, following administration 
of the drug or vehicle, samples were returned to the rocker and incubated without further media 
changes for 24 hours until the second injury time point.  Following the second injury and drug 
delivery, samples were returned to the rocker and incubated without further media changes for 
72 hours until cell death was evaluated and electrophysiological recordings were begun.  Two 
sets of naïve samples were collected to both evaluate the health of uninjured OHSCs and to 
determine if additional medium changes to administer the vehicle / memantine had an effect on 
outcome measures.  One set of naïve samples was imaged on Day 0 (Figure 24), returned to fresh 
full-serum medium, fed 24 hours later, and was undisturbed until Day 4 when PI images were 
taken and electrophysiological recordings began.  One set of naïve samples was imaged on Day 
0, was returned to fresh full-serum medium, and received a full medium change 1 hour later in 
lieu of vehicle / memantine administration; these samples received a full media change to fresh 







Figure 24 Experimental injury and drug delivery paradigm.   
Samples were stretch-injured twice 24-hours apart and received memantine or the vehicle (PBS) 
1 hour following each stretch injury.  Additional naïve samples received media changes at the 
time points for injury and memantine / vehicle administration or no additional media changes.  
Cell death was evaluated with propidium iodide (PI) on Day 0 and Day 4, and 
electrophysiological function was recorded 3-5 days following the second injury. 
 
6.2.4 Cell death quantification 
Propidium iodide (PI), a fluorescent indicator of dead cells, was used to quantify cell 
death present in OHSCs immediately prior to the first injury and 72 hours following the second 
injury time point. 216  For staining, OHSCs were incubated in 1.5 µM PI in serum-free medium 
(75% Minimum Essential Medium, 25% Hank’s Balanced Salt Solution, 2 µM GlutaMAX, 25 
mM D-glucose, 10 mM HEPES, Sigma and Invitrogen)  for 30-60 minutes before imaging.  Cell 
death was determined for specific anatomical regions of interest (ROI: DG, CA1, CA3), as 
previously described, using MetaMorph software (Molecular Devices, Downingtown, PA). 
124  Any sample with more than 5% cell death in any ROI prior to the first injury was excluded 
from the study.  Following pre-injury imaging, samples were immediately stretch-injured or 
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naïve samples were returned to full-serum medium, incubated, and rocked. Following post-injury 
imaging, the staining solution was changed to fresh full-serum medium for all samples and 
electrophysiological recordings began.  
 
6.2.5 Electrophysiological recordings 
Methods for recording and quantifying electrophysiological have been previously 
published. 216  Electrophysiological recordings were performed 72-120 hours following the 
second stretch injury.  Neuron activity was recorded with 60-channel microelectrode arrays (8x8 
electrode grid, 30 µm electrode diameter, 200 µm electrode spacing; MEA, Multi-Channel 
Systems, Reutlingen, Germany).  For all recordings within a slice, the same 2 electrodes located 
in the Schaffer collaterals (SC) were stimulated. 
Stimulus-response (S-R) curves were generated as previously described. 216  A constant 
current, bi-polar, biphasic stimulus (100 µs positive phase followed by a 100 µs negative phase) 
was applied to the stimulating electrodes.  Stimulus magnitude was gradually increased 0-200 
µA in 10 µA increments, and evoked responses were recorded from all non-stimulating 
electrodes.  The range of peak-to-peak responses for each electrode was fit to a sigmoidal curve 
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As described previously, Rmax represents the maximum peak-to-peak amplitude of the 
evoked response, I50 represents the current necessary to generate a half of Rmax, and the term m is 
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proportional to the slope of the linear portion of the sigmoidal fit. 216  These three parameters 
were calculated for each electrode.  Images of each sample on the MEA were used to identify the 
location of each electrode (DG, CA3, CA1).  Subsequently, an average of each parameter was 
calculated for each ROI and slice.   
Short-term plasticity was evaluated by calculating paired-pulse ratios (PPRs), as 
previously described. 216  Samples were stimulated twice at the I50 , and the inter-stimulus interval 
(ISI) was varied from 20-2000 ms. PPRs were calculated as the ratio of the peak-to-peak 
response elicited by the second stimulus as compared to that of the first stimulus in a pair.  ISIs 
were assigned to bins—Short Term ISI (20 ms), Early-Mid ISIs (35-100 ms), Late-Mid ISIs 
(140-500 ms), and Long-Term ISIs (>500 ms), and an average PPR for each ROI, slice, and bin 
was calculated. 
Long-term potentiation (LTP) was evaluated utilizing methods previously published.  
216  Peak-to-peak response to I50 stimulation was recorded for 30 minutes, stimulating every 60 
seconds.  Immediately after this baseline recording, LTP was induced by stimulating at the I50 
with 3 successive, 1-second long, 100 Hz trains with 10-second breaks between trains.  The post-
induction response was recorded for 60 minutes, stimulating at the I50, stimulating every 60 
seconds.  Percent potentiation was calculated as the percent increase in peak-to-peak response of 
the post-induction recording normalized to the pre-induction recording.  The average response of 
the last ten minutes of pre- and post-induction recordings was used for calculations.  Potentiation 
was calculated for electrodes within the CA1 in response to SC stimulation only.  
 
6.2.6 Histology & immunohistology 
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Histology and immunohistology methods have been previously published. 216  A subset of 
samples from each experimental group were fixed with neutral buffered 10% formalin (Sigma) 
for 30 minutes, dehydrated in a gradient of alcohols and xylene, embedded in paraffin, and cut 
into 6 µm thick sections.  For histology, sections were stained with hematoxylin & eosin (H&E; 
Gill’s Hematoxylin 3 and Eosin Y, Thermo Fisher Scientific, Waltham, MA), dehydrated with a 
gradient of alcohols, and mounted on slides for routine pathological analysis.  For 
immunohistology, separate sections were stained with an antibody for microtubule associated 
protein 2 (MAP-2; anti-MAP2 AB5622, Millipore; 1:100), an antibody for phosphorylated 
neurofilament heavy (pNF-H; SMI-31, BioLegend, San Diego, CA; 1:500), an antibody for glial 
fibrillary acidic protein (GFAP; anti-GFAP Ab7260, Abcam, Cambridge, MA; 1:2000), and an 
antibody for IBA1 (anti-IBA1, Wako Pure Chemical Industries, Richmond, VA; 1:400).  
Negative controls received identical handling but were not incubated with the primary, for each 
stain respectively. 
Samples were analyzed semi-quantitatively by an individual blinded to the sample group 
using a rubric previously published.  216  H&E was used to assess integrity of the principal cell 
layers, and stained sections were evaluated for shrunken neurons, vacuolization, neuronal loss, 
and dark neurons (0: none, 1: rare, 2: occasional, 3: frequent).  For MAP-2 and SMI-31, intensity 
and consistency of each stain’s immunoreactivity was assessed (0: uniform staining, 1: patchy 
loss of staining, 2: extensive loss of staining, 3: complete loss of staining).  Relative presence of 
GFAP-positive cells was assessed (0: no GFAP expression; 1: minimal number of GFAP-
positive astrocytes; 2: moderate number of GFAP-positive astrocytes; 3: large number of GFAP 
positive astrocytes).  Presence and morphology of cells positive for IBA1 was assessed (0: no 
IBA1 expression; 1: minimal number of IBA1 positive cells; 2: moderate number of IBA1 
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positive cells with varying presence of activated microglia (amoeboid shape) and macrophages; 
3: high number of IBA1 positive cells with large numbers of activated microglia and 
macrophages).  
 
6.2.7 Statistical analysis 
To evaluate efficacy of memantine to change any outcome measure (cell death, S-R, 
PPR, LTP, GFAP, IBA1, SMI-31, or MAP2), a one-way ANOVA was used to determine 
statistically significant changes in that measure (SPSS v. 19, IBM, Armonk, NY).  For cell death, 
S-R measures, and PPR ISI bins, statistical analysis was performed on data for each ROI 
separately.  A Bonferroni post hoc analysis was performed for data sets with significance in the 
ANOVA.  For semi-quantitative measures, a Dunnett post hoc analysis was performed for data 
sets with significance in the ANOVA. Significance was set to *p < 0.05 for all analyses. 
 
6.3 Results 
6.3.1 Cell death from repetitive mild stretch injury was mitigated by delayed memantine 
treatment 
Cell death was over 8% in each ROI (DG, CA3, CA1) for samples receiving repetitive 
injury and the vehicle (Figure 25).  Cell death was significantly reduced in all ROI in OHSCs 
that received the repetitive injury and memantine.  There was no significant difference in cell 
death between samples receiving memantine and naïve samples.  Cell death from the two naïve 
groups was not significantly different and was combined into one ‘naïve’ data set that was used 





Figure 25 Cell death was reduced by delayed memantine delivery. 
Cell death was significantly increased all regions of OHSCs (DG, CA3, CA1) by repetitive mild 
stretch injury as compared to naïve samples, and memantine significantly reduced cell loss from 
repetitive injury. (N≥20, ±SEM, *p<0.05 as compared to vehicle for each ROI, respectively).  
There was no significant difference in cell death between the injured samples receiving 
memantine and naïve samples for all ROI. 
 
6.3.2 LTP deficits from repetitive mild stretch injury was mitigated by delayed memantine 
treatment 
Percent potentiation of samples that received the repetitive injury and the vehicle was 
15% (Figure 26), and percent potentiation of samples that received repetitive injury with 
memantine was 50%.  Percent potentiation of samples receiving memantine was significantly 
higher than that of samples receiving the vehicle and was not significantly lower than that of 
naïve samples, which was over 60%.  LTP from the two naïve groups was not significantly 
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different and was combined into one ‘naïve’ data set that was used for statistical comparison to 
vehicle and memantine groups for Figure 26. 
	
Figure 26 Long-term potentiation was improved by delayed administration of memantine. 
Percent potentiation was significantly reduced by repetitive mild stretch injury as compared to 
naïve samples, and memantine significantly increased LTP following repetitive mild stretch 
injury (N≥6, ±SEM, *p<0.05).  There was no significant difference between injured, memantine-




6.3.3 S-R parameters were not significantly modified by repetitive stretch injury or memantine 
treatment 
There was no significant difference in any S-R parameter (I50, Rmax, m) among samples 
receiving repetitive injury and the vehicle or memantine and also un-injured, naïve samples 
(Figure 27).  S-R parameters from the two naïve groups were not significantly different and were 
combined into one ‘naïve’ data set that was used for statistical comparison to vehicle and 





Figure 27  Stimulus-response parameters were not modified by repetitive injury or 
memantine administration.  
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A) I50 was not significantly different among samples repetitively injured with vehicle or 
memantine treatment and un-injured, naïve samples (N≥5, ±SEM, not significant).  B) Rmax was 
not significantly different among samples repetitively injured with vehicle or memantine 
treatment and un-injured, naïve samples (N≥7, ±SEM, not significant).  C) The parameter m was 
not significantly different among samples repetitively injured with vehicle or memantine 
treatment and un-injured, naïve samples (N≥5, ±SEM, not significant).   
	
6.3.4 PPRs were mostly unaltered  by repetitive stretch injury or memantine treatment 
There was no significant difference in PPR for any ISI bin (Short-Term, Early-Mid, Late-
Mid, Late-Term) among samples receiving repetitive injury and the vehicle or memantine and 
naïve samples (Figure 28) with one exception.  In the CA1 for the Early-Mid ISIs, PPRs for 
injured, memantine-treated samples was significantly higher than that of injured, vehicle samples 
(Figure 28B); the average PPR for the memantine-treated group was not significantly different 
than that of naïve samples.  PPRs from the two naïve groups was not significantly different and 
were combined into one ‘naïve’ data set that was used for statistical comparison to vehicle and 





Figure 28  Short-term plasticity was mostly not altered by repetitive injury or memantine 
administration. 
A) For Short-Term ISIs, paired-pulse inhibition was observed in all ROI (N≥8, ±SEM, not 
significant).   B) For Early-Mid ISIs, there was a significant increase in PPR for the injured 
memantine-treated group in CA1 only as compared to the injured vehicle group, and there was 
no significant difference between naïve samples and memantine treated samples (N≥7, ±SEM, 
*p <0.05 compared to Injury/Vehicle).  C) For Late-Mid ISIs, no significant change in PPR was 
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observed (N≥8, ±SEM, not significant).  D) For Late-Term ISIs, no significant change in PPR 
was observed (N≥8, ±SEM, not significant). 
 
6.3.5 Cell loss and astrogliosis were prevented by memantine treatment  
Semi-quantitative H&E grade was significantly decreased, corresponding to improved 
outcome, for samples that were injured and received memantine as compared to that of samples 
that were injured and received the vehicle (Figure 29A).  There was no significant difference in 
H&E grade between naïve samples and injured samples that received memantine.  Cell loss from 
repetitive injury was isolated to the principal cell layers and was observed predominantly in the 
CA1 region of OHSCs (Figure 29B), whereas the principal cell layers appeared continuous and 
healthy in injured samples that received memantine (Figure 29C).   
Semi-quantitative GFAP grade was significantly increased, corresponding to astrogliosis, 
for injured samples that received the vehicle as compared to that of samples that received 
memantine or the naïve samples (Figure 29D).  There was no significant difference in GFAP 
grade between injured samples that received memantine and the naïve samples (Figure 29D).  
Density of GFAP-positive cells was increased in all regions of interest in samples that received 
repetitive injury and the vehicle (Figure 29E) as compared to that of injured samples that 
received memantine (Figure 29F).   
There was no observed difference in IBA1, SMI-31, or MAP-2 immunoreactivity among 
all samples (images not shown).  Semi-quantitative analysis of all samples stained with IBA1, 
SMI-31, or MAP-2 antibodies did not reveal any significant difference among experimental 
groups (data not shown). 
130 
	
Semi-quantitative grades for H&E, GFAP, IBA1, SMI-31, and MAP-2 for the two naïve 
groups were not significantly different and were combined into one ‘naïve’ data set that was 
ultimately used for statistical comparison to vehicle and memantine groups. 
 
 
Figure 29 Histology and immunohistology. 
A) Repetitive mild injury caused a significant increase in cell injury as compared to naïve 
samples, and memantine reduced cell injury such that there was no significant difference in H&E 
grade between ‘Injury/Memantine’ and ‘Naïve/Naïve’ groups. (N=4; ±SEM, *p <0.05 as 
compared to ‘Injury/Vehicle’).  B-C) After injury, cell death was evident along the pyramidal 
cell layer in the CA1 (^), which was reduced by memantine treatment (Scale bar= 1mm).  D) 
Repetitive mild injury cause a significant increase in GFAP-positive cells as compared to naïve 
samples, and memantine reduced presence of GFAP-positive cells such that there was no 
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significant difference in GFAP grade between ‘Injury/Memantine’ and ‘Naïve/Naïve’ (N=4; 
±SEM, *p <0.05 as compared to ‘Injury/Vehicle’).  E-F) GFAP-positive cells were evident 
throughout all regions of injured cultures.  GFAP staining was reduced by memantine treatment. 
 
6.4 Discussion 
Memantine may be an effective therapeutic for treating electrophysiological and 
pathological changes resulting from repetitive mTBI.  In this study, memantine improved several 
outcome measures modified by repetitive mild stretch injury and did not alter those outcome 
measures that were unaffected by the injury.  Additionally, memantine was effective when 
administration was delayed 1 hour following the injuries.  Currently, there are no FDA-approved 
therapies that prevent changes in brain function and pathology that can result from repetitive 
mTBI.  Given that memantine is FDA-approved for AD, it may have a more expedient approval 
for other indications like mTBI, making it potentially a successful therapeutic candidate for 
mTBI treatment. 
Memantine reduced cell death (Figure 25), rescued LTP (Figure 26), and prevented 
astrogliosis (Figure 29) after repetitive stretch injury.  Previous studies of repetitive mTBI in vivo 
and in vitro suggest that repetitive mTBI can result in cell loss, LTP deficits, and gliosis.  44, 45, 
172, 204  As of yet, the potential for memantine to improve outcomes from repetitive mTBI has not 
been evaluated.  Few studies have investigated memantine for TBI; however, these studies 
suggest that memantine may be neuroprotective after TBI.  Memantine reduced cell loss when 
delivered following a single moderate to severe TBI. 60, 258  Memantine (20 mg/kg) prevented cell 
loss when delivered 5 minutes following controlled cortical impact (CCI) in vivo, and 1 and 10 
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µM memantine reduced cell death in OHSCs when delivered immediately following severe 
stretch injury. 60  Incubation in 1 µM memantine, the cerebral spinal fluid (CSF) concentration of 
dementia patients treated with memantine, rescued LTP deficits of hippocampal slices induced 
by reduced Mg2+ exposure leading to over-activation of NMDARs. 261  In a mouse model of 
cerebral ischemia, memantine delivered pre-injury reduced neuronal injury, neuronal apoptosis, 
and astrogliosis. 262  In our study, repetitive mild stretch injury did not significantly change PPR 
or S-R parameters from those of the naïve OHSCs, and these measures were not further 
augmented by memantine.  This finding is significant because an ideal therapeutic would rescue 
only those outcome measures modified by the injury with minimal off-target effects.   
Given that memantine preferentially targets NR2B-containing NMDARs, 
electrophysiological and pathological effects of repetitive mTBI may be mediated by over-
activation of these receptors. 58, 260   Previous studies have suggested that NR2B-containing 
NMDARs are mechano-sensitive, specifically they respond to stretch injury, and that activation 
of these receptors can initiate a cytotoxic response. 260   Further studies are necessary to 
determine the role of NR2B-containing NMDARs in mediating the brain’s response to repetitive 
mTBI.  However, our findings suggest that NR2B-containing NMDARs may be activated by 
repetitive stretch leading to injury and that memantine, and potentially other therapeutics that 
target extra-synaptic NMDARs, may be effective therapeutics for treating injury from repetitive 
mTBI.  
In our study, 1.5 µM memantine delivered 1 hour following each of two mild stretch 
injuries was effective.  We chose this concentration because previous preclinical studies 
suggested the 1-10 µM was effective at mitigating TBI or injuries secondary to TBI such as 
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hypoxia, ischemia, or excitotoxic injury with minimal off-target effects in vitro. 53  In vivo studies 
suggest that the free concentration of memantine in the brain after a clinically relevant dose was 
0.5-10 µM within 30-60 minutes of administration, which is approximately that of PD patients 
receiving chronic memantine treatment. 53, 57  Another study reported that CSF concentration in 
dementia patients chronically treated with memantine was 1 µM, and 1 µM memantine rescued 
LTP in rodent-derived hippocampal slices LTP from over-activation of NMDARs. 261  In vitro 
studies suggest that memantine in excess of 11 µM may inhibit LTP. 53  Therefore, 1.5 µM may 
be a relevant concentration in vitro or evaluating the benefit of clinically tolerable concentrations 
of memantine. 
The current standard of care for concussion is rest from work and activity while 
symptoms recover.  As such, any therapeutic that can target the pathology, prevent symptoms, 
and allow the patient to maintain their quality of life would be an improvement on the current 
standard of care.  For most injuries, there can be a delay between onset of the injury and 
administration of a therapeutic, necessitated by transportation to a clinical facility and evaluation 
by a  clinical professional before a therapy can be administered.  Therefore, ideal therapeutics 
that are practical for clinical use are effective at delayed administration time points.  
Each stretch injury was approximately 12% strain and 5 s-1 strain rate.  Based on the cell 
death and functional tolerance criteria our laboratory has defined for OHSCs and this stretch 
injury model, a single mild stretch of this severity should result in no overt cell death or change 
in basal evoked function (i.e. no change in S-R parameters or PPRs); preliminary work in our 
laboratory confirmed these results. 124, 126, 167   Previous preclinical studies suggest that a single 
mild closed-head injury results in minimal pathology but may initiate a window of heightened 
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tissue vulnerability during which additional injury can have a significant negative effect on brain 
samples. 46   These studies suggest this window of heightened vulnerability may last 24 hours to 
15 days or more following an initial mild injury; therefore, we chose a 24-hour inter-injury 
interval. 47, 236, 238, 239  Thus, in our studies the second injury may be the initiator of the pathology 
we observed. Memantine was delivered 24 hours prophylactically to the second injury and also 1 
hour following the second injury.  Prophylactic administration of a therapeutic to a single injury 
is not realistic given the potentially random occurrence of injury and may lead to  over-
medication of patients.  However, for athletes who are at higher risk for concussion and 
especially for athletes who have a recent history of concussion, prophylactic administration of 
memantine prior to play could be beneficial to prevent significant pathology that could result 
from subsequent brain injury.  Given that memantine has minimal side effects, prophylactic 
administration of memantine to this group of high-risk individuals may be beneficial overall.  
However, further preclinical and clinical testing may be necessary for memantine to be approved 
by the FDA for this indication and identify therapeutic windows appropriate for concussion. 
Our model of repetitive concussion was limited to two mild stretch injuries, of the same 
intensity, delivered 24-hours apart.  The injured athlete may experience variable injury severity, 
number of injuries, and interval between exposures.  The time course for pathology development 
in vitro may be more rapid than that for the human.  Further preclinical and clinical studies are 
necessary to evaluate the potential for memantine to improve outcomes for the injured athlete 
and determine dosing and an ideal therapeutic window.  Additionally, further studies are 
necessary to validate the biochemical mechanism whereby memantine rescues LTP, reduces cell 
death, and improves pathology from repetitive mTBI.  
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In preliminary studies, we investigated the potential for a combination treatment of 
memantine (1.5 µM) and 17β estradiol (E2, 1.5 nM) to prevent injury from repetitive mild 
stretch.  The combination therapy was chosen given results from another study performed in our 
lab, which reported that a combination of memantine and E2 delivered immediately after injury 
could successfully prevent cell loss from severe stretch injury.  While the combination therapy 
was successful at preventing cell loss it did not appear to improve outcome more than either of 
the monotherapies.  While there was no significant difference among these treatment groups, on 
average, memantine alone significantly reduced cell death in all ROI more than E2 alone or the 
combination.  Therefore, we investigated memantine treatment alone.258 
The socioeconomic cost associated with mTBI in the United State is estimated to be 
nearly $17 billion annually. 36   Given the high incidence of concussion, the increased likelihood 
for additional injury for patient’s suffering concussion, and the potential for repetitive mTBI to 
lead to more significant cognitive deficits and neurodegenerative disease, there is a need for 
therapeutics that can treat and prevent injury from multiple mTBIs to improve quality of life for 
these patients and reduce the economic burden associated with the short- and long-term care of 
patients with mTBI.  Based on the results of this study, the well-studied mechanism of action, 
and defined toxicology of memantine, memantine may warrant further investigation in 
translational studies to determine its potential to improve outcomes for concussed athletes	  
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7 Summary and discussion 
7.1 In vitro methods for studying primary blast injury in the laboratory 
In this thesis work, we developed a novel methodology for exposing samples of the living 
hippocampus to isolated primary blast in vitro, which is predicted to load the tissue sample in a 
similar manner to isolated shock wave loading of the head without confounding effects of 
tertiary blast. 32   Described in Chapter 2, the fluid-filled receiver performed the functions of a 
surrogate skull-brain complex; the shock wave exiting the shock tube loaded the fluid in the 
sealed receiver, translating it to a fluid-pressure wave that interacted with the sample housed 
within.  This transfer of the pressure wave across media to a nearly incompressible fluid is 
essential given that the brain is loaded from real-world blast exposure following a transfer of the 
in-air shock wave across the skull to the nearly incompressible brain within.  The pressure profile 
experienced by the samples closely matches that of in situ intracranial pressure traces following 
blast exposure. 24, 31, 32  Additionally, the materials within our fluid-filled receiver that reduced 
bulk fluid-flow and isolated the sample were chosen because they matched the impedance of 
water.  Matching the impedance of these materials to the fluid in the receiver was necessary to 1) 
prevent attenuation of the pressure wave as it passed through these materials and 2) prevent 
reflections that could additionally load the sample.  In this way, we were able to correlate the 
biological response of the OHSCs to specific biomechanical parameters of the shock wave 
generated by the shock tube and the resultant fluid pressure wave that passed through the sample.  
Our model was designed such that the shock tube produced a pressure-history much like 
the Friedlander waveform. 32  We then utilized this model for Chapters 3 and 4 to generate a 
tolerance criterion of OHSCs to primary blast and characterize changes in pathology and 
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electrophysiology from repetitive primary blast exposure.  In this thesis, the range of peak 
overpressures tested was 92.7 - 534 kPa, the range of durations tested was 0.25 - 2.3 ms, and the 
range of impulses was 9.2 - 248 kPa·ms (Table 1), which mimic exposure conditions from a 
small mortar round (M49A4 60 mm mortar, standoff distance 0.25-2 m) to a large bomb (M118 
bomb, standoff distance 10-32 m; CONWEP).  These parameters all fall within a range that 
service members may encounter when on duty.  Given that the tissue samples used in these 
studies were derived from the rat brain, we could use Bowen scaling to the mass of the rat brain 
to interpret these blast levels, and this scaling demonstrates that our parameters fall within a 
range for real-world blast exposure. 131   
 
7.2 Isolated primary blast exposure resulted in neurodegeneration in OHSCs 
In Chapter 3 we identified a threshold for blast-induced cell death in OHSCs between 
Level 7 and Level 8 (Table 1).  The delayed progression of cell death following primary blast 
may allow valuable time for effective therapeutic administration to reverse or prevent injury.  
Although there are no FDA-approved therapies that target biochemical sequelae of TBI, different 
compounds such as n-acetyl cysteine, exendin-4, and neurosteroids have had success in 
experimental studies of blast and brain injury. 263, 264, 265  In Chapter 6 we showed delayed 
administration of memantine was effective at mitigating LTP deficits, cell loss, and astrogliosis 
from repetitive mild stretch injury; future studies should evaluate memantine and primary blast 
exposure.  
Additionally in Chapter 3 we observed changes in basal evoked function following 
primary blast (Levels 4 and 9). 66, 216  This was the first study in the literature to report that 
isolated primary blast can cause both cell death and altered neuron function in OHSCs.  Our data 
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suggest that neuron function may be a more sensitive outcome measure than cell death for 
assessing injury from primary blast exposure given that changes in neuron function were 
observed following Level 4 blast exposure below the threshold for cell death. 216  A functional 
tolerance criterion for OHSCs to primary blast developed in our laboratory, not presented in this 
thesis, also reported that the threshold for primary blast-induced changes in neuron function was 
below that of cell death and that LTP may be highly vulnerable to primary blast. 164   
Since publication of the studies in Chapter 3, there remains relatively little data in the 
literature on specific impairments to the hippocampal circuitry from primary blast.  In another 
study, LTP measured in acute mouse hippocampal slices was reduced by a single, in vivo blast 
(167 kPa·ms) out to 4 weeks following exposure accompanied by astrogliosis, axonal injury, and 
cell loss. 28   These results are difficult to interpret further because the head was additionally 
exposed to tertiary blast and allowed to accelerate / decelerate during the blast exposure. LTP 
deficits were not observed when the head was restrained; thus, observed LTP deficits may have 
been, at least in part, due to brain deformation caused by tertiary blast. 42 Another in vivo blast 
injury study reported an increase in potentiation following exposure to a single blast and a 
decrease in potentiation following exposure to three blasts.  Again, confounding effects of rapid 
head motion may have influenced these seemingly contradictory results. 172   Rapid head motion 
resulting in inertial loading of the brain is well known to reduce potentiation in vivo and can be 
accompanied by cell loss. 172, 173, 174, 175, 176, 177  Other in vitro studies with OHSCs have reported 
significant reductions in LTP following barotrauma, which like our studies exposed OHSCs to a 
pressure wave in fluid; however, this pressure history had a different profile with a much longer 
duration and lower peak pressure. 178, 179, 180, 181, 182  There is precedent for observing deficits in 
neuron function after injury without significant cell loss.  One study reported reduced capacity 
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for experience-dependent plasticity in rats following fluid percussion injury (FPI) without neuron 
loss, and a second study reported deficits in working memory in rats subjected to mild and 
moderate FPI for at least 15 days following exposure without neuron loss. 183, 184   
 
7.3 Repetitive primary blast exposure exacerbated loss of long-term potentiation 
without cell loss 
In Chapter 4 we investigated the effect of repetitive primary blast on OHSCs, evaluating 
cell loss, neuron cytoskeletal structure, gliosis, and neuron function.  This was the first study in 
the literature to report that multiple primary blasts delivered closely in time can interact resulting 
in worse outcomes. 216   From our studies, this phenomenon was observed for a Level 2 exposure.  
A single Level 2 primary blast did not significantly alter LTP; however 2 primary blasts 
delivered 24 or 72-hours apart resulted in significant and nearly complete loss of LTP.  This 
phenomenon was not observed for 2 injuries delivered 144-hours apart. 216  Our data suggests that 
an initial primary blast initiates a period of vulnerability during which additional exposure can 
result in significant damage to plasticity and that 144-hours may be a sufficient delay between 
exposures to mitigate this phenomenon.  It is unknown what biochemical or mechanical 
mechanism is responsible for this unique response.  A similar phenomenon has been reported in 
the literature for other types of trauma, such as closed head injury (tertiary blast), and oxidative 
stress and metabolic dysfunction have been suggested to mediate this response. 46  This 
mechanism will be discussed further in sub-chapter 7.4 for repetitive stretch injury. 
In Chapter 3 we reported that a single Level 4 primary blast significantly altered 
stimulus-response parameters (I50 , Rmax) of OHSCs. 66   Yet, in Chapter 4 we observed no change 
in basal evoked response for samples that received one or two Level 2 primary blasts. 216   One 
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conclusion from these data may be that a threshold for primary blast-induced changes in 
stimulus-response may fall between Levels 2 and 4.  However, it is important to note that 
subsequent to publishing the data presented in Chapter 3, electrophysiology analytical methods 
were adjusted.  These new methods were used to generate a functional tolerance criterion of 
OHSCs to a range of primary blast levels, not presented in this thesis, and to generate the data 
presented in Chapter 4.  From the primary blast functional tolerance criterion, we observed no 
change in stimulus-response or short-term plasticity (PPRs) subsequent to a single primary blast 
exposure at any level (Levels 1 to 9); however primary blast did cause LTP loss in a dose-
dependent manner with increasing blast impulse. 164   Given findings from this tolerance criteria 
and our data in Chapter 4, we conclude that a single exposure to any of our nine levels of blast 
does not significantly alter basal evoked function and neither does repetitive exposure to Level 2 
primary blast. 216   
Finite element analysis of our shock tube and in vitro receiver model predicts OHSCs 
exposed to primary blast levels we employed experience less than 5% strain, 80 s -1 strain rate 
deformation. 31  A cell death tolerance criterion for OHSCs to stretch injury previously developed 
in our laboratory reports that stretch injury of this severity would not result in cell death.  
However, the functional tolerance criterion developed for OHSCs with stretch injury was not 
developed with strain rates over 30 s-1, so it is difficult to determine if this functional tolerance 
criterion corroborates our findings.  A LTP tolerance criterion for stretch injury has not been 
developed at this time to the best of our knowledge. 
No change in basal function (S-R parameters) was observed, which may suggest 
repetitive injury did not cause significant loss of cells or damage to axons and dendrites.  We 
further interrogated this theory using immunohistology and histology; axons, dendrites, and cell 
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bodies were largely intact and appeared unaffected by repetitive Level 2 blast.  Unaltered short-
term plasticity (PPR) suggests that pre-synaptic signaling was unaffected by primary blast.  
Taken together, these findings suggest that primary blast may disrupt a sub-cellular post-synaptic 
mechanism important for LTP.  The mechanism for the observed LTP deficit from primary blast 
is unclear, yet potential mechanisms for this pathology will be discussed in sub-chapter 7.5.2.   
Because LTP may be modified without significant disruption of cell structure or basal 
evoked function, LTP may be a highly sensitive outcome measure for assessing the brain’s 
response to primary blast exposure.  Service members exposed to blast experience deficits in 
short-term memory formation, and LTP is considered an in vitro correlate for learning and 
memory. 18, 67, 266  We might speculate that our data supports clinical findings and that observed 
memory deficits among injured service members may be, at least in part, due to shock wave 
exposure.  This connection would strengthen the validity of the model and provide further 
evidence that headgear and other safety procedures for service members should be modified to 
prevent or minimize shock wave exposure.  However, it is difficult to directly compare the 
results of our study generated in the laboratory using in vitro OHSCs derived from rat brain 
directly to the soldier’s experience. 266   We identified that the primary blast can cause injury to 
OHSCs and that a delay between repetitive primary blast exposures can mitigate worse outcomes 
from multiple injuries.  However, further clinical studies are necessary to determine if this occurs 
in humans, and if it does, translational studies are necessary to identify human-appropriate safety 
standards. 
Repetitive primary blast exposure also increased microglia activation.  Microglia can 
migrate to the site of injury and release cytokines that can further exacerbate injury. 193, 267   As 
discussed in Chapter 4, other studies report microglia activation following blast exposure; 
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however, these studies employed complex blast loading, which makes it challenging to separate 
the contribution of primary from tertiary blast. 170, 191  Of particular interest, an in vivo study 
reported microglia activation (IBA1) without increased astrogliosis (GFAP) in rats 7 days 
following low-level exposure (69 kPa, 5.5 ms) similar to our findings. 192  Characterization of 
microglia in OHSCs suggests that they behave and respond to injury much like in vivo. 194, 
195  Microglia may influence changes in hippocampal plasticity and synaptic pruning. 197, 
198  Microglia have been shown to monitor neurons in their micro-environment, and increased 
contact of activated microglia with neurons can decrease potentiation. 199   In the mouse primary 
visual cortex, it was observed that increased microglia contact with synaptic elements resulted in 
a prolonged reduction in size or elimination of dendritic spines. 199   Loss of dendritic spines or 
abnormalities can negatively impact LTP. 200  Increased presence of microglia and activated 
microglia following repetitive primary blast suggests not only that primary blast initiates an 
immune response but also that the functional changes observed following blast may at least in 
part be due to this immune response.  Studies are necessary to determine if primary blast 
increases microglia activation in humans, and if it does, service members exposed to blast may 
benefit from treatment that targets the immune response after injury  
 
7.4 Repetitive mild stretch injury results in deficits in long-term potentiation and 
synergistic cell loss 
Given that service members may experience a complex combination of primary and 
tertiary blast loading, in Chapter 5 we utilized a well-characterized in vitro model of inertial-
loading (stretch injury) with OHSCs to better understand the similarities and differences in the 
pathologies that result from the unique mechanics of primary blast and tertiary blast on brain 
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separately.  Improved understanding of these pathologies will serve as a foundation for 
interpreting pathologies resulting from unique combinations of primary and tertiary blast 
exposure. 
In Chapter 5, a single mild stretch injury did not result in significant cell loss, change in 
nitrite concentration, altered LTP, disruption of pNF-H, NF-H, and MAP-2, and gliosis.  The 
strain and strain rate (~12.9% strain, 5.3 s-1 strain rate) were chosen a priori from a tolerance 
criterion for OHSCs such that a single exposure resulted in minimal pathology in OHSCs and for 
their relevance to real-world loading conditions. 167, 217, 219, 227, 228, 255, 268, 269  However, a single 
mild stretch injury initiated a period of time during which OHSCs were more vulnerable to 
additional stretch.  In our studies, a significant increase in cell death and nitrite production was 
observed for two injuries delivered 24 hours apart, and a significant loss of LTP and astrogliosis 
was observed for 2 injuries 24- and 72-hours apart.  These findings suggest that an initial mild 
stretch injury initiated a period of time during which additional stretch injury would result in 
worse outcomes, and 144 hours may be a sufficient delay between repetitive exposures to 
prevent significant injury from multiple mild stretch injuries.  As discussed previously, other 
experimental studies report a similar phenomenon for repetitive closed-head injury. 47, 236, 237, 238, 
239  Dissociated hippocampal cells had increased vulnerability, indicated by loss of MAP-2 
immunoreactivity for at least one hour but not longer than 24 hours from repetitive stretch injury. 
45  Controlled cortical impact (CCI) or lateral fluid percussion (LFP) injury resulted in a period of 
heightened vulnerability to additional mechanical trauma that lasted at least 3 days. 43, 175, 240, 
241  Clinical studies suggest that this period of vulnerability to additional closed-head injury may 
last for over 15 days following the initial concussion. 47, 236, 237, 238, 239   
Preclinical studies suggest oxidative stress and metabolic dysfunction may mediate this 
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period of repetitive injury vulnerability.  Metabolic dysfunction can lead to oxidative stress and 
increased production of reactive oxygen species (ROS) and oxidative end-products, such as 
nitrite. 270   Damage to the mitochondria and production of oxidative stress products have been 
observed in many studies both in vivo and in vitro following TBI; even mild mechanical 
stimulation of the brain or brain cells can initiate changes in ROS that can persist for days. 46, 
160  In a study of repetitive fluid percussive injury, repetitive injury significantly increased 
presence of activated glia, which release ROS, and lipid peroxidation, an end-product of 
oxidative stress caused by oxidative degradation of cell membrane lipids. 249  In a different study, 
oxidative and nitrosative stress was evaluated in rats receiving two diffuse mTBIs with variable 
inter-injury intervals. 271  Ascorbic acid, glutathione, malondialdehyde, nitrite, and nitrate were 
significantly different from sham-control levels when repetitive injuries were delivered up to 
three days apart but had mostly returned to sham-control levels for the five day inter-injury 
interval. 271  In a study of dissociated cortical neurons in culture, neurons had enhanced 
vulnerability to NMDA exposure following an initial mild stretch injury; however, treatment 
with L-NAME, a nitric oxide (NO) synthase inhibitor mitigated this effect, suggesting that 
enhanced vulnerability of cortical neurons following stretch may be mediated by NO. 246   Nitrite 
is an end-product of NO metabolism, and we showed in Chapter 5 nitrite increased significantly 
following repetitive injury with a 24-hour inter-injury interval. 270   Thus, indicators of oxidative 
stress may be promising biomarkers for diagnosing injury, whereas ROS-generating mechanisms 
may be promising therapeutic targets. 249, 250, 251  Our study provides more evidence for the 
association of repetitive injury vulnerability and metabolic dysfunction; however, we did not 
report that this pathway was the cause of this injury response.  Further studies are necessary to 
determine clinically what mechanism may mediate vulnerability to repetitive injury. 
145 
	
Repetitive mild stretch injury modified LTP for the 24- and 72-hour inter-injury intervals, 
and repetitive mild stretch injury modified LTP without significant cell loss for the 72-hour 
interval.  There were largely no changes in basal evoked function for any of the paradigms 
evaluated in Chapter 5.  This suggests that LTP is more sensitive to tertiary blast than basal 
evoked function or cell loss.  LTP was more vulnerable to repetitive tertiary blast for a longer 
period of time than cell death, nitrite production, and dendritic damage.  Other studies suggest 
that LTP may be modified by mechanical trauma without changes in basal evoked function or 
significant cell loss as discussed in sub-chapter 7.3.  These data further support the theory that 
LTP is a highly sensitive measure of mechanical trauma, which can be modified independent of 
cell loss or altered basal evoked function.   
Astrogliosis was also observed following repetitive injury with a 24- and 72-hour inter-
injury interval but not for the 144-hour interval.  Stretch injury of isolated primary astrocytes can 
initiate astrocyte activation. 247  Additionally, astrocytes can modulate neuron function, 
synaptogenesis, and neural plasticity. 272, 273  Activated astrocytes produce pro-inflammatory 
factors tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β), which when exposed 
to neurons have been shown to mediate LTP loss via p38 mitogen-activated protein kinase (p38 
MAPK). 274, 275  P38 MAPK can cause LTP deficits via endocytosis of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptors (AMPARs) from the post-synaptic density, increased 
GABAergic signaling, and inhibition of voltage-dependent calcium channels. 274, 275  Patients 
diagnosed with mild or moderate TBI had an increase of GFAP breakdown products in their 
plasma and symptoms indicative of damage to the hippocampus and neural plasticity. 276, 
277  These findings correlate tertiary blast exposure with astrogliosis and neuron dysfunction; yet 
we do not know the cause for tertiary blast to result in this pathology specifically.  We may 
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speculate that for TBI patients, astrogliosis can be highly influential or detrimental to the 
neuronal response to injury, potentially influencing, at least in part, significant deficits in 
cognition and memory.  
 
7.5 Comparison of pathologies from primary blast and tertiary blast exposure 
7.5.1 Cell death and cytoskeletal proteins 
In Chapter 3, a high intensity Level 9 primary blast, which is equivalent to exposure to a 
M118 Bomb with a 10-32 m standoff distance (CONWEP), resulted in a maximum of roughly 
14% cell death in the CA1, 9% in the DG, and 7% in the CA3. 66  It is predicted that this level of 
blast deformed the tissue with less than 5% strain at 80 s-1 strain rate. 31  For comparison, a high 
intensity stretch injury of 50% strain, 50 s-1 strain rate generated over 45% cell death in the CA1 
of OHSCs. 124  Thus, a single high intensity primary blast exposure, which is low strain and high 
strain rate, produced less cell death than a high intensity stretch injury, which was high strain and 
high strain rate.  Additionally, in Chapter 4 repetitive low-level primary blast (Level 2) did not 
exacerbate cell loss; however, in Chapter 5 repetitive low-level tertiary blast significantly and 
synergistically increased cell death.  This suggests that cell death indicated by increased PI 
staining may be more closely associated with strain than strain rate regardless of the impetus for 
the mechanical load (primary blast versus tertiary blast).  A tolerance criterion for OHSCs to 
stretch injury supports this theory and reported that cell death was associated with strain, 
independent of strain rate. 129  The predicted deformation of our samples exposed to primary blast 
was less than 5% strain at 80 s-1, and our stretch injury was 12.9% strain at 5.3 s -1. 31  A single 
exposure to either injury did not result in cell loss; however repetitive stretch injury exposure 
with a 24-hour interval did result in cell loss.  Therefore, 5% strain may be sub-threshold for 
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causing cell death even with repetitive injury 24-hours apart.  An initial stretch injury may 
reduce tolerance of OHSCs such that a second exposure 24-hours later is injurious. 
Observed cell loss from either shock wave exposure or stretch injury developed slowly 
over four days following injury. 66, 124, 126  Protracted development of cell death suggests that cell 
loss was the result of slowly developing second messenger signaling and not primary injury or 
dramatic rupture of cell membranes.  As a comparison, cell death resulting from controlled 
cortical impact (CCI) has been observed as soon as 1 hour following CCI. 278   However, one 
limitation of CCI is that it delivers a focal impact directly to the brain tissue, resulting in 
significant tissue loss and damage at the impact site.  Thus CCI cell loss may be due to dramatic 
mechanical forces pulling the cells apart and may not accurately reflect the pathobiology of 
tertiary injury at the impact site.  As discussed in 7.2, slowly developing cell loss suggests there 
may be potential for delivery of therapeutic intervention to prevent cell loss from either 
mechanical injury. 
In Chapter 4 and Chapter 5, a single low-level primary blast and a single low-level 
tertiary blast exposure did not significantly alter immunoreactivity for neuron cytoskeletal 
proteins MAP-2 or pNF-H.  It is unclear what effect higher intensity primary blast exposure may 
have on these cytoskeletal proteins.  Those studies that have investigated changes in 
immunoreactivity for these proteins following blast employed complex blast loading. 28, 168, 169, 
171  The tertiary component of the exposure may have caused this pathology.  There is a large 
body of evidence in the literature that moderate or severe closed-head injuries can alter 
immunoreactivity for axon and dendrite cytoskeletal proteins. 252, 253, 254, 255  We may not have 
observed significant changes in immunoreactivity for these cytoskeletal proteins following single 
exposure to low-level primary or tertiary blast because we were below a threshold for their 
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damage; we did not observe cell death at these levels of exposure as well.  In Chapter 5, MAP-2 
immunoreactivity decreased significantly with repetitive, low-level tertiary blast exposure.  This 
highlights the dearth of knowledge on the effect of isolated primary blast on cytoskeletal 
structural proteins.  More studies are necessary to determine if and how primary blast may cause 
damage to the cytoskeletal structure. 
 
7.5.2 Long-term potentiation 
In Chapters 4, 5, and 6, both primary and tertiary blast resulted in LTP deficits.  Other 
studies in the literature suggest that mechanical brain trauma of different types can alter LTP,  172, 
243, 244, 245  and previous experimental studies report that repetitive injury can result in LTP loss. 
172  As discussed previously, LTP can be modified without significant cell loss or change in basal 
evoked function. 183, 184, 279  Additionally, of all the outcome measures used to assess injury in 
Chapters 3 and 5, LTP required the longest delay between exposures to mitigate significant LTP 
loss from repetitive injuries.  This suggests that not only is LTP highly vulnerable to trauma but 
it has  a slower time course for recovery following trauma. 
Additional studies are necessary to determine the biochemical mechanism for LTP loss 
from primary and tertiary blast exposure.  For the 24-hour inter-injury interval, repetitive 
primary blast significantly altered LTP without significant cell death; however, repetitive tertiary 
blast significantly altered LTP and increased cell death.  This suggests there may be different 
pathways for LTP loss and injury that result from primary blast and tertiary blast.  
We speculate that primary blast leads to a low-level, tonic increase in calcium at the PSD 
that can increase activity of calcineurin leading to de-phosphorylation of cAMP-dependent 
protein kinase (cAMP/PKA) and degradation of post-synaptic density protein 95 (PSD-95), 
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which is necessary for increasing AMPAR expression in the post-synaptic membrane and LTP 
induction. 280, 281, 282, 283   Low-level NMDAR-activation resulting in low-level calcium at the PSD 
may also lead to ubiquitinization and degradation of PSD-95. 283   In a parallel study performed in 
our laboratory, not presented in this thesis, primary blast exposure decreased PSD-95 expression, 
supporting our speculation, and did not affect expression of Ca2+/calmodulin-dependent protein 
kinase II  (CAMKII) or phosphorylated CAMKII (pCAMKII), which are necessary for initial 
activation of the biochemical cascade that leads to LTP induction. 284   This result suggests that 
primary blast does not prevent initial, significant influx of calcium into the PSD following high 
frequency stimulation (HFS) leading to phosphorylation of CAMKII.  It was not determined in 
that study if pCAMKII bound NMDARs following primary blast.  This binding is necessary to 
further increase calcium at the PSD, leading to AMPAR insertion at the PSD and LTP.  If 
primary blast leads to an inability of pCAMKII to bind to NMDARs at the PSD, persistent and 
low-level calcium at the PSD may lead to PSD-95 degradation.  In a study of cortical neurons, 
suppression of PSD-95 prevented NO-toxicity resulting from NMDAR activation. 285   Repetitive 
primary blast did not alter cell death but did significantly alter LTP.  We speculate that primary 
blast results in LTP loss without cell death by decreasing PSD-95 expression thereby preventing 
cell death that may have otherwise resulted from NO-toxicity.  Therapeutics targeting de-
phosphorylation of cAMP/PKA, calcineurin, or ubiquitinization of PSD-95 may be valuable for 
mitigating LTP loss from primary blast. 
We postulate that tertiary blast leads to compromise of excitatory receptors at the post-
synaptic membrane resulting in insufficient calcium entering the PSD following HFS such that 
CAMKII cannot auto-phosphorylate and LTP is not induced.  In an in vivo study, following 
fluid-percussion injury, which reproduces the pathology of tertiary blast exposure, NMDA 
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potential, NMDA current amplitude, and AMPA-mediated current were diminished, suggesting 
that HFS may not allow for sufficient calcium at the PSD to initiate CAMKII auto-
phosphorylation. 286  Additionally, expression of CAMKII decreased following FPI. 
286  Reduction of CAMKII may lead to changes in dendritic spines that can also affect LTP; an 
increase in size of dendritic spines was observed following FPI in that study as well. 286, 
287  Therefore, therapeutics that prevent compromise of NMDARs or AMPARs or prevent loss of 
CAMKII may be effective at preventing LTP-loss after tertiary blast exposure.  
Additionally, as discussed previously, repetitive mTBIs resulting in significant neural 
injury has been associated with metabolic dysfunction and oxidative stress.  Preclinical studies 
suggest that TBI resulting in oxidative stress can modify post-synaptic proteins important to LTP 
induction, including PSD-95. 288, 289 Following contusive injury, glutathione (GSH) decreased 
significantly as soon as 3 hours post-injury, persisting for 96 hours post-injury; glutathione 
peroxidase, glutathione reductase, glutathione-S-transferease, and glucose-6-phosphate 
dehydrogenase activity were all significantly decreased compared to sham-levels at 12-72 hours 
post-injury. 288  Significant reductions of PSD-95, synapsin I, and synapse-associated protein 97 
were observed as soon as 24 hours post-injury.  Therefore, oxidative stress may be an alternative 
or a complementary mechanism, in addition to those mechanisms just described, for LTP 
reduction following repetitive mTBI for primary or tertiary blast.  The duration of impairment of 
GSH, glutathione peroxidase, glutathione reductase, glutathione-S-transferease, and glucose-6-
phosphate dehydrogenase, mirrors the duration of vulnerability for repetitive injuries (primary 
blast or tertiary blast) that we reported in Chapter 4 and 5.  If oxidative stress is an influential 
mechanism for this phenomenon of repetitive mTBI, the duration of vulnerability for repetitive 
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mTBI may be rooted in deficits in GSH and related enzymes that prevent oxidation.  For this 
mechanism of injury, antioxidant treatment may be an important therapeutic for rescuing LTP. 
LTP may be a highly sensitive indicator of injury because many different injury 
responses can have downstream effects on LTP.  As discussed previously, microglia and 
astrocytes interact with neurons in their micro-environment and, upon activation, can inhibit 
plasticity.  193, 273, 274  As just discussed, the sub-cellular proteins important to LTP induction may 
have unique sensitivities to mechanical injury. 283, 286  Additionally, injury can lead to circuit 
remodeling and oxidative stress, influencing changes in neuronal circuit function. 288, 290  A more 
detailed study of these mechanisms in relation to primary blast and tertiary blast separately may 
aid in elucidating the mechanisms for unique sensitivity of LTP to injury, important therapeutic 
targets to prevent LTP loss from injury, and the time course for recovery of this injury 
mechanism so as to more accurately define the duration of vulnerability following mTBI.  
 
7.5.3 Glial response to injury 
No significant change in glial response was observed following a single, low-level 
exposure to primary or tertiary blast.  Repetitive, low-level primary blast injury increased IBA1 
immunoreactivity and presence of IBA1-positive cells with activated microglia morphology but 
did not effect changes in astroglial response.  Conversely, repetitive, low-level tertiary blast 
exposure significantly increased GFAP immunoreactivity, indicating astrogliosis, but did not 
effect a change in microglial response.  This result suggests that astrocytes and microglia 
respond differently to the unique biomechanical loading profiles of primary and tertiary blast. 
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Following trauma, glia are activated.  It has been suggested that microglia are first 
activated, migrating to the site of injury and releasing cytokines that can activate astrocytes. 
273  Microglia and astrocytes respond to injury within minutes following trauma.  We evaluated 
immunohistology of our samples at least three days following the second injury or sham 
exposure.  Astrocytes and glia can become inactivated, so at this time point we may be observing 
a sustained response of glia to trauma. 291, 292  For Chapter 4, it may be possible that astrocytes 
either were not activated by injury or were activated and became inactive over three days 
following trauma such that we only observed persistent microglia activation following repetitive 
primary blast.  Assuming that microglia are activated prior to astrocytes, for Chapter 5 and 6, it 
may be possible that microglia were activated and became inactive over three days following 
trauma such that we only observed persistent astrocyte activation following repetitive primary 
blast.  Prolonged activation of either microglia or astrocytes can have a long-term damaging 
effect on the brain.  As discussed previously, activated astrocytes and microglia can negatively 
impact neuron function, and continued activation of astrocytes and result in formation of a glial 
scar that can have long-term negative effects on cognition. 293, 294  Thus, antioxidant treatments 
for repetitive primary blast and anti-inflammatory treatments for repetitive tertiary blast may be 
important for preventing persistent glia activation and from repetitive mTBI. 
Other studies suggest blast exposure can initiate a glial response; however these studies 
employed complex blast loading. 26, 170, 191  It is well studied in the literature that closed-head 
injuries can initiate a glial response. 190, 193, 194, 197, 199  In vivo studies of single and repetitive 
mTBI (primary and tertiary blast) may result in damage to the BBB, which can independently 
result in gliosis. 26, 170, 191, 193   It is well known that blood-serum constituents can cause injury to 
brain cells and initiate a glial response. 256  However, we observed activation of microglia by a 
153 
	
pressure impulse in the absence of BBB opening.  Our studies interrogate the response of glia in 
OHSCs to mechanical loading alone.   
Primary blast was predicted to injure OHSCs at 5% strain, 80 s-1 rate, and tertiary blast 
deformed OHSCs with 12.9% strain at 5.3 s-1.  Thus, microglia may be more sensitive to a high 
strain rate exposure, and astrocytes may be more sensitive to strains in excess of 5% regardless 
of the strain rate.  A tolerance criteria of isolated primary astrocytes to shear from fluid flow 
suggests that shear at or above 11.5 dyn/cm2 applied for 10 ms can cause significant influx of 
calcium ion, and increasing the rate of the ramp up to maximum applied shear can increase 
calcium ion influx. 295  Unfortunately tolerance of the cells based on their deformation was not 
reported, but this study does suggest that astrocytes are mechano-sensitive with rate sensitivity.  
Other studies have investigated the effect of stretch injury on isolated astrocyte cultures.  A 30% 
strain, 20 s -1 strain rate injury of primary astrocytes significantly increase nitrite and GAG 
production. 247  To the best of our knowledge, the effect of stretch injury on isolated microglia 
cultures has not been studied, highlighting an area for further research to improve understanding 
of microglial and astroglial response to mechanical trauma. 
 
7.6 Clinical perspective on experimental findings 
Breachers are service members with specialized training to use explosives and artillery to 
penetrate closed perimeters and gain entry into locked spaces.  Breachers stand a specific 
distance from placement of an explosive prior to detonation that has been deemed to be sufficient 
to prevent injury from debris or blunt impact.  Thus, breachers are regularly exposed to low-level 
primary blast exposure.  At a 2008 multi-national military meeting, representatives from the US, 
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Canada, and New Zealand each presented anecdotal reports of breachers reporting symptoms 
much like those that result from concussion or repetitive exposure to concussion, informally 
called “breachers brain.”  67  These symptoms include headache, fatigue, and difficulty 
remembering or thinking. 67  Unlike sport-related concussion, these symptoms developed without 
blunt impact to the head.  This anecdotal evidence suggests primary blast may cause brain injury, 
and symptoms of “breachers brain,” which include difficulty thinking or remembering, may 
suggest deficits in plasticity or dysfunction of the hippocampus.  Data presented in Chapters 2, 3 
and 4, suggest that primary blast exposure can result in neurodegeneration and changes in neuron 
function, and we identified a unique phenomenon wherein repetitive low-level, primary blast 
exposure delivered closely in time can interact resulting in significant loss of plasticity for 
OHSCs.  Therefore, clinical and preclinical studies should further evaluate the potential for 
primary blast, or shock wave loading, to cause damage to the brain under conditions relevant to 
breachers and military conditions.   
Repetitive tertiary blast injury is biomechanical trauma to the brain like blunt impact, 
which can be considered similar to sport-related concussion.  Our studies of tertiary blast in 
Chapter 5 and 6 suggests that a single mild stretch injury can result in minimal change in 
pathology and neuron function; however multiple stretch injuries delivered closely in time can 
interact, resulting in significant cell loss, oxidative stress, and loss of plasticity.  Clinical studies 
suggest that for the injured athlete, with each additional concussion, symptom severity and 
recovery time increases.  Our findings identified in OHSCs along with these clinical studies 
suggest further work should focus on improved understanding of this phenomenon clinically so 




7.7 Strategies to mitigate worse outcomes from multiple mTBIs 
Current strategies to treat concussion or mitigate worse outcomes from multiple 
concussions, whether for the soldier or civilian, include rest, removal from activities where 
another injury may be sustained, and pain relief from headache. 11, 48   
 
7.7.1 Rest periods to prevent synergistic injury response to repetitive mild traumatic brain 
injury 
The soldier that reports a potential brain injury undergoes physician assessment and is 
removed from duty for 24 hours.  11  If the soldier does not report a TBI, he or she may remain on 
duty with the potential for subsequent exposure.  Similarly, for the injured athlete, physician 
assessment is used to categorize injury, and rest is prescribed.  Professional athletes in the NFL 
who experience concussion with similar biomechanics to those of mild stretch injury are 
removed from activity until symptoms abate, typically one week. 48   
We report that a delay of 144 hours may be sufficient to prevent interaction of repetitive 
mild injuries.  Other preclinical and clinical studies suggest that a delay of 24 hours to 15 days is 
necessary following an initial tertiary blast to prevent significant injury from additional mTBI. 47, 
236, 237, 238, 239  Although it is difficult to precisely relate the time course of pathology development 
in vitro or in rodents to that of a human, it is evident that the time course of brain maturation in 
animals is accelerated as compared to humans. 231, 296  Therefore, we may speculate that the inter-
injury intervals that result in worse outcomes in our studies may be longer in humans.  It is 
possible that rest periods following concussion to prevent more significant deficits from multiple 
mTBIs may need to be longer than 144-hours (6 days).  More studies are necessary to evaluate 




7.7.2 Memantine and other therapeutic strategies to mitigate worse outcomes from repetitive 
mild stretch injury 
There are no FDA-approved therapies that target the biochemical sequelae of TBI that 
can be administered to prevent or reverse neurodegeneration or altered brain function from 
mechanical trauma.  At this time, the National Institutes of Health identifies 643 interventional 
studies underway for TBI.  There are three clinical studies investigating memantine for traumatic 
brain injury.  One study was terminated due to low patient enrollment; however, results from this 
study of 11 patients with mild to moderate TBI suggest that 6-12 weeks of memantine improved 
visuospatial memory, trail making, verbal learning, and executive function with no adverse 
events. 297  
Our in vitro data suggests that memantine may prevent significant loss of cells and 
altered neuron function when administered 1 hour following each of 2 mild stretch injuries 
delivered 24 hours apart, as reported in Chapter 6.  NMDA antagonists that block excitotoxic 
glutamate have been tested preclinically with success in preventing injury from TBI, hypoxia, 
and ischemia. 53, 58, 262  Memantine was chosen because it has minimal side effects as compared to 
other NMDA antagonists, and it is FDA approved for mild to moderate AD.  
Additionally, experimental data suggest that concussion may alter metabolic function that 
can influence repetitive injury resulting in worse outcomes. 160   In Chapter 5 we reported that 
repetitive mild stretch injury resulted in an increase in nitrite concentration.  As previously 
discussed, other studies similarly suggest that repetitive mTBI initiates an inflammatory and 
oxidative stress response, which suggests an antioxidant or anti-inflammatory intervention may 
be beneficial for preventing significant injury from multiple injuries.  In fact, progesterone was 
successful in a preclinical study of repetitive mTBI, reducing lipid peroxidation, activation of 
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microglia and astrocytes, and neurodegeneration; however, progesterone ultimately did not show 
efficacy in clinical trials. 249, 298    
As discussed in sub-chapter 7.4, NMDAR-mediated injury produces NO via neural NO 
synthase. 299, 300  Heightened vulnerability to NMDA following stretch injury was prevented in 
neurons treated with L-NAME, a NO synthase inhibitor, and was exacerbated in neurons treated 
with sodium nitroprusside, a NO donor. 246   In a separate study by the same group, heightened 
vulnerability following mild stretch injury was shown to specifically be mediated by NMDARs 
because neither kainite nor the calcium ion ionophare A23187 resulted in a synergistic injury 
response following an initial mild stretch injury. 301   We would postulate that interaction of 
repetitive mTBIs is mediated by NMDAR activation leading to oxidative stress, and our data 
from Chapter 5 and Chapter 6 may support this theory.  In Chapter 5 we reported that repetitive 
mild stretch injury with a 24-hour interval significantly increased nitrite and resulted in worse 
outcomes for LTP and cell death, and in Chapter 6 we report that the NMDAR antagonist 
memantine significantly prevented worse outcomes from repetitive stretch injury. We did not 
evaluate the effect of memantine on nitrite production.  This is an area of study with the potential 




As described in Chapter 2, levels of blast used in this thesis fall between human-relevant 
exposure levels and relevant levels of blast scaled to the rat. 32, 130, 131  However, in our receiver 
design, the in-fluid pressure wave travels through 8 cm of water before interacting with the 
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sample, and the sample is housed within a receiver containing over 57 L of water.  These 
conditions may require alternate scaling to interpret the blast levels employed.   
Additionally, we predicted that samples exposed to any level of primary blast experienced 
strains below 5% and strain rates were below 80 s-1 based on finite element modeling of our 
experimental set-up. 31  However, we have not yet directly measured the strain and strain rate 
experienced by the samples during blast exposure in our experimental set-up. 
In each of these studies, we have investigated the effects of mechanical loading on in vitro 
samples of the hippocampus.  Loading of the whole brain, head, and body may influence the 
brain’s injury response and resultant set of symptoms.  Therefore, our conclusions must be 
limited to the inherent response of the rat hippocampus.  Studying the injury response of the 
whole animal is important for translation of our findings to the human to determine appropriate 
safe rest-periods or test potential therapeutics for the injured soldier or athlete. 
OHSCs were harvested at age P8-10 and maintained until P30-32 until experiments were 
completed.  Developmentally for the rodent, P30-32 is a stage of maturity just approaching 
adulthood, and in relation to the human brain, P30-32 is relevant for studying the juvenile brain 
aged 10-12 years.  Older brain tissue samples would be more appropriate for studying these 
injury paradigms in the context of the adult brain.  However, culturing brain tissue from older 
animals is difficult as OHSCs are most robust and healthy when harvested P8-10.  For this 
reason, our conclusions may be limited to the juvenile brain’s response to injury. 
Injury levels we used in this thesis were chosen based on tolerance criteria for OHSCs to 
primary and tertiary blast as well as data from FEM and video analysis of sports impacts.  There 
are limitations to choosing injury biomechanics based on FEM and video analysis.  For example, 
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several studies have examined systematic as well as large random errors associated with helmet-
based accelerometers. 221, 222, 223  Additionally, parameters extracted from video analysis can be 
limited by the frame rate of the recording and ability to extract three-dimensional measures 
stereographically. 224  Predicting the tissue-level response from macroscopic biomechanics is 
limited by the biofidelity of the FEMs, many of which have not been adequately validated for 
shear strain and are constrained by the limited characterization of brain tissue mechanical 
properties under large deformations at high strain rates. 225, 226   
Real-world sports injuries and blast injuries can be complex.  To better understand the 
brain’s response to real-world loading conditions, it may be necessary to study more complex 
loading profiles than those we used in this thesis.   
Among all electrophysiological data reported in this thesis, we identify abnormal activity 
as that which significantly deviates from the response of naïve or sham-exposed OHSCs.  
General trends in activity relative to these control conditions can suggest injury; for example, a 
decrease in LTP as compared to the control suggests loss of plasticity.  However, it is difficult to 
know what the absolute values of these measures mean and how they may influence or relate to 
functional measures from behavioral studies employed with animals or humans.  
 
7.9 Future Directions 
Future work is warranted to assess the mechanism of LTP loss specific to single and 
repetitive primary blast exposure.  Future studies to identify the mechanism for LTP loss from 
primary blast exposure may aid in identifying therapeutic targets to prevent LTP loss and injury 
from primary blast exposure.  In Chapter 6, we showed a therapeutic benefit of memantine for 
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repetitive stretch injury; however, the primary and tertiary blast may result in LTP loss via 
different biochemical pathways.  We will need to test memantine and other therapies in our 
model of primary blast exposure to determine therapeutics that can prevent injury from primary 
blast.  Improved understanding of the mechanism for primary blast injury may identify 
biomarkers that can be used as a diagnostic indicator of injury to remove the soldier from duty 
and administer treatment as necessary. 
In military theater, the soldier may experience a complex combination of primary and 
tertiary blast exposure.  Future studies to investigate more complex loading conditions may be 
necessary to understand pathologies from complex blast loading.  In vivo studies of blast 
exposure deliver both primary and tertiary blast loading to the animal brain, so there is precedent 
for study of complex blast experimentally.  28, 30, 201  In vitro models of complex blast where 
primary and tertiary loading can be independently modified may help to understand the 
interaction of these distinct mechanical stimuli that results in pathology.   
Primary blast exposure loads the body prior to tertiary blast exposure.  It is possible that 
an initial primary blast exposure may alter the brain’s response to subsequent tertiary blast 
exposure.  Future studies could investigate how primary blast may alter the tolerance of OHSCs 
to tertiary blast.  Currently, OHSCs exposed to primary blast are grown on porous Millipore 
membranes that are minimally stretchable, and OHSCs exposed to stretch injury are grown on 
non-porous, stretchable membranes.  Therefore, the experimental set-up may need to be 
modified to integrate these models. 
In this thesis both the primary blast exposure and the tertiary blast exposure initiated 
different responses from the different ROI for the hippocampus.  The DG, CA1, and CA3 may 
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respond to injury differently because they are comprised of different ratios of neurons and glia 
that may have different vulnerability to injury.  In future studies we could generate primary cell 
cultures and investigate the cell-specific response to primary or tertiary blast separately.  Our 
laboratory has previously studied isolated primary astrocytes and reported that a 30% strain, 20 s-
1 strain rate stretch injury increased production of nitrite and glycosaminoglycans. 247  The unique 
injury response of the ROIs may be due to their differences in mechanical properties.  Our 
laboratory has previously shown that the three ROI have unique mechanical properties relevant 
for stretch injury at post-natal day 10, day 17, and adult. 302   Given that brain tissue properties 
are rate dependent, it is unclear what the ROIs mechanical properties are relevant to primary 
blast exposure. 
Future studies are necessary to identify the biochemical mechanism responsible for 
heightened vulnerability.  Improved understanding of this mechanism will help to identify 
biomarkers for concussion and heightened vulnerability.  These biomarkers can be used to 
accurately and objectively diagnose mTBI and monitor a patient’s recovery through the period of 
heightened vulnerability.  Accurate diagnosis and patient monitoring is essential to remove the 
injured soldier from active duty to prevent synergistic injury response in the event of additional 
concussion.  Better understanding of this mechanism can also identify targets for therapeutic 
intervention to prevent injury from multiple concussions. 
Given that the findings in this thesis are limited to the hippocampus, future studies could 
replicate our work for other regions of the brain in vitro.  Additionally, future studies could 
design complex in vitro models incorporating the hippocampus and other brain regions and an in 
vitro model of the BBB.  We have previously investigated the effect of single and repetitive 
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primary blast exposure on an in vitro model of the BBB,  33, 303  and we have also generated 
tolerance criteria of cortical slice cultures to stretch injury. 128   The results from these in vitro 
studies could be used in the future to design and interpret results from in vitro studies using 
complex biological tissue explants. 
As discussed, our in vitro studies will need to be replicated in vivo to better understand 
the response of the whole brain and animal to single and repetitive primary and tertiary blast 
exposure.  Future in vivo studies will be necessary to translate the rest periods we identified in 
Chapter 4 and Chapter 5 to relevant rest periods for the injured solder or athlete to prevent more 
significant injury from synergistic interaction of multiple injuries.  
 Similarly, memantine will need to be evaluated with in vivo models of repetitive mTBI 
before its benefit in the clinic can be tested.  Previously, monotherapies have not had success 
clinically for treating TBI.  Therefore, combination therapies, which target multiple pathways 
activated by TBI have been studied.  Other studies in our laboratory suggested that memantine 
and 17β estradiol, an estrogen, may successfully prevent injury from moderate to severe stretch 
injury. 258  It may be valuable to investigate memantine in combination, potentially with 17β 
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